{"article": "PMC1325254.txt", "subject": "APOE genotype", "relationship": "RELATED_TREATMENT", "object": "was related to increased risk for AD", "chunk": 1}
{"article": "PMC1325254.txt", "subject": "APOE \u03b54 allele", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased risk of Alzheimer's Disease", "chunk": 2}
{"article": "PMC1325254.txt", "subject": "APOE \u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "Poorer cognitive outcomes", "chunk": 2}
{"article": "PMC1325254.txt", "subject": "BMI", "relationship": "RELATED_PROGNOSIS", "object": "Reduced brain volume", "chunk": 3}
{"article": "PMC1325254.txt", "subject": "BMI", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Brain atrophy", "chunk": 3}
{"article": "PMC1325254.txt", "subject": "BMI", "relationship": "PREDICT", "object": "Increased vulnerability to brain atrophy over subsequent years", "chunk": 3}
{"article": "PMC1325254.txt", "subject": "BMI", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cognitive decline or dementia", "chunk": 3}
{"article": "PMC1325254.txt", "subject": "obesity (classification by the WHO)", "relationship": "INDICATES_PRESENCE_OF", "object": "Greater global brain atrophy", "chunk": 3}
{"article": "PMC1325254.txt", "subject": "BMI", "relationship": "RELATED_TO", "object": "Lesser brain volume", "chunk": 4}
{"article": "PMC1325254.txt", "subject": "BMI", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased risk of adverse consequences related to overweight individuals", "chunk": 4}
{"article": "PMC1325254.txt", "subject": "Elevated BMI", "relationship": "RELATED_PROGNOSIS", "object": "Greater rate of cerebral atrophy over time", "chunk": 4}
{"article": "PMC1325254.txt", "subject": "Elevated BMI", "relationship": "RELATED_PROGNOSIS", "object": "Increased risk of future cognitive decline and incidence of dementia", "chunk": 4}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "INDICATES_PRESENCE_OF", "object": "Risk for Alzheimer's disease", "chunk": 1}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "ASSOCIATED_WITH", "object": "Metabolic brain changes several years before the onset of typical AD symptoms", "chunk": 1}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "Increased risk and reduced age of onset in people with the late-onset form of AD", "chunk": 1}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Determining risk of Alzheimer's disease and potential interventions", "chunk": 1}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Tailoring treatment plans to individual risk profiles", "chunk": 1}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "RELATED_TREATMENT", "object": "Development of targeted therapies to mitigate the risk or progression of AD", "chunk": 1}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "Increased risk for Alzheimer's Disease", "chunk": 2}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "increased risk of memory impairment and AD", "chunk": 5}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "greater risk for memory impairment and AD", "chunk": 5}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "reduced hippocampal volume", "chunk": 5}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "poorer memory ability", "chunk": 5}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "PREDICT_MORATILITY", "object": "cognitive impairment over a 4-year follow-up period", "chunk": 5}
{"article": "PMC1373642.txt", "subject": "RAVLT", "relationship": "INDICATES_PRESENCE_OF", "object": "better learning ability", "chunk": 5}
{"article": "PMC1373642.txt", "subject": "reduced fMRI activation in \u03b53/4 heterozygotes", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "requires further studies to understand the conditions under which the APOE \u03b54 allele results in reduced MTL volume", "chunk": 5}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "High Risk of AD", "chunk": 6}
{"article": "PMC1373642.txt", "subject": "APOE3/3 homozygotes", "relationship": "INDICATES_PRESENCE_OF", "object": "Low Risk of AD", "chunk": 6}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54", "relationship": "RELATED_PROGNOSIS", "object": "Greater longitudinal decline in fMRI activation in the inferotemporal cortex", "chunk": 6}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 carriers", "relationship": "RELATED_TREATMENT", "object": "Require additional cognitive effort to achieve comparable performance", "chunk": 6}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 carriers", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Compensatory response", "chunk": 6}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "accelerate[s] with increasing age", "chunk": 7}
{"article": "PMC1373642.txt", "subject": "APOE \u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "reduced hippocampal volume in elderly \u03b54 carriers", "chunk": 7}
{"article": "PMC1373642.txt", "subject": "resting state cerebral metabolic rate of glucose (CMRgl)", "relationship": "RELATED_TREATMENT", "object": "reductions in resting state cerebral metabolic rate of glucose (CMRgl) in the MTL and cortical regions of AD patients", "chunk": 7}
{"article": "PMC1373642.txt", "subject": "reduced hippocampal BOLD signal", "relationship": "RELATED_TREATMENT", "object": "reduced glucose metabolism would lead to reduced neuronal activation", "chunk": 7}
{"article": "PMC1373642.txt", "subject": "Homocysteine", "relationship": "RELATED_PROGNOSIS", "object": "Measured in the study, but no specific relationship to Alzheimer's prognosis stated", "chunk": 9}
{"article": "PMC1373642.txt", "subject": "Blood Cholesterol", "relationship": "RELATED_PROGNOSIS", "object": "Measured in the study, but no specific relationship to Alzheimer's prognosis stated", "chunk": 9}
{"article": "PMC1779282.txt", "subject": "Strength training", "relationship": "ASSOCIATED_WITH_PREVENTING", "object": "Falls", "chunk": 2}
{"article": "PMC1779282.txt", "subject": "Flexibility", "relationship": "ASSOCIATED_WITH_PREVENTING", "object": "Falls", "chunk": 2}
{"article": "PMC1851724.txt", "subject": "Individuals with 2 y or more of sustained NSAID treatment", "relationship": "INDICATES_PRESENCE_OF", "object": "Reduced relative hazard of Alzheimer's dementia", "chunk": 2}
{"article": "PMC1851724.txt", "subject": "Naproxen sodium", "relationship": "RELATED_TREATMENT", "object": "Prevention ofAlzheimer's Disease", "chunk": 2}
{"article": "PMC1851724.txt", "subject": "Celecoxib", "relationship": "RELATED_TREATMENT", "object": "Prevention ofAlzheimer's Disease", "chunk": 2}
{"article": "PMC1851724.txt", "subject": "NSAID", "relationship": "RELATED_TREATMENT", "object": "treatment of chronic conditions frequently necessitating decades of analgesic therapy", "chunk": 5}
{"article": "PMC1851724.txt", "subject": "NSAID", "relationship": "RELATED_TREATMENT", "object": "conditions such as osteoarthritis and rheumatoid arthritis, and the potential risks need to be weighed against the known immediate benefits of treatment", "chunk": 5}
{"article": "PMC1851724.txt", "subject": "Alzheimer's disease", "relationship": "RELATED_TREATMENT", "object": " NSAIDs for the prevention of Alzheimer's disease", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Cognitive impairment", "relationship": "INDICATES_PRESENCE_OF", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "SPMSQ >= 4 errors", "relationship": "INDICATES_PRESENCE_OF", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Prior nursing home use", "relationship": "PREDICTS_SURVIVAL", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Age", "relationship": "PREDICTS_SURVIVAL", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "White (vs. all other races/ethnicities)", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Married", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Owning a home", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Being female", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Diabetes", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Falls", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Cancer", "relationship": "HAS_RELATONSHIP_TO", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Stroke", "relationship": "HAS_RELATONSHIP_TO", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Arthritis", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Blood pressure", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Cardiovascular disease", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Lung disease", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Incontinence", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Number prescription drugs", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "Living with others", "relationship": "RELATED_PROGNOSIS", "object": "Nursing home admission", "chunk": 5}
{"article": "PMC1914346.txt", "subject": "ADL dependencies", "relationship": "RELATED_PROGNOSIS", "object": "Predict NH admission", "chunk": 7}
{"article": "PMC1914346.txt", "subject": "Cognitive impairment", "relationship": "RELATED_PROGNOSIS", "object": "Predict NH admission", "chunk": 7}
{"article": "PMC1914346.txt", "subject": "3 or more ADL dependencies", "relationship": "RELATED_PROGNOSIS", "object": "Predict NH admission", "chunk": 7}
{"article": "PMC1914346.txt", "subject": "Prior NH use", "relationship": "RELATED_PROGNOSIS", "object": "Predict NH admission", "chunk": 7}
{"article": "PMC1914346.txt", "subject": "Non-Caucasian race/ethnicity", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased risk for NH admission", "chunk": 7}
{"article": "PMC1914346.txt", "subject": "Lack of informal support or socioeconomic resources", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased risk for NH admission", "chunk": 7}
{"article": "PMC2194921.txt", "subject": "indomethacin", "relationship": "RELATED_TREATMENT", "object": "Slowing cognitive decline in patients with Alzheimer's disease", "chunk": 1}
{"article": "PMC2194921.txt", "subject": "indomethacin", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treating Alzheimer's disease", "chunk": 1}
{"article": "PMC2194921.txt", "subject": "indomethacin", "relationship": "PREDICTED_SURVIVAL", "object": "To retard clinical progression of AD", "chunk": 1}
{"article": "PMC2194921.txt", "subject": "ADAS-cog", "relationship": "RELATED_TREATMENT", "object": "measured the effect of indomethacin treatment on cognitive decline", "chunk": 2}
{"article": "PMC2194921.txt", "subject": "MMSE", "relationship": "RELATED_TREATMENT", "object": "measured dementia severity in patients receiving indomethacin or placebo", "chunk": 2}
{"article": "PMC2194921.txt", "subject": "CIBIC+", "relationship": "RELATED_TREATMENT", "object": "assessed the change in clinical status in patients receiving indomethacin or placebo", "chunk": 2}
{"article": "PMC2194921.txt", "subject": "ADAS-noncog", "relationship": "RELATED_TREATMENT", "object": "evaluated non-cognitive functions in patients receiving indomethacin or placebo", "chunk": 2}
{"article": "PMC2194921.txt", "subject": "NPI", "relationship": "RELATED_TREATMENT", "object": "assessed neuropsychiatric symptoms in patients receiving indomethacin or placebo", "chunk": 2}
{"article": "PMC2194921.txt", "subject": "IDDD", "relationship": "RELATED_TREATMENT", "object": "measured deterioration in daily living activities in patients receiving indomethacin or placebo", "chunk": 2}
{"article": "PMC2194921.txt", "subject": "ADAS-cog", "relationship": "RELATED_PROGNOSIS", "object": "Change in score after one year of treatment", "chunk": 3}
{"article": "PMC2194921.txt", "subject": "ADAS-noncog", "relationship": "RELATED_PROGNOSIS", "object": "Change in score after one year of treatment", "chunk": 3}
{"article": "PMC2194921.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Change in score after one year of treatment", "chunk": 3}
{"article": "PMC2194921.txt", "subject": "NPI", "relationship": "RELATED_PROGNOSIS", "object": "Change in score after one year of treatment", "chunk": 3}
{"article": "PMC2194921.txt", "subject": "NPI-D", "relationship": "RELATED_PROGNOSIS", "object": "Change in score after one year of treatment", "chunk": 3}
{"article": "PMC2194921.txt", "subject": "IDDD", "relationship": "RELATED_PROGNOSIS", "object": "Change in score after one year of treatment", "chunk": 3}
{"article": "PMC2194921.txt", "subject": "CIBIC+", "relationship": "RELATED_PROGNOSIS", "object": "Change in score after one year of treatment", "chunk": 3}
{"article": "PMC2194921.txt", "subject": "creatinine", "relationship": "MONITORED_DURING_TREATMENT", "object": "Indomethacin treatment", "chunk": 4}
{"article": "PMC2194921.txt", "subject": "creatininine", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Avoid indomethacin administration", "chunk": 4}
{"article": "PMC2194921.txt", "subject": "blood pressure", "relationship": "MONITORED_DURING_TREATMENT", "object": "Indomethacin treatment", "chunk": 4}
{"article": "PMC2194921.txt", "subject": "alanine aminotransferase", "relationship": "MONITORED_DURING_TREATMENT", "object": "Indomethacin treatment", "chunk": 4}
{"article": "PMC2194921.txt", "subject": "aspartate aminotransferase", "relationship": "MONITORED_DURING_TREATMENT", "object": "Indomethacin treatment", "chunk": 4}
{"article": "PMC2241592.txt", "subject": "TNF", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuroinflammation", "chunk": 1}
{"article": "PMC2241592.txt", "subject": "TNF", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Impairment in spatial memory", "chunk": 1}
{"article": "PMC2241592.txt", "subject": "TNF", "relationship": "RELATED_TO", "object": "Synaptic dysregulation", "chunk": 1}
{"article": "PMC2241592.txt", "subject": "IL-1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Impairment in LTP and related behaviors", "chunk": 1}
{"article": "PMC2241592.txt", "subject": "etanercept", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Cognitive recovery", "chunk": 1}
{"article": "PMC2241592.txt", "subject": "etanercept", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Direct-to-the-brain delivery of anti-cytokine therapies", "chunk": 1}
{"article": "PMC2241592.txt", "subject": "perispinal etanercept", "relationship": "RELATED_PROGNOSIS", "object": "Sustained improvement in cognitive function", "chunk": 1}
{"article": "PMC2291469.txt", "subject": "electronic tagging", "relationship": "INDICATES_PRESENCE_OF", "object": "Boundary transgressions", "chunk": 2}
{"article": "PMC2291469.txt", "subject": "electronic tagging", "relationship": "RELATED_TO", "object": "reduced distress and burden of family caregivers", "chunk": 2}
{"article": "PMC2291469.txt", "subject": "electronic tagging", "relationship": "RELATED_TO", "object": "improving both caregiver and elder's quality of life", "chunk": 2}
{"article": "PMC2291469.txt", "subject": "electronic tagging", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "care for the elder in the community", "chunk": 2}
{"article": "PMC2291469.txt", "subject": "Clinical dementia Rating (CDR)", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC2291469.txt", "subject": "Mini Mental State Examination (MMSE)", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC2291469.txt", "subject": "Cambridge Cognitive Examination \u2013 Revised (CAMCOG-R)", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC2291469.txt", "subject": "Apathy Evaluation Scale, Clinical Version (AES-C)", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC2291469.txt", "subject": "Clock Drawing Test \u2013 Modified and Integrated Approach (CDT-MIA)", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC2291469.txt", "subject": "Neuropsychiatric Inventory (NPI)", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC2291469.txt", "subject": "Trail Making Test (TMT)", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC2291469.txt", "subject": "Geriatric Depression scale (GDS)", "relationship": "INDICATES_PRESENCE_OF", "object": "Depression", "chunk": 7}
{"article": "PMC2500042.txt", "subject": "TNF-alpha", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC2500042.txt", "subject": "Excess TNF-alpha", "relationship": "RELATED_TO", "object": "Pathogenesis of Alzheimer's disease", "chunk": 1}
{"article": "PMC2500042.txt", "subject": "Etanercept", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC2500042.txt", "subject": "Excess TNF-alpha", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Etanercept", "chunk": 1}
{"article": "PMC2500042.txt", "subject": "MMSE", "relationship": "RELATED_TREATMENT", "object": "Improvement in the main outcome measures which were the Mini-Mental State Examination (MMSE)", "chunk": 2}
{"article": "PMC2500042.txt", "subject": "ADAS-Cog", "relationship": "RELATED_TREATMENT", "object": "Improvement in the main outcome measures which were the Mini-Mental State Examination (MMSE), the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog)", "chunk": 2}
{"article": "PMC2500042.txt", "subject": "Severe Impairment Battery", "relationship": "RELATED_TREATMENT", "object": "Improvement in the main outcome measures which were the Mini-Mental State Examination (MMSE), the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog), and the Severe Impairment Battery", "chunk": 2}
{"article": "PMC2500042.txt", "subject": "TNF-alpha", "relationship": "RELATED_PROGNOSIS", "object": "Pro-inflammatory effects may be associated with negative outcomes in Alzheimer's disease", "chunk": 5}
{"article": "PMC2702274.txt", "subject": "Firmicutes", "relationship": "RELATED_PROGNOSIS", "object": "Elevated Firmicutes/Bacteroidetes ratio also observed in obese subjects", "chunk": 1}
{"article": "PMC2702274.txt", "subject": "Bacteroidetes", "relationship": "RELATED_PROGNOSIS", "object": "Elevated Firmicutes/Bacteroidetes ratio also observed in obese subjects", "chunk": 1}
{"article": "PMC2702274.txt", "subject": "Firmicutes/Bacteroidetes ratio", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Elevated Firmicutes/Bacteroidetes ratio observed in obese subjects", "chunk": 1}
{"article": "PMC2702274.txt", "subject": "Firmicutes/Bacteroidetes ratio", "relationship": "RELATED_TREATMENT", "object": "Decreased Firmicutes/Bacteroidetes ratio associated with weight loss", "chunk": 1}
{"article": "PMC2702274.txt", "subject": "C. leptum", "relationship": "RELATED_TO_AGE", "object": "Lower levels in infants compared to adults and seniors", "chunk": 2}
{"article": "PMC2702274.txt", "subject": "C. coccoides", "relationship": "RELATED_TO_AGE", "object": "Lower levels in infants compared to adults and seniors", "chunk": 2}
{"article": "PMC2702274.txt", "subject": "E. coli", "relationship": "RELATED_TO_AGE", "object": "Dominant in infants compared to adults and seniors", "chunk": 2}
{"article": "PMC2702274.txt", "subject": "Bifidobacterium", "relationship": "RELATED_TO_AGE", "object": "Dominant in infants compared to adults and seniors", "chunk": 2}
{"article": "PMC2731764.txt", "subject": "APOE", "relationship": "RELATED_PROGNOSIS", "object": "Risk of developing Alzheimer's disease", "chunk": 1}
{"article": "PMC2731764.txt", "subject": "APOE epsilon 4 (E4) variant", "relationship": "DIAGNOSTIC_OF", "object": "Sporadic or late onset Alzheimer's disease", "chunk": 1}
{"article": "PMC2731764.txt", "subject": "APOE epsilon 4 (E4) variant", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased risk of developing Alzheimer's disease", "chunk": 1}
{"article": "PMC2731764.txt", "subject": "APOE epsilon 4 (E4) variant", "relationship": "RELATED_PROGNOSIS", "object": "Higher risk of developing Alzheimer's disease (dose-dependent)", "chunk": 1}
{"article": "PMC2731764.txt", "subject": "\u03b2-hydroxybutyrate (BHB)", "relationship": "RELATED_TO_TREATMENT_ELIGIBILITY", "object": "Induction of ketosis (a potential therapy for Alzheimer's disease)", "chunk": 1}
{"article": "PMC2731764.txt", "subject": "A\u03b2 peptide", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Toxic effects in cultured neurons", "chunk": 2}
{"article": "PMC2731764.txt", "subject": "A\u03b240", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC2731764.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC2731764.txt", "subject": "apoe4 allele", "relationship": "RELATED_PROGNOSIS", "object": "Response to ketosis", "chunk": 2}
{"article": "PMC2731764.txt", "subject": "\u03b2-hydroxybutyrate", "relationship": "MONITORED_DURING_TREATMENT", "object": " Safety evaluations", "chunk": 4}
{"article": "PMC2731764.txt", "subject": "\u03b2-hydroxybutyrate", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "pre-defined additional analyses", "chunk": 4}
{"article": "PMC2731764.txt", "subject": "\u03b2-hydroxybutyrate", "relationship": "RELATED_PROGNOSIS", "object": "2 hour post-dose serum BHB levels at Day 90", "chunk": 4}
{"article": "PMC2731764.txt", "subject": "\u03b2-hydroxybutyrate", "relationship": "RELATED_PROGNOSIS", "object": "change from Baseline ADAS-Cog total score", "chunk": 4}
{"article": "PMC2731764.txt", "subject": "APOE4", "relationship": "RELATED_PROGNOSIS", "object": "4/4 genotype", "chunk": 5}
{"article": "PMC2731764.txt", "subject": "APOE4", "relationship": "RELATED_PROGNOSIS", "object": "3/3 genotype", "chunk": 5}
{"article": "PMC2731764.txt", "subject": "ADAS-Cog", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased cognitive impairment", "chunk": 6}
{"article": "PMC2731764.txt", "subject": "ADAS-Cog", "relationship": "RELATED_PROGNOSIS", "object": "Change from baseline in ADAS-Cog scores at Day 90 and total CGIC scores at Day 90 were primary outcomes defined by the protocol", "chunk": 6}
{"article": "PMC2731764.txt", "subject": "apoe4", "relationship": "RELATED_TREATMENT", "object": "Cumulative dose", "chunk": 6}
{"article": "PMC2731764.txt", "subject": "apoe4", "relationship": "RELATED_TO_TREATMENT_ELIGIBILITY", "object": "Effects of AC-1202 administration on ADAS-Cog, MMSE and CGIC were stratified by apoe4 carriage status", "chunk": 7}
{"article": "PMC2731764.txt", "subject": "apoe4-", "relationship": "INDICATES_PRESENCE_OF", "object": "Compared to a 3.05 point decline in Placebo at Day 45", "chunk": 7}
{"article": "PMC2731764.txt", "subject": "apoe4-", "relationship": "INDICATES_PRESENCE_OF", "object": "compared to a 1.61 point decline in Placebo at Day 90", "chunk": 7}
{"article": "PMC2731764.txt", "subject": "apoe4-", "relationship": "IS_TARGET_OF_TREATMENT", "object": " AC-1202 resulted in improvement in ADAS-Cog in apoe4(-) AD patients", "chunk": 7}
{"article": "PMC2731764.txt", "subject": "apoe4", "relationship": "INDICATES_PRESENCE_OF", "object": "Associated with significant statistical differences in ADAS-Cog scores from Baseline between AC-1202 and Placebo groups on Day 45 in dosage compliant subjects", "chunk": 9}
{"article": "PMC2731764.txt", "subject": "apoe4", "relationship": "INDICATES_PRESENCE_OF", "object": "Associated with significant statistical differences in ADAS-Cog scores from Baseline between AC-1202 and Placebo groups at Day 45 in dosage compliant subjects", "chunk": 9}
{"article": "PMC2731764.txt", "subject": "apoe4", "relationship": "INDICATES_PRESENCE_OF", "object": "Associated with significant statistical differences in ADAS-Cog scores from Baseline between AC-1202 and Placebo groups on Day 90 in dosage compliant subjects", "chunk": 9}
{"article": "PMC2731764.txt", "subject": "apoe4", "relationship": "INDICATES_PRESENCE_OF", "object": "Associated with significant statistical differences in ADAS-Cog scores from Baseline between AC-1202 and Placebo groups on Day 104 in dosage compliant subjects", "chunk": 9}
{"article": "PMC2731764.txt", "subject": "apoe4", "relationship": "RELATED_PROGNOSIS", "object": "Associated with specific effects on cognitive function in the per protocol population", "chunk": 9}
{"article": "PMC2731764.txt", "subject": "apoe4", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Associated with significant improvement in MMSE scores on Day 104 among dosage compliant subjects", "chunk": 9}
{"article": "PMC2731764.txt", "subject": "apoe4", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": " Associated with worse than Placebo results for MMSE scores on Day 104 in dosage compliant subjects", "chunk": 9}
{"article": "PMC2731764.txt", "subject": "ADAS-Cog", "relationship": "MONITORED_DURING_TREATMENT", "object": "Monitoring of cognitive function", "chunk": 10}
{"article": "PMC2731764.txt", "subject": "ADAS-Cog", "relationship": "RELATED_TREATMENT", "object": "Correlation between ADAS-Cog scores and total dose of AC-1202", "chunk": 10}
{"article": "PMC2731764.txt", "subject": "ADAS-Cog", "relationship": "RELATED_TREATMENT", "object": "Correlation between ADAS-Cog scores and serum BHB levels", "chunk": 10}
{"article": "PMC2731764.txt", "subject": "MMSE", "relationship": "RELATED_TREATMENT", "object": "Changes in MMSE scores were significantly different between AC-1202 and Placebo groups among E4(+) subjects on Day 104", "chunk": 10}
{"article": "PMC2731764.txt", "subject": "BHB", "relationship": "RELATED_TREATMENT", "object": "Serum BHB levels and change in ADAS-Cog scores were significantly correlated", "chunk": 10}
{"article": "PMC2731764.txt", "subject": "BUN", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Dehydration", "chunk": 11}
{"article": "PMC2731764.txt", "subject": "creatinine", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Dehydration", "chunk": 11}
{"article": "PMC2731764.txt", "subject": "uric acid", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Dehydration", "chunk": 11}
{"article": "PMC2731764.txt", "subject": "BUN/creatinine ratio", "relationship": "RELATED_TO", "object": "Dehydration", "chunk": 11}
{"article": "PMC2731764.txt", "subject": "BHB", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Treatment with AC-1202", "chunk": 11}
{"article": "PMC2731764.txt", "subject": "BHB", "relationship": "RELATED_PROGNOSIS", "object": "Levels of BHB (above 1 mM) have been reported to be associated with positive cognitive effects in E4(-) subjects.", "chunk": 12}
{"article": "PMC2731764.txt", "subject": "BHB", "relationship": "RELATED_TREATMENT", "object": "Induction of mild ketosis by AC-1202, increasing BHB levels.", "chunk": 12}
{"article": "PMC2731764.txt", "subject": "BHB", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Mild ketosis, induced by AC-1202, resulting in increased BHB levels, was associated with improved respiration rates in the parietal regions of the brain in an aged dog model.", "chunk": 12}
{"article": "PMC2731764.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "BHB was found to protect cultured hippocampal neurons from the toxic effects of A\u03b242.", "chunk": 12}
{"article": "PMC2731764.txt", "subject": "AC-1202", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "The effects of AC-1202 on cognitive performance were examined in AD patients, with the aim of guiding treatment selection based on an individual's APOE4 genotype.", "chunk": 12}
{"article": "PMC2731764.txt", "subject": "AD", "relationship": "RELATED_PROGNOSIS", "object": " improvement in cognition may be feasible", "chunk": 13}
{"article": "PMC2731764.txt", "subject": "ADAS-Cog", "relationship": "USED_TO_DIAGNOSE", "object": "clinically significant changes in AD trials", "chunk": 13}
{"article": "PMC2731764.txt", "subject": "BHB", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "higher levels of ketosis appear to confer greater benefit", "chunk": 13}
{"article": "PMC2731764.txt", "subject": "AC-1202", "relationship": "RESPONDED_TO", "object": "E4(-) subjects who were dosage compliant experienced a -4 point or greater improvement", "chunk": 13}
{"article": "PMC2764863.txt", "subject": "hippocampal volume", "relationship": "PREDICTS_SURVIVAL", "object": "conversion from mild cognitive impairment to probable AD", "chunk": 1}
{"article": "PMC2764863.txt", "subject": "decreased hippocampal volume", "relationship": "RELATED_PROGNOSIS", "object": "imminent conversion from mild cognitive impairment to probable AD", "chunk": 1}
{"article": "PMC2764863.txt", "subject": "hippocampal volume", "relationship": "RELATED_TREATMENT", "object": "detection of subtle changes in brain structure associated with disease progression", "chunk": 1}
{"article": "PMC2764863.txt", "subject": "Hippocampal GM density", "relationship": "RELATED_TREATMENT", "object": "Monitored during treatment", "chunk": 2}
{"article": "PMC2764863.txt", "subject": "Amygdalar volume", "relationship": "RELATED_TREATMENT", "object": "Monitored during treatment", "chunk": 2}
{"article": "PMC2764863.txt", "subject": "Entorhinal, temporal, and parietal cortical thickness", "relationship": "RELATED_TREATMENT", "object": "Monitored during treatment", "chunk": 2}
{"article": "PMC2764863.txt", "subject": "hippocampus", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC2764863.txt", "subject": "hippocampus", "relationship": "RELATED_PROGNOSIS", "object": "Reduced hippocampal GM density", "chunk": 4}
{"article": "PMC2764863.txt", "subject": "amygdala", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease symptoms", "chunk": 4}
{"article": "PMC2764863.txt", "subject": "entorhinal cortex", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC2764863.txt", "subject": "grey matter (GM)", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC2764863.txt", "subject": "Grey Matter density", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC2764863.txt", "subject": "Hippocampal volume", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment  -Converters", "chunk": 5}
{"article": "PMC2764863.txt", "subject": "Amygdalar volume", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment -Converters", "chunk": 5}
{"article": "PMC2764863.txt", "subject": "Entorhinal cortex thickness", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment -Converters", "chunk": 5}
{"article": "PMC2764863.txt", "subject": "Bilateral hippocampal volume", "relationship": "RELATED_PROGNOSIS", "object": "Imminent conversion from mild cognitive impairment to probable AD", "chunk": 5}
{"article": "PMC2764863.txt", "subject": "Mean cortical thickness values from lateral temporal cortices", "relationship": "RELATED_PROGNOSIS", "object": "Imminent conversion from mild cognitive impairment to probable AD", "chunk": 5}
{"article": "PMC2764863.txt", "subject": "Cortical thickness values from the inferior and middle temporal gyri", "relationship": "RELATED_PROGNOSIS", "object": "Imminent conversion from mild cognitive impairment to probable AD", "chunk": 5}
{"article": "PMC2764863.txt", "subject": "Cortical thickness values from the entorhinal cortex", "relationship": "RELATED_PROGNOSIS", "object": "Imminent conversion from mild cognitive impairment to probable AD", "chunk": 5}
{"article": "PMC2764863.txt", "subject": "Amygdalar volume", "relationship": "RELATED_PROGNOSIS", "object": "Imminent conversion from mild cognitive impairment to probable AD", "chunk": 5}
{"article": "PMC2764863.txt", "subject": "Cortical thickness in bilateral inferior parietal gyrus", "relationship": "RELATED_PROGNOSIS", "object": "Imminent conversion from mild cognitive impairment to probable AD", "chunk": 5}
{"article": "PMC2764863.txt", "subject": "Cortical thickness in precuneus", "relationship": "RELATED_PROGNOSIS", "object": "Imminent conversion from mild cognitive impairment to probable AD", "chunk": 5}
{"article": "PMC2764863.txt", "subject": "hippocampal volumes", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease ", "chunk": 6}
{"article": "PMC2764863.txt", "subject": "hippocampal GM density", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease ", "chunk": 6}
{"article": "PMC2764863.txt", "subject": "hippocampal volumes", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Conversion to AD within a year", "chunk": 6}
{"article": "PMC2764863.txt", "subject": "amygdalar volume", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Conversion to AD within a year", "chunk": 6}
{"article": "PMC2764863.txt", "subject": "cortical thickness in entorhinal cortex, inferior, middle, and superior temporal gyri, inferior parietal gyrus, and precuneus", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Conversion to AD within a year", "chunk": 6}
{"article": "PMC2764863.txt", "subject": "APOE genotype", "relationship": "RELATED_PROGNOSIS", "object": "Prediction of  disease course ", "chunk": 7}
{"article": "PMC2764863.txt", "subject": "VBM", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Clinical trials in mild cognitive impairment and AD ", "chunk": 7}
{"article": "PMC2764863.txt", "subject": "automated parcellation", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Clinical trials in mild cognitive impairment and AD ", "chunk": 7}
{"article": "PMC2764863.txt", "subject": " hippocampal GM density", "relationship": "RELATED_TREATMENT", "object": "Decreased hippocampal GM density is associated with a poor prognosis in AD.", "chunk": 8}
{"article": "PMC2764863.txt", "subject": "hippocampal volume", "relationship": "RELATED_TREATMENT", "object": "Decreased hippocampal volume is associated with a poor prognosis in AD.", "chunk": 8}
{"article": "PMC2764863.txt", "subject": " entorhinal cortex thickness", "relationship": "RELATED_TREATMENT", "object": "Decreased entorhinal cortex thickness is associated with a poor prognosis in AD.", "chunk": 8}
{"article": "PMC2764863.txt", "subject": "inferior temporal gyrus cortical thickness", "relationship": "RELATED_TREATMENT", "object": "Decreased inferior temporal gyrus cortical thickness is associated with a poor prognosis in AD.", "chunk": 8}
{"article": "PMC2764863.txt", "subject": "middle temporal gyrus cortical thickness", "relationship": "RELATED_TREATMENT", "object": "Decreased middle temporal gyrus cortical thickness is associated with a poor prognosis in AD.", "chunk": 8}
{"article": "PMC2764863.txt", "subject": "superior temporal gyrus cortical thickness", "relationship": "RELATED_TREATMENT", "object": "Decreased superior temporal gyrus cortical thickness is associated with a poor prognosis in AD.", "chunk": 8}
{"article": "PMC2764863.txt", "subject": "inferior parietal gyrus cortical thickness", "relationship": "RELATED_TREATMENT", "object": "Decreased inferior parietal gyrus cortical thickness is associated with a poor prognosis in AD.", "chunk": 8}
{"article": "PMC2764863.txt", "subject": "precuneus cortical thickness", "relationship": "RELATED_TREATMENT", "object": "Decreased precuneus cortical thickness is associated with a poor prognosis in AD.", "chunk": 8}
{"article": "PMC2764863.txt", "subject": "Amygdala Volume", "relationship": "RELATED_TREATMENT", "object": "Decreased amygdala volume is associated with a poor prognosis in AD.", "chunk": 8}
{"article": "PMC2765081.txt", "subject": "amyloid-\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Senile plaques, histopathological hallmark of AD", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "amyloid-\u03b2", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Reduction of amyloid-\u03b2 via inhibiting production, aggregation, or promoting degradation and removal", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "amyloid-\u03b2", "relationship": "IS_TARGET_OF_TREATMENT", "object": "active or passive immunization", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "amyloid-\u03b2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Deposition of amyloid-\u03b2 in the cerebral blood vessels via down-regulation of RAR-\u03b1 in the forebrain neurons", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "amyloid precursor protein (APP)", "relationship": "RELATED_TO_THE_LEVELS_OF", "object": "amyloid-\u03b2", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "retinoids", "relationship": "RELATED_TO_THE_LEVELS_OF", "object": "amyloid-\u03b2", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "ChAT", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Loss of choline acetyltransferase (ChAT) expression", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "retinoic acid", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Activates the \u03b1-secretase", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "vitamin A", "relationship": "RELATED_TREATMENT", "object": "Dietary deficiency disrupts the retinoid signaling pathway and leads to amyloid-\u03b2 deposition", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "retinoic acid", "relationship": "RELATED_TREATMENT", "object": "Can reverse the changes caused by vitamin A deficiency", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "rheumatoid arthritis", "relationship": "RELATED_TREATMENT", "object": "Anti-inflammatory drugs can treat rheumatoid arthritis", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "IL6", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Chronic inflammation and astrocytosis are histopathological hallmarks of AD patients", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "IL6", "relationship": "RELATED_TREATMENT", "object": "Retinoids strongly suppress the production of IL6", "chunk": 2}
{"article": "PMC2765081.txt", "subject": "IL17", "relationship": "INDICATES_PRESENCE_OF", "object": "autoimmune response in neurodegenerative diseases", "chunk": 3}
{"article": "PMC2765081.txt", "subject": "IL17", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "central nervous system inflammation in MS lesions", "chunk": 3}
{"article": "PMC2765081.txt", "subject": "IL17", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "neuron killing ", "chunk": 3}
{"article": "PMC2765081.txt", "subject": "IL17", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "treatment of autoimmune diseases", "chunk": 3}
{"article": "PMC2765081.txt", "subject": " IL22 receptors", "relationship": "INDICATES_PRESENCE_OF", "object": "autoimmune response in neurodegenerative diseases", "chunk": 3}
{"article": "PMC2765081.txt", "subject": "Th17 cells", "relationship": "RELATED_TREATMENT", "object": "suppression of autoimmune response, slowing the progression of autoimmune diseases", "chunk": 3}
{"article": "PMC2765081.txt", "subject": "Th17 cells", "relationship": "INDICATES_PRESENCE_OF", "object": "neuroinflammation", "chunk": 3}
{"article": "PMC2765081.txt", "subject": "Treg", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "therapies for activation or proliferation of Treg for autoimmune diseases", "chunk": 3}
{"article": "PMC2765081.txt", "subject": "Treg", "relationship": "RELATED_PROGNOSIS", "object": "immune homeostasis", "chunk": 3}
{"article": "PMC2765081.txt", "subject": "Treg", "relationship": "RELATED_PROGNOSIS", "object": "disease-related immune mechanisms", "chunk": 3}
{"article": "PMC2765081.txt", "subject": "Treg", "relationship": "MONITORED_DURING_TREATMENT", "object": "MTPT-treated mouse model of PD", "chunk": 3}
{"article": "PMC2765081.txt", "subject": "Foxp3", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treg activation or proliferation therapies", "chunk": 3}
{"article": "PMC2765081.txt", "subject": "TTR", "relationship": "RELATED_TREATMENT", "object": "Treatment of Alzheimer's disease", "chunk": 5}
{"article": "PMC2765081.txt", "subject": "TTR", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Lower levels found in Alzheimer's patients", "chunk": 5}
{"article": "PMC2765081.txt", "subject": "TTR", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "RA uptake was shown to improve memory deficits", "chunk": 5}
{"article": "PMC2765081.txt", "subject": "ChAT", "relationship": "RELATED_PROGNOSIS", "object": "An increase seems to be beneficial", "chunk": 5}
{"article": "PMC2765081.txt", "subject": "RA", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Development of retinoids selective for individual RARs", "chunk": 5}
{"article": "PMC2765081.txt", "subject": "RA", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Retinoids are under investigation for treatment of Alzheimer's disease", "chunk": 5}
{"article": "PMC2765081.txt", "subject": "TrkB", "relationship": "RELATED_TREATMENT", "object": "Development of retinoids for treatment of neurodegenerative diseases", "chunk": 5}
{"article": "PMC2765081.txt", "subject": "t-PA", "relationship": "RELATED_TREATMENT", "object": "Development of retinoids for treatment of neurodegenerative diseases", "chunk": 5}
{"article": "PMC2765081.txt", "subject": "Gap43", "relationship": "RELATED_TREATMENT", "object": "Development of retinoids for treatment of neurodegenerative diseases", "chunk": 5}
{"article": "PMC2765081.txt", "subject": "amyloid-\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "decrease", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "IL-1b", "relationship": "INDICATES_PRESENCE_OF", "object": "Inflammatory response", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "IL-1b", "relationship": "INDICATES_PRESENCE_OF", "object": "Inflammatory response, triggered by amyloid-\u03b2", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "IL-6", "relationship": "INDICATES_PRESENCE_OF", "object": "Inflammatory response", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "TNFa", "relationship": "INDICATES_PRESENCE_OF", "object": "Inflammatory response", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "MCP1", "relationship": "INDICATES_PRESENCE_OF", "object": "Inflammatory response", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "actin", "relationship": "RELATED_TREATMENT", "object": "Differentiation", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "neurotransmission", "relationship": "RELATED_TREATMENT", "object": "influencing memory and learning", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "T cells", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "regulation of autoimmune pathways", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "Th17 cells", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Retinoid-mediated suppression in autoimmune responses", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "IL-12", "relationship": "RELATED_TREATMENT", "object": "Th1 cell differentiation", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "TGF\u03b2", "relationship": "RELATED_TREATMENT", "object": "Th2 cell differentiation.", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "IL-4", "relationship": "RELATED_TREATMENT", "object": "Th2 cell differentiation", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "Treg cells", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Immune system homeostasis and self-tolerance", "chunk": 6}
{"article": "PMC2765081.txt", "subject": "retinoids", "relationship": "MONITORED_DURING_TREATMENT", "object": "Response", "chunk": 6}
{"article": "PMC2868024.txt", "subject": "A\u03b2 plaque pathology", "relationship": "RELATED_PROGNOSIS", "object": "Reduces plaque pathology in TgCRND8 mice.", "chunk": 1}
{"article": "PMC2868024.txt", "subject": "A\u03b2 plaque pathology", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Amloid toxicity", "chunk": 1}
{"article": "PMC2868024.txt", "subject": "anti-A\u03b2 antibodies", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnose: Alzheimer's disease", "chunk": 1}
{"article": "PMC2868024.txt", "subject": "anti-A\u03b2 antibodies", "relationship": "RELATED_TREATMENT", "object": "Treating Alzheimer's disease.", "chunk": 1}
{"article": "PMC2868024.txt", "subject": "anti-A\u03b2 antibodies", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Drug development for Alzheimer's disease.", "chunk": 1}
{"article": "PMC2868024.txt", "subject": "anti-A\u03b2 antibodies", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Selecting appropriate treatments for Alzheimer's disease.", "chunk": 1}
{"article": "PMC2868024.txt", "subject": "anti-A\u03b2 antibodies", "relationship": "RESPONDED_TO", "object": "Targeted delivery via MRIgFUS.", "chunk": 1}
{"article": "PMC2868024.txt", "subject": "BAM-10", "relationship": "IS_TARGET_OF_TREATMENT", "object": "A\u03b2 plaques", "chunk": 2}
{"article": "PMC2868024.txt", "subject": "BAM-10", "relationship": "DIRECTED_AGAINST", "object": "N-terminus of A\u03b2 (residues 1\u201310)", "chunk": 2}
{"article": "PMC2868024.txt", "subject": "BAM-10", "relationship": "SHOWS_EFFECT", "object": "Dissociating A\u03b2 aggregates and rescuing cognitive function", "chunk": 2}
{"article": "PMC2868024.txt", "subject": "BAM-10", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "A\u03b2 clearance", "chunk": 2}
{"article": "PMC2868024.txt", "subject": "A\u03b2", "relationship": "ASSOCIATED_WITH", "object": "Alzheimer's disease", "chunk": 2}
{"article": "PMC2868024.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid plaques", "chunk": 2}
{"article": "PMC2868024.txt", "subject": "A\u03b240", "relationship": "RELATED_TREATMENT", "object": "determined using commercially available ELISA kits (BioSource, Invitrogen, Burlington, ON, Canada)", "chunk": 3}
{"article": "PMC2868024.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "determined using commercially available ELISA kits (BioSource, Invitrogen, Burlington, ON, Canada)", "chunk": 3}
{"article": "PMC2868024.txt", "subject": "BAM-10", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "MRI-guided Focused Ultrasound (MRIgFUS) delivery of BAM-10 to the brain", "chunk": 4}
{"article": "PMC2868024.txt", "subject": "BAM-10", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "treatment of A\u03b2-plaque pathology", "chunk": 4}
{"article": "PMC2868024.txt", "subject": "BAM-10", "relationship": "RELATED_TREATMENT", "object": "MRI-guided Focused Ultrasound (MRIgFUS) delivery", "chunk": 4}
{"article": "PMC2868024.txt", "subject": "BAM-10", "relationship": "IS_TARGET_OF_TREATMENT", "object": "MRIgFUS-delivery", "chunk": 4}
{"article": "PMC2868024.txt", "subject": "BAM-10", "relationship": "RESPONDED_TO", "object": "MRIgFUS treatment", "chunk": 4}
{"article": "PMC2868024.txt", "subject": "A\u03b240", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment with BAM-10/FUS, BAM-10, FUS", "chunk": 4}
{"article": "PMC2868024.txt", "subject": "A\u03b242", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment with BAM-10/FUS, BAM-10, FUS", "chunk": 4}
{"article": "PMC2868024.txt", "subject": "A\u03b2 plaques", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment with BAM-10/FUS", "chunk": 4}
{"article": "PMC2868024.txt", "subject": "A\u03b2 plaques", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "MRIgFUS and BAM-10 treatment", "chunk": 4}
{"article": "PMC2868024.txt", "subject": "A\u03b2 plaque pathology", "relationship": "RELATED_TREATMENT", "object": "MRIgFUS delivery of anti-A\u03b2 antibodies", "chunk": 5}
{"article": "PMC2868024.txt", "subject": "A\u03b2 plaques", "relationship": "RELATED_TREATMENT", "object": "MRIgFUS delivery of anti-A\u03b2 antibodies", "chunk": 5}
{"article": "PMC2868024.txt", "subject": "A\u03b2-positive plaques", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 5}
{"article": "PMC2868024.txt", "subject": "BAM-10", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "MRIgFUS immunotherapy", "chunk": 5}
{"article": "PMC2868024.txt", "subject": "A\u03b2 plaque burden", "relationship": "MONITORED_DURING_TREATMENT", "object": "MRIgFUS immunotherapy", "chunk": 5}
{"article": "PMC2868024.txt", "subject": "BAM-10", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "MRIgFUS immunotherapy", "chunk": 5}
{"article": "PMC2868024.txt", "subject": "A\u03b2-positive plaques", "relationship": "RESPONDED_TO", "object": "MRIgFUS delivered antibodies", "chunk": 5}
{"article": "PMC2868024.txt", "subject": "BBB permeability", "relationship": "MONITORED_DURING_TREATMENT", "object": "MRIgFUS", "chunk": 5}
{"article": "PMC2871786.txt", "subject": "Proteobacteria", "relationship": "INDICATES_PRESENCE_OF", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Bacilli", "relationship": "INDICATES_PRESENCE_OF", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Clostridium cluster XIVa", "relationship": "RELATED_TO", "object": "Decreased in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Bacteroidetes", "relationship": "ASSOCIATED_WITH", "object": "Decrease in gut microbiota", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Escherichia coli et rel.", "relationship": "ASSOCIATED_WITH", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Haemophilus", "relationship": "ASSOCIATED_WITH", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Klebsiella pneumoniae et rel.", "relationship": "ASSOCIATED_WITH", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Leminorella", "relationship": "ASSOCIATED_WITH", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Proteus et rel.", "relationship": "ASSOCIATED_WITH", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Pseudomonas", "relationship": "ASSOCIATED_WITH", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Serratia", "relationship": "ASSOCIATED_WITH", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Vibrio", "relationship": "ASSOCIATED_WITH", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Yersinia et rel.", "relationship": "ASSOCIATED_WITH", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Bacillus", "relationship": "ASSOCIATED_WITH", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Staphylococcus", "relationship": "ASSOCIATED_WITH", "object": "Enriched in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Faecalibacterium prausnitzii et rel.", "relationship": "ASSOCIATED_WITH", "object": "Decreased in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Clostridium leptum et rel.", "relationship": "ASSOCIATED_WITH", "object": "Increased in centenarians", "chunk": 2}
{"article": "PMC2871786.txt", "subject": "Bifidobacterium", "relationship": "INDICATES_PRESENCE_OF", "object": "Old age decrease", "chunk": 4}
{"article": "PMC2871786.txt", "subject": "Archaea", "relationship": "RELATED_TO", "object": "Centenarians  harbouring Archaea more frequently than the elderly or young adults", "chunk": 4}
{"article": "PMC2871786.txt", "subject": "Akkermansia muciniphila", "relationship": "INDICATES_PRESENCE_OF", "object": "Old age decrease", "chunk": 4}
{"article": "PMC2871786.txt", "subject": "Fusobacteria", "relationship": "INDICATES_PRESENCE_OF", "object": "higher prevalence in centenarians and their offspring", "chunk": 4}
{"article": "PMC2871786.txt", "subject": "Proteobacteria", "relationship": "INDICATES_PRESENCE_OF", "object": "higher prevalence in centenarians and their offspring", "chunk": 4}
{"article": "PMC2871786.txt", "subject": "Campylobacter", "relationship": "INDICATES_PRESENCE_OF", "object": "higher prevalence in centenarians and their offspring", "chunk": 4}
{"article": "PMC2871786.txt", "subject": "Helicobacter", "relationship": "INDICATES_PRESENCE_OF", "object": "higher prevalence in centenarians and their offspring", "chunk": 4}
{"article": "PMC2871786.txt", "subject": "Fusobacterium", "relationship": "INDICATES_PRESENCE_OF", "object": "higher prevalence in centenarians and their offspring", "chunk": 4}
{"article": "PMC2871786.txt", "subject": "IL-6", "relationship": "RELATED_TO", "object": "The gut microbiota", "chunk": 6}
{"article": "PMC2871786.txt", "subject": "IL-8", "relationship": "RELATED_PROGNOSIS", "object": "Gut microbiota composition", "chunk": 6}
{"article": "PMC2871786.txt", "subject": "IL-6", "relationship": "RELATED_TO", "object": "Gut microbiota composition", "chunk": 6}
{"article": "PMC2871786.txt", "subject": "Bacteroidetes", "relationship": "INDICATES_PRESENCE_OF", "object": "Healthy adults", "chunk": 6}
{"article": "PMC2871786.txt", "subject": "Firmicutes", "relationship": "INDICATES_PRESENCE_OF", "object": "Healthy adults", "chunk": 6}
{"article": "PMC2871786.txt", "subject": "Actinobacteria", "relationship": "INDICATES_PRESENCE_OF", "object": "Healthy adults", "chunk": 6}
{"article": "PMC2871786.txt", "subject": "Proteobacteria", "relationship": "INDICATES_PRESENCE_OF", "object": "Centenarians", "chunk": 6}
{"article": "PMC2871786.txt", "subject": "Clostridium cluster XIVa", "relationship": "RELATES_TO", "object": "Lower relative contribution found in centenarians", "chunk": 7}
{"article": "PMC2871786.txt", "subject": "Clostridium cluster IV", "relationship": "RELATED_PROGNOSIS", "object": "Proportion comparable in all subjects", "chunk": 7}
{"article": "PMC2871786.txt", "subject": "Bacilli", "relationship": "INDICATES_PRESENCE_OF", "object": "Higher proportions in centenarians", "chunk": 7}
{"article": "PMC2871786.txt", "subject": "Ruminococcus obeum et rel.", "relationship": "ASSOCIATED_WITH", "object": "Lower amount in centenarians", "chunk": 7}
{"article": "PMC2871786.txt", "subject": "IL-1\u03b1", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma cytokine levels", "chunk": 9}
{"article": "PMC2871786.txt", "subject": "IL-1\u03b2", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma cytokine levels", "chunk": 9}
{"article": "PMC2871786.txt", "subject": "IL-2", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma cytokine levels", "chunk": 9}
{"article": "PMC2871786.txt", "subject": "IL-6", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma cytokine levels", "chunk": 9}
{"article": "PMC2871786.txt", "subject": "IL-8", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma cytokine levels", "chunk": 9}
{"article": "PMC2871786.txt", "subject": "IL-10", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma cytokine levels", "chunk": 9}
{"article": "PMC2871786.txt", "subject": "IL-12p70", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma cytokine levels", "chunk": 9}
{"article": "PMC2871786.txt", "subject": "IFN-\u03b3", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma cytokine levels", "chunk": 9}
{"article": "PMC2871786.txt", "subject": "TNF-\u03b1", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma cytokine levels", "chunk": 9}
{"article": "PMC2871786.txt", "subject": "TGF-\u03b21", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma cytokine levels", "chunk": 9}
{"article": "PMC2871786.txt", "subject": "white blood cell count", "relationship": "RELATED_TO_TREATMENT", "object": "Inflammatory Score (IS)", "chunk": 10}
{"article": "PMC2871786.txt", "subject": "C reactive protein", "relationship": "RELATED_TO_TREATMENT", "object": "Inflammatory Score (IS)", "chunk": 10}
{"article": "PMC2871786.txt", "subject": "number of central memory helper and cytotoxic T lymphocytes (CD45RA\u2212CCR7+)", "relationship": "RELATED_TO_TREATMENT", "object": "Inflammatory Score (IS)", "chunk": 10}
{"article": "PMC2871786.txt", "subject": "number of effector helper and cytotoxic T lymphocytes (CD28\u2212)", "relationship": "RELATED_TO_TREATMENT", "object": "Inflammatory Score (IS)", "chunk": 10}
{"article": "PMC2871786.txt", "subject": "IL-6", "relationship": "RELATED_TO_TREATMENT", "object": "Inflammatory Score (IS)", "chunk": 10}
{"article": "PMC2871786.txt", "subject": "IL-8", "relationship": "RELATED_TO_TREATMENT", "object": "Inflammatory Score (IS)", "chunk": 10}
{"article": "PMC2876785.txt", "subject": "A\u03b21-42", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer disease", "chunk": 1}
{"article": "PMC2876785.txt", "subject": "A\u03b21-40", "relationship": "RELATED_TO", "object": "most abundant isoform", "chunk": 1}
{"article": "PMC2876785.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TO", "object": "most prone to aggregation", "chunk": 1}
{"article": "PMC2876785.txt", "subject": "A\u03b21-14", "relationship": "MONITORED_DURING_TREATMENT", "object": "\u03b3-secretase inhibitor treatment", "chunk": 1}
{"article": "PMC2876785.txt", "subject": "A\u03b21-15", "relationship": "MONITORED_DURING_TREATMENT", "object": "\u03b3-secretase inhibitor treatment", "chunk": 1}
{"article": "PMC2876785.txt", "subject": "A\u03b21-16", "relationship": "MONITORED_DURING_TREATMENT", "object": "\u03b3-secretase inhibitor treatment", "chunk": 1}
{"article": "PMC2876785.txt", "subject": "A\u03b21-14", "relationship": "Levels_Reflect_Response", "object": "\u03b3-secretase inhibitor treatment", "chunk": 1}
{"article": "PMC2876785.txt", "subject": "A\u03b21-15", "relationship": "Levels_Reflect_Response", "object": "\u03b3-secretase inhibitor treatment", "chunk": 1}
{"article": "PMC2876785.txt", "subject": "A\u03b21-16", "relationship": "Levels_Reflect_Response", "object": "\u03b3-secretase inhibitor treatment", "chunk": 1}
{"article": "PMC2876785.txt", "subject": "A\u03b21-14, A\u03b21-15, and A\u03b21-16", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Clinical trials response to \u03b3-secretase inhibitors", "chunk": 1}
{"article": "PMC2876785.txt", "subject": "A\u03b21-40", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Monitoring the effect of \u03b3-secretase inhibitors", "chunk": 2}
{"article": "PMC2876785.txt", "subject": "A\u03b21-42", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Monitoring the effect of \u03b3-secretase inhibitors", "chunk": 2}
{"article": "PMC2876785.txt", "subject": "A\u03b21-16", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC2876785.txt", "subject": "A\u03b21-14", "relationship": "RESPONDED_TO", "object": "\u03b3-secretase inhibitor treatment", "chunk": 2}
{"article": "PMC2876785.txt", "subject": "A\u03b21-15", "relationship": "RESPONDED_TO", "object": "\u03b3-secretase inhibitor treatment", "chunk": 2}
{"article": "PMC2876785.txt", "subject": "A\u03b21-16", "relationship": "RESPONDED_TO", "object": "\u03b3-secretase inhibitor treatment", "chunk": 2}
{"article": "PMC2876785.txt", "subject": "A\u03b21-14", "relationship": "RELATED_TREATMENT", "object": "LY450139 is used to monitor for efficacy", "chunk": 2}
{"article": "PMC2876785.txt", "subject": "A\u03b21-15", "relationship": "RELATED_TREATMENT", "object": "LY450139 is used to monitor for efficacy", "chunk": 2}
{"article": "PMC2876785.txt", "subject": "A\u03b21-16", "relationship": "RELATED_TREATMENT", "object": "LY450139 is used to monitor for efficacy", "chunk": 2}
{"article": "PMC2876785.txt", "subject": "LY450139", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Therapeutic choice for AD", "chunk": 3}
{"article": "PMC2876785.txt", "subject": "A\u03b21-14", "relationship": "RELATED_TREATMENT", "object": "Reduction observed with LY450139 treatment", "chunk": 3}
{"article": "PMC2876785.txt", "subject": "A\u03b21-15", "relationship": "RELATED_TREATMENT", "object": "Reduction observed with LY450139 treatment", "chunk": 3}
{"article": "PMC2876785.txt", "subject": "A\u03b21-16", "relationship": "RELATED_TREATMENT", "object": "Reduction observed with LY450139 treatment", "chunk": 3}
{"article": "PMC2876785.txt", "subject": "A\u03b21-34", "relationship": "RELATED_TREATMENT", "object": "Reduction observed with LY450139 treatment", "chunk": 3}
{"article": "PMC2876785.txt", "subject": "A\u03b21-14", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Detection of \u03b3-secretase inhibitor treatment effects", "chunk": 4}
{"article": "PMC2876785.txt", "subject": "A\u03b21-15", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Detection of \u03b3-secretase inhibitor treatment effects", "chunk": 4}
{"article": "PMC2876785.txt", "subject": "A\u03b21-16", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Detection of \u03b3-secretase inhibitor treatment effects", "chunk": 4}
{"article": "PMC2876785.txt", "subject": "A\u03b21-14, A\u03b21-15, and A\u03b21-16", "relationship": "INDICATES_PRESENCE_OF", "object": "\u03b3-secretase inhibitor treatment", "chunk": 4}
{"article": "PMC2880123.txt", "subject": "MMSE sum score", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment", "chunk": 1}
{"article": "PMC2880123.txt", "subject": "MMSE sum score", "relationship": "RELATED_TREATMENT", "object": "Initial cognitive screening", "chunk": 1}
{"article": "PMC2880123.txt", "subject": "MMSE", "relationship": "DIAGNOSITC_OF", "object": "AD", "chunk": 2}
{"article": "PMC2880123.txt", "subject": "MMSE", "relationship": "USED_TO_DIAGNOSE", "object": "Dementia", "chunk": 2}
{"article": "PMC2880123.txt", "subject": "MMSE score", "relationship": "INDICATES_PRESENCE_OF", "object": "early stage AD", "chunk": 3}
{"article": "PMC2880123.txt", "subject": "MMSE sum score", "relationship": "HIGHER", "object": "Younger and more often male patients", "chunk": 3}
{"article": "PMC2880123.txt", "subject": "Cognition", "relationship": "RELATED_PROGNOSIS", "object": "Progression of dementia", "chunk": 3}
{"article": "PMC2880123.txt", "subject": "Cognitive impairment", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Disregard by both relatives and health professionals", "chunk": 3}
{"article": "PMC2880593.txt", "subject": "\u03b2-amyloid", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC2880593.txt", "subject": "\u03b2-amyloid", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive impairment", "chunk": 1}
{"article": "PMC2880593.txt", "subject": "A\u03b240 and A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive impairment", "chunk": 1}
{"article": "PMC2880593.txt", "subject": "chol\u00edne acetyltransferase (ChAT) levels", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive function", "chunk": 1}
{"article": "PMC2880593.txt", "subject": "A\u03b240", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Cognitive function improvement in Ts65Dn mice", "chunk": 2}
{"article": "PMC2880593.txt", "subject": "A\u03b242", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Cognitive function improvement in Ts65Dn mice", "chunk": 2}
{"article": "PMC2880593.txt", "subject": "A\u03b2", "relationship": "RELATED_TO_TREATMENT", "object": "Controlling A\u03b2 production", "chunk": 2}
{"article": "PMC2880593.txt", "subject": "A\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Targeting A\u03b2 levels to improve cognitive function", "chunk": 2}
{"article": "PMC2880593.txt", "subject": "DAPT", "relationship": "RELATED_TREATMENT", "object": "Cognitive dysfunction in Ts65Dn mice", "chunk": 2}
{"article": "PMC2880593.txt", "subject": "DAPT", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Developing treatments for cognitive dysfunction in Down Syndrome", "chunk": 2}
{"article": "PMC2880593.txt", "subject": "DAPT", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Synagmatic regulation in genetically modified mice", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "ADAS-Cog", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Impairment", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "BIMC", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Impairment", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "CAMCOG", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Impairment", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "MDRS", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Impairment", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Impairment", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "NTB", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Impairment", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "SCIP", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Impairment", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "SIB", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Impairment", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "SKT", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Impairment", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "ADL-PI", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "ADLQ", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "ADCS-ADL19/23", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "B-ADL", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "Bristol ADL", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "BANS-S", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "Barthel ADL", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "DAD", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "GERRI", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "IADL", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "IDDD", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "Katz ADL", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "PGDRS", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "RDRS", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "PSMS", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "SMAF", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "Weintraub ADL", "relationship": "INDICATES_PRESENCE_OF", "object": "Activities of Daily Living", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "ADCS-CGIC", "relationship": "INDICATES_PRESENCE_OF", "object": "Global Impression", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "CDR", "relationship": "INDICATES_PRESENCE_OF", "object": "Global Impression", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "CGI", "relationship": "INDICATES_PRESENCE_OF", "object": "Global Impression", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "CIBI", "relationship": "INDICATES_PRESENCE_OF", "object": "Global Impression", "chunk": 2}
{"article": "PMC2949590.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "DIAGNOSITC_OF", "object": "Cognitive disturbances derived from dementia syndromes, affective or personality disorders", "chunk": 3}
{"article": "PMC2949590.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "RELATED_PROGNOSIS", "object": "Disease progression and pharmacological treatment effects", "chunk": 3}
{"article": "PMC2949590.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "INDICA TES_PRESENCE_OF", "object": "Cognitive impairment", "chunk": 3}
{"article": "PMC2949590.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC2949590.txt", "subject": "Alzheimer's Disease Assessment Scale (ADAS)", "relationship": "RELATED_PROGNOSIS", "object": "Disease progression", "chunk": 3}
{"article": "PMC2949590.txt", "subject": "Alzheimer's Disease Assessment Scale -Cognitive (ADAS-Cog)", "relationship": "INDICA TES_PRESENCE_OF", "object": "Cognitive impairment", "chunk": 3}
{"article": "PMC2949590.txt", "subject": "Alzheimer's Disease Assessment Scale - Cognitive (ADAS-Cog)", "relationship": "DIAGNOSITC_OF", "object": "Symptomatic Alzheimer's Disease therapy efficacy", "chunk": 3}
{"article": "PMC2949590.txt", "subject": "Neuropsychological Test Battery (NTB)", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Treatment effects in early disease stages", "chunk": 3}
{"article": "PMC2949590.txt", "subject": "BEHAVE-AD", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "assess behavior in patients with AD apart of cognitive symptomatology", "chunk": 4}
{"article": "PMC2949590.txt", "subject": "BEHAVE-AD", "relationship": "RELATED_TREATMENT", "object": "assess behavior in patients with AD apart of cognitive symptomatology", "chunk": 4}
{"article": "PMC2949590.txt", "subject": "BPRS", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "assess behavior in AD", "chunk": 4}
{"article": "PMC2949590.txt", "subject": "BPRS", "relationship": "RELATED_TREATMENT", "object": "assess behavior in AD", "chunk": 4}
{"article": "PMC2949590.txt", "subject": "NPI", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "compensates for shortcomings of the BEHAVE-AD", "chunk": 4}
{"article": "PMC2949590.txt", "subject": "NPI", "relationship": "RELATED_TREATMENT", "object": "compensates for shortcomings of the BEHAVE-AD", "chunk": 4}
{"article": "PMC3126705.txt", "subject": "donepezil 23 mg/d", "relationship": "INDICATES_PRESENCE_OF", "object": "typical cholinergic AEs, particularly gastrointestinal-related AEs", "chunk": 1}
{"article": "PMC3126705.txt", "subject": "donepezil 23 mg/d", "relationship": "RELATED_TREATMENT", "object": "increased cognitive benefit", "chunk": 1}
{"article": "PMC3126705.txt", "subject": "MMSE", "relationship": "RELATED_TREATMENT", "object": "Baseline MMSE was 13.1 (4.99) in the 23 mg/d group and 13.0 (4.75) in the 10 mg/d group", "chunk": 2}
{"article": "PMC3126705.txt", "subject": "GI bleeding", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "GI bleeding was more common in the 23 mg/d group as compared to the 10 mg/d group", "chunk": 3}
{"article": "PMC3126705.txt", "subject": "Bradycardia", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "All but 1 of the bradycardia events in the 23 mg/d group were mild or moderate in severity; none of the events in the 10 mg/d group was severe and only 4 of the 23 mg/d events were defined as serious.", "chunk": 3}
{"article": "PMC3126705.txt", "subject": "Weight loss", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Weight loss was reported as an AE more frequently in the donepezil 23 mg/d group (4.7%) than in the donepezil 10 mg/d group (2.5%). By the end of the study, 8.4% of patients in the donepezil 23 mg/d group experienced a weight decrease of \u2265 7%, compared with 4.9% of those in the 10 mg/d group.", "chunk": 3}
{"article": "PMC3126705.txt", "subject": "Donepezil 23 mg/d", "relationship": "RELATED_PROGNOSIS", "object": "higher rate of gastrointestinal side-effects", "chunk": 4}
{"article": "PMC3126705.txt", "subject": "Donepezil 23 mg/d", "relationship": "RELATED_PROGNOSIS", "object": "higher rate of adverse events", "chunk": 4}
{"article": "PMC3126705.txt", "subject": "Donepezil 10 mg/d", "relationship": "RELATED_PROGNOSIS", "object": "lower rate of adverse events", "chunk": 4}
{"article": "PMC3126705.txt", "subject": "Donepezil", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "in treating  mild to moderate AD", "chunk": 4}
{"article": "PMC3126705.txt", "subject": "donepezil", "relationship": "RELATED_TREATMENT", "object": "Treatment for Alzheimer's disease", "chunk": 5}
{"article": "PMC3126705.txt", "subject": "donepezil 23 mg/d", "relationship": "RELATED_TREATMENT", "object": "Treatment for moderate to severe Alzheimer's disease", "chunk": 5}
{"article": "PMC3126705.txt", "subject": "donepezil", "relationship": "ASSOCIATED_WITH", "object": "cholinergic-related GI AEs", "chunk": 5}
{"article": "PMC3126705.txt", "subject": "donepezil 23 mg/d", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased risk of bradycardia", "chunk": 5}
{"article": "PMC3126705.txt", "subject": "donepezil 23 mg/d", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased incidence of weight decrease", "chunk": 5}
{"article": "PMC3126705.txt", "subject": "donepezil 23 mg/d", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Higher incidence of fatigue, somnolence, and urinary incontinence", "chunk": 5}
{"article": "PMC3126705.txt", "subject": "donepezil", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Choice of treatment for Alzheimer's disease", "chunk": 5}
{"article": "PMC3212921.txt", "subject": "vitamin D", "relationship": "RELATED_TO_TREATMENT", "object": "Coupling an antioxidant with memantine could provide a solution to the problem of neuronal apoptosis induced by glutamatergic excitotoxicity.", "chunk": 1}
{"article": "PMC3212921.txt", "subject": "vitamin D", "relationship": "INDICATES_PRESENCE_OF", "object": "neuroprotective properties against glutamate toxicity", "chunk": 1}
{"article": "PMC3212921.txt", "subject": "vitamin D", "relationship": "INDICATES_PRESENCE_OF", "object": "antioxidant effects", "chunk": 1}
{"article": "PMC3212921.txt", "subject": "vitamin D", "relationship": "PREDICT_SURVIVAL", "object": "vitamin D deficiency has been associated with cognitive decline", "chunk": 1}
{"article": "PMC3212921.txt", "subject": "memantine", "relationship": "RELATED_TO_TREATMENT", "object": "Memantine has no immediate treatment effect, but after 3 to 6 months of use, patients report better cognitive performance and autonomy than those receiving placebo", "chunk": 1}
{"article": "PMC3212921.txt", "subject": "memantine", "relationship": "RELATED_TREATMENT", "object": "Coupling an antioxidant with memantine could provide a solution to the problem of neuronal apoptosis induced by glutamatergic excitotoxicity.", "chunk": 1}
{"article": "PMC3212921.txt", "subject": "memantine", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "One of the most prescribed drugs to slow the progression of ADRD", "chunk": 1}
{"article": "PMC3212921.txt", "subject": "25OHD", "relationship": "MONITORED_DURING_TREATMENT", "object": "These outcomes are assessed at baseline, 12 and 24 weeks, together with the serum concentrations of 25OHD, calcium and parathyroid hormone.", "chunk": 1}
{"article": "PMC3212921.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Patients aged 60 years and older presenting with moderate ADRD (i.e., Mini-Mental State Examination (MMSE) score between 10-20)", "chunk": 1}
{"article": "PMC3212921.txt", "subject": "serum 25-hydroxyvitamin D [25OHD]", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Patients aged 60 years and older presenting with moderate ADRD (i.e., Mini-Mental State Examination (MMSE) score between 10-20), hypovitaminosis D (i.e., serum 25-hydroxyvitamin D [25OHD] < 30 ng/mL)", "chunk": 1}
{"article": "PMC3212921.txt", "subject": "25OHD concentration", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Dosage of vitamin D supplementation", "chunk": 3}
{"article": "PMC3212921.txt", "subject": "serum 25OHD concentration", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Inclusion criteria for the study", "chunk": 3}
{"article": "PMC3212921.txt", "subject": "serum calcium concentration", "relationship": "DIAGNOSITC_OF", "object": "Hypercalcemia in patients", "chunk": 3}
{"article": "PMC3212921.txt", "subject": "25OHD concentration", "relationship": "RELATED_TO", "object": "Hypovitaminosis D", "chunk": 3}
{"article": "PMC3212921.txt", "subject": "serum 25-hydroxyvitamin D [25OHD] concentration \u226430 ng/mL", "relationship": "INDICATES_PRESENCE_OF", "object": "Hypovitaminosis D", "chunk": 3}
{"article": "PMC3212921.txt", "subject": "25OHD concentration", "relationship": "MONITORED_DURING_TREATMENT", "object": "Blood samples collection procedures", "chunk": 4}
{"article": "PMC3212921.txt", "subject": "25OHD concentration", "relationship": "RELATED_TREATMENT", "object": "Compliance", "chunk": 4}
{"article": "PMC3212921.txt", "subject": "vitamin D", "relationship": "RELATED_TREATMENT", "object": "treating Alzheimer's disease", "chunk": 6}
{"article": "PMC3212921.txt", "subject": "vitamin D", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "improved cognitive function in AD patients", "chunk": 6}
{"article": "PMC3212921.txt", "subject": "vitamin D", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "could be added to standard Alzheimer's medication regimen", "chunk": 6}
{"article": "PMC3213220.txt", "subject": "apoe4", "relationship": "DIAGNOSITC_OF", "object": "Risk of developing Early-onset or Sporadic Alzheimer's Disease", "chunk": 1}
{"article": "PMC3213220.txt", "subject": "apoe4", "relationship": "INDICATES_PRESENCE_OF", "object": "Dominant, dose-dependent effect on the risk of Alzheimer's Disease", "chunk": 1}
{"article": "PMC3213220.txt", "subject": "apoe4", "relationship": "RELATED_PROGNOSIS", "object": "Increased risk of developing Alzheimer's Disease", "chunk": 1}
{"article": "PMC3213220.txt", "subject": "apoe4", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Reduced response to induced ketosis therapy", "chunk": 1}
{"article": "PMC3213220.txt", "subject": "IDE", "relationship": "RELATED_TREATMENT", "object": "Cognitive outcomes during induced ketosis therapy", "chunk": 1}
{"article": "PMC3213220.txt", "subject": "IL1B", "relationship": "RELATED_TREATMENT", "object": "Cognitive outcomes during induced ketosis therapy", "chunk": 1}
{"article": "PMC3213220.txt", "subject": "IL1B", "relationship": "RELATED_PROGNOSIS", "object": "Progression of Alzheimer's Disease", "chunk": 1}
{"article": "PMC3213220.txt", "subject": "\u03b2-hydroxybutyrate", "relationship": "RELATED_TREATMENT", "object": "AC-1202 treatment", "chunk": 2}
{"article": "PMC3213220.txt", "subject": "\u03b2-hydroxybutyrate", "relationship": "MONITORED_DURING_TREATMENT", "object": "AC-1202 treatment", "chunk": 2}
{"article": "PMC3213220.txt", "subject": "\u03b2-hydroxybutyrate", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Change in ADAS-Cog scores", "chunk": 2}
{"article": "PMC3213220.txt", "subject": "APOE", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Genotyping", "chunk": 2}
{"article": "PMC3213220.txt", "subject": "apoe4", "relationship": "DIAGNOSTIC_OF", "object": "Prognosis of cognitive performance", "chunk": 2}
{"article": "PMC3213220.txt", "subject": "IDE rs2251101", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive improvement in Alzheimer's Disease patients", "chunk": 3}
{"article": "PMC3213220.txt", "subject": "IDE rs2251101 C/T", "relationship": "RELATED_PROGNOSIS", "object": "Significant improvement compared to Placebo at Days 45 and 90", "chunk": 3}
{"article": "PMC3213220.txt", "subject": "IDE rs2251101 C/C(-)", "relationship": "RELATED_PROGNOSIS", "object": "Significant improvement compared to Placebo at Days 45 and 90", "chunk": 3}
{"article": "PMC3213220.txt", "subject": "rs1143627 T/T", "relationship": "RELATED_PROGNOSIS", "object": "Improvement in cognitive performance", "chunk": 4}
{"article": "PMC3213220.txt", "subject": "rs16944 C/C", "relationship": "RELATED_PROGNOSIS", "object": "Improvement in cognitive performance", "chunk": 4}
{"article": "PMC3213220.txt", "subject": "APOE E3", "relationship": "RELATED_PROGNOSIS", "object": "Significant improvement in ADAS-Cog scores", "chunk": 4}
{"article": "PMC3213220.txt", "subject": "APOE E4", "relationship": "RELATED_PROGNOSIS", "object": "No significant effects on ADAS-Cog scores", "chunk": 4}
{"article": "PMC3213220.txt", "subject": "APOE E4(-)", "relationship": "RELATED_PROGNOSIS", "object": "Significant improvement in ADAS-Cog scores with AC-1202", "chunk": 4}
{"article": "PMC3213220.txt", "subject": "IDE rs2251101 heterozygous C/T", "relationship": "RELATED_PROGNOSIS", "object": "Additive improvements in cognitive performance", "chunk": 4}
{"article": "PMC3213220.txt", "subject": "IL1B rs1143627 homozygous T/T", "relationship": "RELATED_PROGNOSIS", "object": "Additive improvements in cognitive performance", "chunk": 4}
{"article": "PMC3213220.txt", "subject": "APOE4", "relationship": "INDICATES_PRESENCE_OF", "object": "Change in serum \u03b2-hydroxybutyrate levels", "chunk": 5}
{"article": "PMC3213220.txt", "subject": "apoe4", "relationship": "DIAGNOSITC_OF", "object": "late onset AD", "chunk": 7}
{"article": "PMC3213220.txt", "subject": "apoe4", "relationship": "RELATED_PROGNOSIS", "object": "response to ketosis", "chunk": 7}
{"article": "PMC3218804.txt", "subject": "ROSA", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "determining the severity of relevant symptoms in AD and to document disease progression and therapy effects over time", "chunk": 1}
{"article": "PMC3218804.txt", "subject": "memantine", "relationship": "RELATED_TREATMENT", "object": "Treatment for Alzheimer's Disease", "chunk": 2}
{"article": "PMC3218804.txt", "subject": "cholinesterase inhibitors", "relationship": "RELATED_TREATMENT", "object": "Eligible patients were on a stable dosage of this for at least 2 months prior to study enrollment", "chunk": 2}
{"article": "PMC3218804.txt", "subject": "MMSE score", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease severity", "chunk": 3}
{"article": "PMC3218804.txt", "subject": "ADAS-cog score", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease severity", "chunk": 3}
{"article": "PMC3218804.txt", "subject": "SIB score", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease severity", "chunk": 3}
{"article": "PMC3218804.txt", "subject": "DAD score", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease severity", "chunk": 3}
{"article": "PMC3218804.txt", "subject": "NPI score", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease severity", "chunk": 3}
{"article": "PMC3218804.txt", "subject": "ADAS-cog", "relationship": "RELATED_TO", "object": "ROSA used for construct validity", "chunk": 4}
{"article": "PMC3218804.txt", "subject": "SIB", "relationship": "RELATED_TO", "object": "ROSA used for construct validity", "chunk": 4}
{"article": "PMC3218804.txt", "subject": "NPI", "relationship": "RELATED_TO", "object": "ROSA used for construct validity", "chunk": 4}
{"article": "PMC3218804.txt", "subject": "DAD", "relationship": "RELATED_TO", "object": "ROSA used for construct validity", "chunk": 4}
{"article": "PMC3218804.txt", "subject": "ROSA", "relationship": "INDIVIDUAL_COMPONENT_OF", "object": "Relevant Outcome Scale for Alzheimer's Disease", "chunk": 5}
{"article": "PMC3218804.txt", "subject": "ROSA", "relationship": "RELATED_TREATMENT", "object": "Measures treatment effects in AD", "chunk": 5}
{"article": "PMC3218804.txt", "subject": "ROSA", "relationship": "RESPONDED_TO", "object": "Treatment in patients with Alzheimer's Disease", "chunk": 5}
{"article": "PMC3218804.txt", "subject": "ROSA", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "assessing change in long-term clinical trials", "chunk": 7}
{"article": "PMC3218804.txt", "subject": "ROSA", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "identifying particular symptoms assessed with single ROSA items that necessitate treatment and counseling", "chunk": 7}
{"article": "PMC3218804.txt", "subject": "ROSA", "relationship": "MONITORED_DURING_TREATMENT", "object": "assessing short-term longitudinal change assessments", "chunk": 7}
{"article": "PMC3226277.txt", "subject": "amyloid-beta (A\u03b2) peptides", "relationship": "RELATED_PROGNOSIS", "object": "minimising accumulation is a new therapeutic approach", "chunk": 1}
{"article": "PMC3226277.txt", "subject": "mast cells", "relationship": "INDICATES_PRESENCE_OF", "object": "neuroinflammation", "chunk": 1}
{"article": "PMC3226277.txt", "subject": "mast cells", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Masitinib targets c-Kit, platelet-derived growth factor receptors (PDGFR), and, to a lesser extent, Lyn, Fyn, and the FAK pathway, without inhibiting kinases of known toxicities", "chunk": 1}
{"article": "PMC3226277.txt", "subject": "defective blood-brain barrier (BBB)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Neuroinflammatory and Neurodegenerative Disorders, including AD", "chunk": 1}
{"article": "PMC3226277.txt", "subject": "Masitinib", "relationship": "IS_TARGET_OF_TREATMENT", "object": "to control the survival, differentiation, and degranulation of mast cells", "chunk": 1}
{"article": "PMC3226277.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "SUBJECT_OF", "object": "Baseline MMSE score", "chunk": 2}
{"article": "PMC3226277.txt", "subject": "Clinical dementia Rating (CDR)", "relationship": "SUBJECT_OF", "object": "baseline CDR of 1 or 2", "chunk": 2}
{"article": "PMC3226277.txt", "subject": "Alzheimer's Disease Assessment Scale - cognitive subscale (ADAS-Cog)", "relationship": "DIAGNOSITC_OF", "object": "Primary endpoint to assess cognitive function", "chunk": 2}
{"article": "PMC3226277.txt", "subject": "ADAS-Cog", "relationship": "RELATED_PROGNOSIS", "object": "Response expressed as the mean difference in ADAS-Cog at week 24 relative to baseline", "chunk": 2}
{"article": "PMC3226277.txt", "subject": "Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory (ADCS-ADL)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "ASSESSES self-care", "chunk": 2}
{"article": "PMC3226277.txt", "subject": "Clinician's Interview-Based Impression of Change-plus caregiver input (CIBIC-Plus)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Evaluates overall clinical response", "chunk": 2}
{"article": "PMC3226277.txt", "subject": "MMSE", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Evaluates cognitive function", "chunk": 2}
{"article": "PMC3226277.txt", "subject": "CDR", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Characterises cognitive and functional performance", "chunk": 2}
{"article": "PMC3226277.txt", "subject": "ADAS-Cog", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment of Alzheimer's Disease", "chunk": 4}
{"article": "PMC3226277.txt", "subject": "ADCS-ADL", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment of Alzheimer's Disease", "chunk": 4}
{"article": "PMC3226277.txt", "subject": "MMSE", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment of Alzheimer's Disease", "chunk": 4}
{"article": "PMC3226277.txt", "subject": "CIBIC-plus", "relationship": "INDICATES_PRESENCE_OF", "object": "Change in disease progression", "chunk": 4}
{"article": "PMC3226277.txt", "subject": "CDR", "relationship": "INDICATES_PRESENCE_OF", "object": "Change in disease progression", "chunk": 4}
{"article": "PMC3226277.txt", "subject": "A\u03b242", "relationship": "RELATED_TO", "object": "Neurotoxicity in Alzheimer's Disease", "chunk": 4}
{"article": "PMC3226277.txt", "subject": "A\u03b242", "relationship": "TARGET_OF_THERAPY_CHOICES", "object": "Therapies aimed at reducing neurotoxicity in Alzheimer's Disease", "chunk": 4}
{"article": "PMC3226277.txt", "subject": "Neuroinflammatory response", "relationship": "TARGET_OF_THERAPY_CHOICES", "object": "Therapies aimed at reducing neuroinflammatory response in Alzheimer's Disease", "chunk": 4}
{"article": "PMC3226277.txt", "subject": "A\u03b2 peptides", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC3226277.txt", "subject": "A\u03b2 peptides", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 5}
{"article": "PMC3226277.txt", "subject": "A\u03b2 peptides", "relationship": "RELATED_TREATMENT", "object": "Therapies to maintain or reinforce the integrity of the BBB", "chunk": 5}
{"article": "PMC3226277.txt", "subject": "A\u03b2 peptides", "relationship": "RELATED_PROGNOSIS", "object": "Plaque formation", "chunk": 5}
{"article": "PMC3226277.txt", "subject": "A\u03b2 peptides", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Neuroinflammation", "chunk": 5}
{"article": "PMC3226277.txt", "subject": "A\u03b2 peptides", "relationship": "RELATED_TREATMENT", "object": "Masitinib (as an adjunct to standard treatments)", "chunk": 5}
{"article": "PMC3226277.txt", "subject": "A\u03b2 peptides", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Masitinib", "chunk": 5}
{"article": "PMC3226277.txt", "subject": "ADAS-Cog score", "relationship": "INDICATES_PRESENCE_OF", "object": "worsening of ADAS-Cog score", "chunk": 6}
{"article": "PMC3226277.txt", "subject": "ADAS-Cog score", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline in AD", "chunk": 6}
{"article": "PMC3226311.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "USED_TO_DIAGNOSE", "object": "Moderate to Severe Alzheimer's Disease", "chunk": 1}
{"article": "PMC3226311.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "RELATED_PROGNOSIS", "object": "Prognosis of progression of AD symptoms", "chunk": 1}
{"article": "PMC3226311.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment with Donepezil", "chunk": 1}
{"article": "PMC3226311.txt", "subject": "Severe Impairment Battery-Language scale (SIB-L)", "relationship": "RELATED_PROGNOSIS", "object": "Assessment of language function in AD", "chunk": 1}
{"article": "PMC3226311.txt", "subject": "Severe Impairment Battery-Language scale (SIB-L)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Dose adjustment of Donepezil", "chunk": 1}
{"article": "PMC3226311.txt", "subject": "Severe Impairment Battery (SIB)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment strategies for patients with moderate to severe AD", "chunk": 1}
{"article": "PMC3226311.txt", "subject": "Severe Impairment Battery (SIB)", "relationship": "RELATED_PROGNOSIS", "object": "Predicting cognitive decline in AD", "chunk": 1}
{"article": "PMC3226311.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Moderate to severe AD", "chunk": 2}
{"article": "PMC3226311.txt", "subject": "CIBIC-plus", "relationship": "RELATED_PROGNOSIS", "object": "Global function", "chunk": 2}
{"article": "PMC3226311.txt", "subject": "SIB-L", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment of moderate to severe AD", "chunk": 2}
{"article": "PMC3226311.txt", "subject": "SIB[lang]", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of moderate to severe AD", "chunk": 2}
{"article": "PMC3226311.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "RELATED_PROGNOSIS", "object": "Decline in language is associated with increased risk of mortality", "chunk": 3}
{"article": "PMC3226311.txt", "subject": "Severe Impairment Battery (SIB)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Therapy to slow or reduce the loss of language abilities has the potential to result in additional quality time for patients and caregivers alike.", "chunk": 3}
{"article": "PMC3226311.txt", "subject": "Severe Impairment Battery-Language scale (SIB-L)", "relationship": "RELATED_TREATMENT", "object": "Patients treated with donepezil 23 mg/day showed significant improvement in cognition, as measured by the SIB, compared with patients taking donepezil 10 mg/day", "chunk": 3}
{"article": "PMC3226311.txt", "subject": "SIB-derived language scales", "relationship": "RELATED_TREATMENT", "object": "Treatment with donepezil 23 mg/day was associated with improvement in language function in the full ITT population", "chunk": 3}
{"article": "PMC3226311.txt", "subject": "Severe Impairment Battery (SIB)", "relationship": "INDICATES_PRESENCE_OF", "object": "The already fragile relationships in the lives of patients with AD can become profoundly disrupted as patients lose the ability to communicate coherently. ", "chunk": 3}
{"article": "PMC3226311.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Cognition as measured by the MMSE is strongly related to language abilities as measured by SIB-derived language scales", "chunk": 4}
{"article": "PMC3226311.txt", "subject": "MMSE", "relationship": "RELATED_TREATMENT", "object": "The findings of this post hoc language analysis have important clinical implications. One is to support the assertion that language and the ability to communicate can be reliably and easily assessed in patients with moderate to severe AD using SIB-derived language scales.", "chunk": 4}
{"article": "PMC3226311.txt", "subject": "SIB-L", "relationship": "RELATED_TREATMENT", "object": "Donepezil 23 mg/day treatment", "chunk": 5}
{"article": "PMC3226311.txt", "subject": "SIB[lang]", "relationship": "RELATED_TREATMENT", "object": "Donepezil 23 mg/day treatment", "chunk": 5}
{"article": "PMC3226311.txt", "subject": "SIB-L", "relationship": "MONITORED_DURING_TREATMENT", "object": "Donepezil 23 mg/day treatment", "chunk": 5}
{"article": "PMC3226311.txt", "subject": "SIB[lang]", "relationship": "MONITORED_DURING_TREATMENT", "object": "Donepezil 23 mg/day treatment", "chunk": 5}
{"article": "PMC3335851.txt", "subject": "DHA", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease risk reduction", "chunk": 1}
{"article": "PMC3335851.txt", "subject": "EPA", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease risk reduction", "chunk": 1}
{"article": "PMC3335851.txt", "subject": "n-3 FAs", "relationship": "RELATED_WITH_BETTER_OUTCOME", "object": "Cognitive decline delay", "chunk": 1}
{"article": "PMC3335851.txt", "subject": "DHA", "relationship": "RELATED_ traitement", "object": "inflammation regulation", "chunk": 1}
{"article": "PMC3335851.txt", "subject": "DHA", "relationship": "RELATED_TO_TREATMENT", "object": "treatment with DHA and EPA supplementation", "chunk": 2}
{"article": "PMC3335851.txt", "subject": "EPA", "relationship": "RELATED_TO_TREATMENT", "object": "treatment with DHA and EPA supplementation", "chunk": 2}
{"article": "PMC3335851.txt", "subject": "NAIP", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 3}
{"article": "PMC3335851.txt", "subject": "NAIP", "relationship": "RELATED_PROGNOSIS", "object": "Protect AD patients against tangle pathology and cognitive decline", "chunk": 3}
{"article": "PMC3335851.txt", "subject": "DRG1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Hereditary variant of Charcot-Marie-Tooth disease (type Lom)", "chunk": 3}
{"article": "PMC3335851.txt", "subject": "CD63", "relationship": "RELATED_TREATMENT", "object": "Regulation of inflammation", "chunk": 3}
{"article": "PMC3335851.txt", "subject": "HSD17B11", "relationship": "RELATED_TREATMENT", "object": "Regulation of inflammation", "chunk": 3}
{"article": "PMC3335851.txt", "subject": "RAB27A", "relationship": "RELATED_TREATMENT", "object": "Regulation of inflammation", "chunk": 3}
{"article": "PMC3335851.txt", "subject": "CASP4", "relationship": "RELATED_TREATMENT", "object": "Apoptosis signalling in AD", "chunk": 3}
{"article": "PMC3335851.txt", "subject": "CASP4", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "INNATE IMMUNITY", "chunk": 3}
{"article": "PMC3335851.txt", "subject": "SORL1", "relationship": "RELATED_PROGNOSIS", "object": "The expression of SORL1 is reduced in the brain of AD patients, thus being of considerable interest for understanding of the AD pathology", "chunk": 4}
{"article": "PMC3335851.txt", "subject": "PARP1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "An over activity of PARP-1 has been shown in the AD brain", "chunk": 4}
{"article": "PMC3335851.txt", "subject": "DHA", "relationship": "RELATED_TO", "object": "Changes in the expression of ANAPC5 and RHOB genes", "chunk": 5}
{"article": "PMC3335851.txt", "subject": "EPA", "relationship": "RELATED_TO", "object": "Changes in the expression of ANAPC5 and RHOB genes", "chunk": 5}
{"article": "PMC3335851.txt", "subject": "EPA", "relationship": "RELATED_TO", "object": "Changes in the expression of the CASP4 gene", "chunk": 5}
{"article": "PMC3335851.txt", "subject": "n-3 FAs", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "The aim of the OmegAD study to investigate", "chunk": 5}
{"article": "PMC3382377.txt", "subject": "Falls", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's dementia", "chunk": 1}
{"article": "PMC3382377.txt", "subject": "Fractures", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased rate of falls in individuals with Alzheimer's dementia", "chunk": 1}
{"article": "PMC3382377.txt", "subject": "Hospitalization", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased rate of falls in individuals with Alzheimer's dementia", "chunk": 1}
{"article": "PMC3382377.txt", "subject": "Institutionalization", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased rate of falls in individuals with Alzheimer's dementia", "chunk": 1}
{"article": "PMC3481364.txt", "subject": "MMSE scores", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment: Donepezil or placebo", "chunk": 1}
{"article": "PMC3481364.txt", "subject": "MMSE scores", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive function in AD", "chunk": 1}
{"article": "PMC3481364.txt", "subject": "ADAS-Cog", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment: Donepezil or placebo", "chunk": 1}
{"article": "PMC3481364.txt", "subject": "ADAS-Cog", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive function in AD", "chunk": 1}
{"article": "PMC3481364.txt", "subject": "Clock Drawing Test", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment: Donepezil or placebo", "chunk": 1}
{"article": "PMC3481364.txt", "subject": "Clock Drawing Test", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive function in AD", "chunk": 1}
{"article": "PMC3481364.txt", "subject": "MMSE", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC3481364.txt", "subject": "Clock Drawing Test (CDT)", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC3481364.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 2}
{"article": "PMC3481364.txt", "subject": "Clock Drawing Test (CDT)", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 2}
{"article": "PMC3481364.txt", "subject": "IQ-CODE", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive decline", "chunk": 2}
{"article": "PMC3481364.txt", "subject": "Montgomery and Aasberg Depression Rating Scale (MADRS)", "relationship": "INDICATES_PRESENCE_OF", "object": "Depressive symptoms", "chunk": 2}
{"article": "PMC3481364.txt", "subject": "MMSE", "relationship": "DIAGNOSTIC_OF", "object": "Cognitive function", "chunk": 3}
{"article": "PMC3481364.txt", "subject": "ADAS-Cog", "relationship": "DIAGNOSTIC_OF", "object": "Cognitive function", "chunk": 3}
{"article": "PMC3481364.txt", "subject": "MMSE", "relationship": "PRIMARY_OUTCOME", "object": "Study", "chunk": 3}
{"article": "PMC3481364.txt", "subject": "ADAS-Cog", "relationship": "SECONDARY_OUTCOME", "object": "Study", "chunk": 3}
{"article": "PMC3481364.txt", "subject": "CDT", "relationship": "SECONDARY_OUTCOME", "object": "Study", "chunk": 3}
{"article": "PMC3481364.txt", "subject": "MMSE", "relationship": "RELATED_TREATMENT", "object": "Drug", "chunk": 4}
{"article": "PMC3481364.txt", "subject": "Clock Drawing Test", "relationship": "RELATED_TREATMENT", "object": "Drug", "chunk": 4}
{"article": "PMC3481364.txt", "subject": "ADAS-cog", "relationship": "RELATED_TREATMENT", "object": "Drug", "chunk": 4}
{"article": "PMC3481364.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment", "chunk": 5}
{"article": "PMC3481364.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline in AD", "chunk": 5}
{"article": "PMC3481364.txt", "subject": "ADAS-Cog", "relationship": "RELATED_PROGNOSIS", "object": "Progression of AD", "chunk": 5}
{"article": "PMC3481364.txt", "subject": "Memantin", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Not used in this study", "chunk": 5}
{"article": "PMC3481364.txt", "subject": "ChEI", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Not used in this study", "chunk": 5}
{"article": "PMC3481364.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive function during the one-year follow-up", "chunk": 6}
{"article": "PMC3481364.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Lower cognitive performance", "chunk": 6}
{"article": "PMC3481364.txt", "subject": "ADAS-cog", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Cognitive Assessment", "chunk": 6}
{"article": "PMC3481364.txt", "subject": "BI", "relationship": "RELATED_TREATMENT", "object": "Barthel Index for assessing disability", "chunk": 6}
{"article": "PMC3518146.txt", "subject": "Mini Mental Status Examination (MMSE)", "relationship": "RELATED_PROGNOSIS", "object": "MMSE severity groups", "chunk": 3}
{"article": "PMC3518146.txt", "subject": "Health Aging Brain Care (HABC) Monitor", "relationship": "MONITORED_DURING_TREATMENT", "object": "patient and caretaker", "chunk": 3}
{"article": "PMC3518146.txt", "subject": "HABC Monitor", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Individualized recommendations", "chunk": 3}
{"article": "PMC3518146.txt", "subject": "HABC Monitor", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Behavioral intervention protocols", "chunk": 3}
{"article": "PMC3518146.txt", "subject": "ADCS Group Activities of Daily Living Inventory", "relationship": "PRIMARY_OUTCOME_MEASURE", "object": "Assessment of Functional Status in Alzheimer's Disease Patient", "chunk": 4}
{"article": "PMC3518146.txt", "subject": "Neuropsychiatric Inventory (NPI)", "relationship": "SECONDARY_OUTCOME_MEASURE", "object": "Assessment of Behavioral and Psychological Symptoms in Alzheimer's Disease Patients", "chunk": 4}
{"article": "PMC3518146.txt", "subject": "Short Physical Performance Battery (SPPB)", "relationship": "SECONDARY_OUTCOME_MEASURE", "object": "Assessment of Lower Extremity Physical Performance in Older Adults", "chunk": 4}
{"article": "PMC3518146.txt", "subject": "ADL Inventory", "relationship": "RELATED_TO_OUTCOME", "object": "Efficacy Analysis of the Clinical Trial", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "Mini Mental State Examination (MMSE)", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive function", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "Word List Learning Test", "relationship": "INDICATES_PRESENCE_OF ", "object": "Cognitive function ", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "Mini Nutritional Assessment (MNA)", "relationship": "INDICATES_PRESENCE_OF", "object": "Nutritional status ", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "Patient Health Questionnaire-9 (PHQ-9)", "relationship": "INDICATES_PRESENCE_OF", "object": "Depressive symptoms", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "Generalized Anxiety Disorder-7 (GAD-7) Scale", "relationship": "INDICATES_PRESENCE_OF", "object": "Anxiety symptoms", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "Blood pressure", "relationship": "RELATED_TO_TREATMENt", "object": "Pharmacological management", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "height", "relationship": "RELATED_TO_TREATMENt", "object": "Pharmacological management", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "weight", "relationship": "RELATED_TO_TREATMENt", "object": "Pharmacological management", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "body composition (by bioelectrical impedance analysis)", "relationship": "RELATED_TO_TREATMENt", "object": "Pharmacological management", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "anti-dementia drug", "relationship": "USED_TO_TREAT", "object": " AD-related Condition", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "antipsychotic drug", "relationship": "USED_TO_TREAT", "object": "AD-related Condition", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "antidepressant", "relationship": "USED_TO_TREAT", "object": "AD-related Condition", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "sedative-hypnotic", "relationship": "USED_TO_TREAT", "object": "AD-related Condition", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "cholinesterase inhibitor and anticholinergic medications", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Pharmacological management", "chunk": 5}
{"article": "PMC3518146.txt", "subject": "anticholinergic medication", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Pharmacological management", "chunk": 5}
{"article": "PMC3543284.txt", "subject": "Memory Impairment Screen (MIS)", "relationship": "USED_TO_DIAGNOSE", "object": "Identify individuals who need further evaluation for dementia", "chunk": 4}
{"article": "PMC3580400.txt", "subject": "A\u03b21-40", "relationship": "RELATED_TO", "object": "levels measured in plasma", "chunk": 1}
{"article": "PMC3580400.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TO", "object": "levels measured in plasma and cerebral spinal fluid", "chunk": 1}
{"article": "PMC3580400.txt", "subject": "t-tau", "relationship": "RELATED_TO", "object": "levels measured in cerebral spinal fluid", "chunk": 1}
{"article": "PMC3580400.txt", "subject": "p-tau181", "relationship": "RELATED_TO", "object": "levels measured in cerebral spinal fluid", "chunk": 1}
{"article": "PMC3580400.txt", "subject": "F2-isoprostanes", "relationship": "RELATED_TO", "object": "levels measured in cerebral spinal fluid", "chunk": 1}
{"article": "PMC3580400.txt", "subject": "Plasma levels of curcumin", "relationship": "RELATED_TO", "object": "measured up to four hours after drug administration", "chunk": 1}
{"article": "PMC3580400.txt", "subject": "A\u03b21-40", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma levels at baseline and at the 24 week visit", "chunk": 2}
{"article": "PMC3580400.txt", "subject": "A\u03b21-42", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma levels at baseline and at the 24 week visit", "chunk": 2}
{"article": "PMC3580400.txt", "subject": "A\u03b21-42", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebrospinal fluid levels at baseline and at week 24", "chunk": 2}
{"article": "PMC3580400.txt", "subject": "Total tau (t-tau)", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebrospinal fluid levels at baseline and at week 24", "chunk": 2}
{"article": "PMC3580400.txt", "subject": "Tau phosphorylated at threonine 181 (p-tau181)", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebrospinal fluid levels at baseline and at week 24", "chunk": 2}
{"article": "PMC3580400.txt", "subject": "isoprostanes (F2-IsoPs)", "relationship": "MONITORED_DURING_TREATMENT", "object": "Cerebrospinal fluid levels ", "chunk": 2}
{"article": "PMC3580400.txt", "subject": "curcumin", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment phase", "chunk": 3}
{"article": "PMC3580400.txt", "subject": "curcumin", "relationship": "RESPONDED_TO", "object": "LC/MS/MS analysis", "chunk": 3}
{"article": "PMC3580400.txt", "subject": "curcumin", "relationship": "RELATED_TREATMENT", "object": "Curcumin was given at 2 and 4 grams daily doses", "chunk": 3}
{"article": "PMC3580400.txt", "subject": "Glucose", "relationship": "ASSOCIATED_WITH_TREATMENT", "object": "Curcumin treatment resulted in higher glucose levels.", "chunk": 4}
{"article": "PMC3580400.txt", "subject": "Hematocrit", "relationship": "ASSOCIATED_WITH_TREATMENT", "object": "Curcumin treatment resulted in lower hematocrit levels.", "chunk": 4}
{"article": "PMC3580400.txt", "subject": "Plasma A\u03b242", "relationship": "MONITORED_DURING_TREATMENT", "object": "Levels were measured in plasma during the study.", "chunk": 4}
{"article": "PMC3580400.txt", "subject": "Plasma A\u03b240", "relationship": "MONITORED_DURING_TREATMENT", "object": "Levels were measured in plasma during the study.", "chunk": 4}
{"article": "PMC3580400.txt", "subject": "Cerebral cerebral cerebral cerebral spinal fluid A\u03b242", "relationship": "MONITORED_DURING_TREATMENT", "object": "Levels were measured in cerebrospinal fluid during the study.", "chunk": 4}
{"article": "PMC3580400.txt", "subject": "Cerebral cerebral cerebral cerebral spinal fluid Tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "Levels were measured in cerebrospinal fluid during the study.", "chunk": 4}
{"article": "PMC3580400.txt", "subject": "Cerebral cerebral cerebral cerebral spinal fluid Phospho-tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "Levels were measured in cerebrospinal fluid during the study.", "chunk": 4}
{"article": "PMC3580400.txt", "subject": "Cerebral cerebral cerebral cerebral spinal fluid F2-IsoPs", "relationship": "MONITORED_DURING_TREATMENT", "object": "Levels were measured in cerebrospinal fluid during the study.", "chunk": 4}
{"article": "PMC3580400.txt", "subject": "Native curcumin", "relationship": "IS_BASELINE_FOR_THERAPY_CHOICE", "object": "Limited bioavailability suggests the need to establish optimal dosages.", "chunk": 4}
{"article": "PMC3580400.txt", "subject": "Tetrahydrocurcumin", "relationship": "IS_BASELINE_FOR_THERAPY_CHOICE", "object": "Limited bioavailability suggests the need to establish optimal dosages.", "chunk": 4}
{"article": "PMC3580400.txt", "subject": "A\u03b240", "relationship": "RELATED_TREATMENT", "object": "Mobilization of A\u03b240 ", "chunk": 5}
{"article": "PMC3580400.txt", "subject": "A\u03b242", "relationship": "MONITORED_DURING_TREATMENT", "object": "cerebral cerebral cerebral cerebral spinal fluid", "chunk": 5}
{"article": "PMC3580400.txt", "subject": "t-tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "cerebral cerebral cerebral cerebral spinal fluid", "chunk": 5}
{"article": "PMC3580400.txt", "subject": "p-tau181", "relationship": "MONITORED_DURING_TREATMENT", "object": "cerebral cerebral cerebral cerebral spinal fluid", "chunk": 5}
{"article": "PMC3580400.txt", "subject": "isoprostanes", "relationship": "MONITORED_DURING_TREATMENT", "object": "cerebral cerebral cerebral cerebral spinal fluid", "chunk": 5}
{"article": "PMC3681660.txt", "subject": "MMSE score", "relationship": "RELATED_PROGNOSIS", "object": "Severity of dementia", "chunk": 3}
{"article": "PMC3681660.txt", "subject": "MMSE score", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild stage dementia (25-21 score)", "chunk": 3}
{"article": "PMC3681660.txt", "subject": "MMSE score", "relationship": "INDICATES_PRESENCE_OF", "object": "Moderate stage dementia (20-10 score)", "chunk": 3}
{"article": "PMC3681660.txt", "subject": "MMSE score", "relationship": "INDICATES_PRESENCE_OF", "object": "Severe stage dementia (Below 10 score)", "chunk": 3}
{"article": "PMC3681971.txt", "subject": "Fractional anisotropy (FA)", "relationship": "RELATED_PROGNOSIS", "object": "can differentiate between IPD and MSA/PSP, while FA and MD values within specific white matter tracts can be helpful in differentiating PSP and the parkinsonian variant of MSA (MSA-P) from both each other and from IPD", "chunk": 1}
{"article": "PMC3681971.txt", "subject": "Mean diffusivity (MD)", "relationship": "RELATED_PROGNOSIS", "object": "can differentiate between IPD and MSA/PSP, while FA and MD values within specific white matter tracts can be helpful in differentiating PSP and the parkinsonian variant of MSA (MSA-P) from both each other and from IPD", "chunk": 1}
{"article": "PMC3681971.txt", "subject": "Radial diffusivity (RD)", "relationship": "RELATED_PROGNOSIS", "object": "can differentiate between IPD and MSA/PSP, while FA and MD values within specific white matter tracts can be helpful in differentiating PSP and the parkinsonian variant of MSA (MSA-P) from both each other and from IPD", "chunk": 1}
{"article": "PMC3681971.txt", "subject": "Apparent area coefficient (AAC)", "relationship": "RELATED_PROGNOSIS", "object": "can differentiate between IPD and MSA/PSP, while FA and MD values within specific white matter tracts can be helpful in differentiating PSP and the parkinsonian variant of MSA (MSA-P) from both each other and from IPD", "chunk": 1}
{"article": "PMC3681971.txt", "subject": "FA", "relationship": "RELATED_TO", "object": "Demographic and clinical data", "chunk": 3}
{"article": "PMC3681971.txt", "subject": "MD", "relationship": "RELATED_TO", "object": "Demographic and clinical data", "chunk": 3}
{"article": "PMC3681971.txt", "subject": "RD", "relationship": "RELATED_TO", "object": "Demographic and clinical data", "chunk": 3}
{"article": "PMC3681971.txt", "subject": "AAC", "relationship": "RELATED_TO", "object": "Demographic and clinical data", "chunk": 3}
{"article": "PMC3681971.txt", "subject": "AAC in the CG", "relationship": "INDICATES_PRESENCE_OF", "object": "Progressive supranuclear palsy (PSP)", "chunk": 4}
{"article": "PMC3681971.txt", "subject": "MD in the CST", "relationship": "INDICATES_PRESENCE_OF", "object": "Progressive supranuclear palsy (PSP)", "chunk": 4}
{"article": "PMC3681971.txt", "subject": "MD in the CC", "relationship": "INDICATES_PRESENCE_OF", "object": "Progressive supranuclear palsy (PSP)", "chunk": 4}
{"article": "PMC3764973.txt", "subject": "donepezil", "relationship": "USED_TO_DIAGNOSE", "object": "Mild to moderate Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC3764973.txt", "subject": "galantamine", "relationship": "USED_TO_DIAGNOSE", "object": "Mild to moderate Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC3764973.txt", "subject": "rivastigmine", "relationship": "USED_TO_DIAGNOSE", "object": "Mild to moderate Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC3764973.txt", "subject": "CYP2D6", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Hepatic metabolism of acetylcholinesterase inhibitors", "chunk": 4}
{"article": "PMC3764973.txt", "subject": "CYP3A4", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Hepatic metabolism of acetylcholinesterase inhibitors", "chunk": 4}
{"article": "PMC3764973.txt", "subject": "CYP3A5", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Hepatic metabolism of acetylcholinesterase inhibitors", "chunk": 4}
{"article": "PMC3764973.txt", "subject": "ApoE\u03f52", "relationship": "RELATED_PROGNOSIS", "object": "Response to approved drugs", "chunk": 5}
{"article": "PMC3764973.txt", "subject": "ApoE\u03f53", "relationship": "RELATED_PROGNOSIS", "object": "Response to approved drugs", "chunk": 5}
{"article": "PMC3764973.txt", "subject": "ApoE\u03f54", "relationship": "RELATED_PROGNOSIS", "object": "Response to approved drugs", "chunk": 5}
{"article": "PMC3764973.txt", "subject": "CYP450 genotypes", "relationship": "INDICATES_PRESENCE_OF", "object": "Influences on drug pharmacokinetics", "chunk": 5}
{"article": "PMC3764973.txt", "subject": "CYP2D6", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Donepezil metabolism pathway", "chunk": 5}
{"article": "PMC3764973.txt", "subject": "CYP3A4/5", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Galantamine metabolism pathway", "chunk": 5}
{"article": "PMC3764973.txt", "subject": "CYP2D6 poor metabolizer", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Potential for increased side effects", "chunk": 5}
{"article": "PMC3764973.txt", "subject": "CYP3A4/5 poor metabolizer", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Potential for increased side effects", "chunk": 5}
{"article": "PMC3764973.txt", "subject": "CYP2D6 non-functional allele", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "CYP2D6 poor metabolizer status", "chunk": 5}
{"article": "PMC3764973.txt", "subject": "CYP3A4/5 inhibitor", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "CYP3A4/5 poor metabolizer status", "chunk": 5}
{"article": "PMC3804449.txt", "subject": "Dementia of the Alzheimer's type", "relationship": "INDICATES_PRESENCE_OF", "object": "Functional Impairments", "chunk": 1}
{"article": "PMC3804449.txt", "subject": "Dementia of the Alzheimer's type", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Impairments", "chunk": 1}
{"article": "PMC3804449.txt", "subject": "Folstein Mini-Mental State Examination (MMSE)", "relationship": "USED_TO_DIAGNOSE", "object": "Global cognition", "chunk": 3}
{"article": "PMC3804449.txt", "subject": "MMSE", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Determine the need for interventions", "chunk": 4}
{"article": "PMC3804449.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Predict cognitive decline", "chunk": 4}
{"article": "PMC3804449.txt", "subject": "MMSE", "relationship": "DIAGNOSTIC_OF", "object": "Mild cognitive impairment", "chunk": 4}
{"article": "PMC3804449.txt", "subject": "MMSE", "relationship": "MONITORED_DURING_TREATMENT", "object": "Evaluate the effectiveness of interventions", "chunk": 4}
{"article": "PMC3804449.txt", "subject": "MMSE score", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Care Recipient Characteristics", "chunk": 5}
{"article": "PMC3804449.txt", "subject": "PSMS score", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Care Recipient Characteristics", "chunk": 5}
{"article": "PMC3804449.txt", "subject": "FAQ score", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Care Recipient Characteristics", "chunk": 5}
{"article": "PMC3804449.txt", "subject": "MBRC score", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Care Recipient Characteristics", "chunk": 5}
{"article": "PMC3804449.txt", "subject": "MOS-SSS score", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Care Recipient Characteristics", "chunk": 5}
{"article": "PMC3849204.txt", "subject": "Apolipoprotein E (ApoE)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treating late onset Alzheimer's Disease", "chunk": 1}
{"article": "PMC3849204.txt", "subject": "ApoE \u03f54 allele", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased risk of both familial and sporadic forms of Alzheimer's", "chunk": 1}
{"article": "PMC3849204.txt", "subject": "ApoE \u03f54 allele", "relationship": "DIAGNOSITC_OF", "object": "Late onset Alzheimer's disease", "chunk": 1}
{"article": "PMC3849204.txt", "subject": "Geriatric Depression Scale", "relationship": "RELATED_TO", "object": "Diagnosis of depression", "chunk": 3}
{"article": "PMC3849204.txt", "subject": "DSM IV-TR", "relationship": "USED_TO_DIAGNOSE", "object": "Dementia", "chunk": 3}
{"article": "PMC3849204.txt", "subject": "NINCDS/ADRDA criteria", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC3849204.txt", "subject": "NINDS-AIREN criteria", "relationship": "USED_TO_DIAGNOSE", "object": "Vascular dementia", "chunk": 3}
{"article": "PMC3849204.txt", "subject": "DLB Consortium criteria", "relationship": "USED_TO_DIAGNOSE", "object": "Dementia with Lewy Bodies", "chunk": 3}
{"article": "PMC3849204.txt", "subject": "Manchester Royal Infirmary group criteria", "relationship": "USED_TO_DIAGNOSE", "object": "Frontotemporal dementia", "chunk": 3}
{"article": "PMC3849204.txt", "subject": "Petersen\u2019s criteria", "relationship": "USED_TO_DIAGNOSE", "object": "Mild cognitive impairment", "chunk": 3}
{"article": "PMC3849204.txt", "subject": "CES-D scale", "relationship": "RELATED_TO", "object": "Diagnosis of depression", "chunk": 3}
{"article": "PMC3849204.txt", "subject": "Neuropsychological tests", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Cognitive diagnosis", "chunk": 3}
{"article": "PMC3849204.txt", "subject": "TSH", "relationship": "RELATED_TO", "object": "Thyroid Function", "chunk": 4}
{"article": "PMC3849204.txt", "subject": "Cyanocobalamin", "relationship": "RELATED_TO", "object": "Thyroid Function", "chunk": 4}
{"article": "PMC3849204.txt", "subject": "Folate", "relationship": "RELATED_TO", "object": "Thyroid Function", "chunk": 4}
{"article": "PMC3849204.txt", "subject": "Blood cell count", "relationship": "RELATED_TO", "object": "Thyroid Function", "chunk": 4}
{"article": "PMC3898226.txt", "subject": "donepezil", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of patients with Alzheimer\u2019s disease and related disorders (ADRD)", "chunk": 1}
{"article": "PMC3898226.txt", "subject": "galantamine", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of patients with Alzheimer\u2019s disease and related disorders (ADRD)", "chunk": 1}
{"article": "PMC3898226.txt", "subject": "rivastigimine", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of patients with Alzheimer\u2019s disease and related disorders (ADRD)", "chunk": 1}
{"article": "PMC3898226.txt", "subject": "memantine", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of patients with Alzheimer\u2019s disease and related disorders (ADRD)", "chunk": 1}
{"article": "PMC3898226.txt", "subject": "donepezil", "relationship": "RELATED_TREATMENT", "object": "Effective Daily Dose", "chunk": 2}
{"article": "PMC3898226.txt", "subject": "galantamine", "relationship": "RELATED_TREATMENT", "object": "Effective Daily Dose", "chunk": 2}
{"article": "PMC3898226.txt", "subject": "rivastigmine", "relationship": "RELATED_TREATMENT", "object": "Effective Daily Dose", "chunk": 2}
{"article": "PMC3898226.txt", "subject": "memantine", "relationship": "RELATED_TREATMENT", "object": "Effective Daily Dose", "chunk": 2}
{"article": "PMC3898226.txt", "subject": "MMSE", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC3898226.txt", "subject": "MMSE score", "relationship": "RELATED_PROGNOSIS", "object": "MMSE score at baseline assessment\u00a0associated with a significant decrease of CoV of stride time", "chunk": 3}
{"article": "PMC3898226.txt", "subject": "Femal gender", "relationship": "RELATED_PROGNOSIS", "object": "Female gender associated with a significant decrease of CoV of stride time", "chunk": 3}
{"article": "PMC3898226.txt", "subject": "Memantine", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Memantine decreases gait variability in patients with ADRD", "chunk": 3}
{"article": "PMC3898226.txt", "subject": "Memantine", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Memantine is a basis for therapy choice", "chunk": 3}
{"article": "PMC3898226.txt", "subject": "CEIs", "relationship": "RELATED_TREATMENT", "object": "CEIs showed no effect on gait variability", "chunk": 3}
{"article": "PMC3978714.txt", "subject": "Blessed Orientation-Memory-Concentration Test", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnose: Dementia", "chunk": 3}
{"article": "PMC3978714.txt", "subject": "Blessed Orientation-Memory-Concentration Test", "relationship": "USED_TO_DIAGNOSE", "object": "Determine Veteran's Eligibility for Research Interview", "chunk": 3}
{"article": "PMC3978714.txt", "subject": "cognitive impairment", "relationship": "RELATED_PROGNOSIS", "object": "Improvements in outcomes were related to cognitive impairment levels.", "chunk": 7}
{"article": "PMC3978714.txt", "subject": "personal-care dependencies", "relationship": "RELATED_PROGNOSIS", "object": "Improvements in some outcomes were related to personal-care dependencies levels.", "chunk": 7}
{"article": "PMC3978714.txt", "subject": "unmet need", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Veterans with higher unmet needs received more benefit from the PDC intervention.", "chunk": 7}
{"article": "PMC3978714.txt", "subject": "embarrassment about memory problems", "relationship": "RELATED_TREATMENT", "object": "Experiencing embarrassment about memory problems was linked to benefits from the PDC intervention.", "chunk": 7}
{"article": "PMC3978714.txt", "subject": "relationship strain", "relationship": "RELATED_TREATMENT", "object": "Veterans experiencing high relationship strain saw benefits from the PDC intervention.", "chunk": 7}
{"article": "PMC3978714.txt", "subject": "depression", "relationship": "RELATED_TREATMENT", "object": "Veterans with higher levels of depression benefitted from the PDC intervention.", "chunk": 7}
{"article": "PMC3978714.txt", "subject": "PDC intervention", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "This intervention was selected based on the needs of veterans receiving it.", "chunk": 7}
{"article": "PMC4003513.txt", "subject": "amyloid-\u03b2 (A\u03b2) pathology", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4003513.txt", "subject": "Bielschowsky silver stain", "relationship": "RELATED_TREATMENT", "object": "Confirmation of Alzheimer\u2019s disease diagnosis", "chunk": 1}
{"article": "PMC4003513.txt", "subject": "[18F]flutemetamol PET imaging", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Alzheimer\u2019s disease diagnosis and intervention", "chunk": 1}
{"article": "PMC4003513.txt", "subject": "[cerebral cerebral cerebral cerebral spinal fluid] A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Brain A\u03b2 clearance", "chunk": 1}
{"article": "PMC4003513.txt", "subject": "A\u03b2 oligomers", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 2}
{"article": "PMC4003513.txt", "subject": "A\u03b2 oligomers", "relationship": "RELATED_TREATMENT", "object": "Treatment is the surgical placement of a ventriculoperitoneal shunt", "chunk": 2}
{"article": "PMC4003513.txt", "subject": "elevated soluble A\u03b2 oligomers", "relationship": "ASSOCIATED_WITH", "object": "AD", "chunk": 2}
{"article": "PMC4003513.txt", "subject": "Biopsies from iNPH patients", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Study correlations between PET amyloid imaging and pathology in living subjects", "chunk": 2}
{"article": "PMC4003513.txt", "subject": "Concomitant AD pathology", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Response to ventriculoperitoneal shunting", "chunk": 2}
{"article": "PMC4003513.txt", "subject": "A\u03b2 plaque burden", "relationship": "RELATED_TREATMENT", "object": "Treatment is the surgical placement of a ventriculoperitoneal shunt", "chunk": 2}
{"article": "PMC4003513.txt", "subject": "[18F]flutemetamol", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Assess brain amyloid density", "chunk": 2}
{"article": "PMC4003513.txt", "subject": "A\u03b2 plaque burden", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-\u03b2 deposition in the brain", "chunk": 4}
{"article": "PMC4003513.txt", "subject": "[18F]flutemetamol", "relationship": "RELATED_PROGNOSIS", "object": "SUVR  reflects the level of amyloid in the brain", "chunk": 4}
{"article": "PMC4003513.txt", "subject": "4G8 percentage area", "relationship": "RELATED_PROGNOSIS", "object": "Dichotomise 4G8 data (normal/abnormal)", "chunk": 5}
{"article": "PMC4003513.txt", "subject": "4G8 percentage area", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnosis of normal/abnormal based on a threshold of 2.5%", "chunk": 5}
{"article": "PMC4003513.txt", "subject": "Bielschowsky silver plaque score", "relationship": "INDICATES_PRESENCE_OF", "object": "Abnormal pathology", "chunk": 5}
{"article": "PMC4003513.txt", "subject": "Thioflavin S plaque score", "relationship": "INDICATES_PRESENCE_OF", "object": "Abnormal pathology", "chunk": 5}
{"article": "PMC4003513.txt", "subject": "4G8 antibody", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Histometric analysis of 4G8 stained sections for pathology assessment", "chunk": 5}
{"article": "PMC4003513.txt", "subject": "4G8 positivity", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Dichotomization of 4G8 data into normal/abnormal categories", "chunk": 5}
{"article": "PMC4003513.txt", "subject": "4G8", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-Beta Pathology in Cerebellum", "chunk": 7}
{"article": "PMC4003513.txt", "subject": "4G8", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-Beta Pathology in Pons", "chunk": 7}
{"article": "PMC4003513.txt", "subject": "Bielschowsky Silver Plaque", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-Beta Pathology in Cerebellum", "chunk": 7}
{"article": "PMC4003513.txt", "subject": "Bielschowsky Silver Plaque", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-Beta Pathology in Pons", "chunk": 7}
{"article": "PMC4003513.txt", "subject": "Thioflavin S Plaque Score", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-Beta Pathology in Cerebellum", "chunk": 7}
{"article": "PMC4003513.txt", "subject": "Thioflavin S Plaque Score", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid-Beta Pathology in Pons", "chunk": 7}
{"article": "PMC4003513.txt", "subject": "SUVR", "relationship": "RELATED_PROGNOSIS", "object": "diagnoses Alzheimer's Disease", "chunk": 8}
{"article": "PMC4003513.txt", "subject": "Bielschowsky silver stain", "relationship": "INDICATES_PRESENCE_OF", "object": "amyloid plaques", "chunk": 8}
{"article": "PMC4003513.txt", "subject": "SUVR", "relationship": "RELATED_TREATMENT", "object": "assists in the identification of areas in the brain deserving of investigation", "chunk": 8}
{"article": "PMC4003513.txt", "subject": "SUVR", "relationship": "RELATED_PROGNOSIS", "object": "Sum (sensitivity + specificity) for 4G8, Bielschowsky, Thioflavin S, and Overall pathology in various regions of the brain", "chunk": 9}
{"article": "PMC4003513.txt", "subject": "BIE", "relationship": "RELATED_PROGNOSIS", "object": "Sum (sensitivity + specificity) for 4G8, Bielschowsky, Thioflavin S, and Overall pathology in various regions of the brain", "chunk": 9}
{"article": "PMC4003513.txt", "subject": "4G8", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease when used as the SoT in imaging studies along with SUVR and BIE", "chunk": 9}
{"article": "PMC4003513.txt", "subject": "Bielschowsky", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease when used as the SoT in imaging studies along with SUVR and BIE", "chunk": 9}
{"article": "PMC4003513.txt", "subject": "Thioflavin S", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease when used as the SoT in imaging studies along with SUVR and BIE", "chunk": 9}
{"article": "PMC4003513.txt", "subject": "Overall pathology", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease when used as the SoT in imaging studies along with SUVR and BIE", "chunk": 9}
{"article": "PMC4003513.txt", "subject": "composite-cerebellum", "relationship": "INDICATES_PRESENCE_OF", "object": "Overall pathology (for retrospective studies)", "chunk": 10}
{"article": "PMC4003513.txt", "subject": "composite-cerebellum", "relationship": "INDICATES_PRESENCE_OF", "object": "Bielschowsky silver (for retrospective studies)", "chunk": 10}
{"article": "PMC4003513.txt", "subject": "composite-cerebellum", "relationship": "INDICATES_PRESENCE_OF", "object": "Overall pathology (for all studies)", "chunk": 10}
{"article": "PMC4003513.txt", "subject": "contralateral-cerebellum", "relationship": "INDICATES_PRESENCE_OF", "object": "Overall pathology in prospective studies", "chunk": 10}
{"article": "PMC4003513.txt", "subject": "composite-cerebellum", "relationship": "INDICATES_PRESENCE_OF", "object": "Overall pathology  (for all studies)", "chunk": 10}
{"article": "PMC4003513.txt", "subject": "composite-cerebellum", "relationship": "RELATION_PROGNOSIS", "object": "Overall Pathology", "chunk": 10}
{"article": "PMC4003513.txt", "subject": "4G8", "relationship": "RELATION_PROGNOSIS", "object": "Diagnosis: Early onset Alzheimer's disease", "chunk": 10}
{"article": "PMC4003513.txt", "subject": "Bielschowsky silver", "relationship": "RELATION_PROGNOSIS", "object": "Diagnoses:  Overall Pathology", "chunk": 10}
{"article": "PMC4003513.txt", "subject": "Thioflavin S", "relationship": "RELATION_PROGNOSIS", "object": "Diagnoses: Overall Pathology", "chunk": 10}
{"article": "PMC4003513.txt", "subject": "Bielschowsky silver", "relationship": "BETTER_TOOL_FOR_PREDICTING", "object": "Bielschowsky pathology findings", "chunk": 11}
{"article": "PMC4003513.txt", "subject": "SUVR", "relationship": "RELATED_TO", "object": "cerebellum", "chunk": 11}
{"article": "PMC4003513.txt", "subject": "SUVR", "relationship": "RELATED_TO", "object": "pons", "chunk": 11}
{"article": "PMC4003513.txt", "subject": "4G8 antibody", "relationship": "DETECTING", "object": "amino acids 17-23 (or 17-24) of A\u03b2 ", "chunk": 11}
{"article": "PMC4003513.txt", "subject": "4G8", "relationship": "IS_BASIS_FOR_", "object": "morphology of deposits in AD brain", "chunk": 11}
{"article": "PMC4003513.txt", "subject": "4G8", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Decision to investigate molecular biology of A\u03b2", "chunk": 12}
{"article": "PMC4003513.txt", "subject": "4G8", "relationship": "MONITORED_DURING_TREATMENT", "object": "Testing of drugs that exploit the molecular biology of A\u03b2", "chunk": 12}
{"article": "PMC4003513.txt", "subject": "4G8", "relationship": "RELATED_PROGNOSIS", "object": "Diagnosing AD or other age-related pathologies", "chunk": 12}
{"article": "PMC4003513.txt", "subject": "Apolipoprotein E (\u03f54 allele)", "relationship": "DIAGNOSITC_OF", "object": "AD risk", "chunk": 12}
{"article": "PMC4003513.txt", "subject": "post mortem examination", "relationship": "USED_TO_DIAGNOSE", "object": "AD", "chunk": 12}
{"article": "PMC4013077.txt", "subject": "ApoE \u03b54", "relationship": "STRONGEST KNOWN GENETIC PREDICTOR", "object": "Sporadic late-onset Alzheimer\u2019s Disease", "chunk": 1}
{"article": "PMC4013077.txt", "subject": "A\u03b2 protofibrils", "relationship": "MORE NEUROTOXIC", "object": "Monomers", "chunk": 1}
{"article": "PMC4013077.txt", "subject": "Cytomegalovirus (CMV) seropositivity", "relationship": "ASSOCIATED_WITH", "object": "IFN-\u03b3 in cerebral spinal fluid and Neurofibrillary tangles density", "chunk": 1}
{"article": "PMC4013077.txt", "subject": "HIV", "relationship": "CORRELATION BETWEEN INFECTION", "object": "Systemic inflammation and risk of age-related diseases", "chunk": 1}
{"article": "PMC4013077.txt", "subject": "Infection with multiple agents in the herpes virus family", "relationship": "POSSIBLE CUMULATIVE COGNITIVE EFFECT", "object": "Including cytomegalovirus (CMV)", "chunk": 1}
{"article": "PMC4013077.txt", "subject": "APOE \u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "AD", "chunk": 2}
{"article": "PMC4013077.txt", "subject": "CMV IgG", "relationship": "DIAGNOSITC_OF", "object": "CMV infection", "chunk": 2}
{"article": "PMC4013077.txt", "subject": "IFN-\u03b3", "relationship": "MONITORED_DURING_TREATMENT", "object": "antigen stimulation", "chunk": 4}
{"article": "PMC4013077.txt", "subject": "IFN-\u03b3", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "antigen stimulation", "chunk": 4}
{"article": "PMC4013077.txt", "subject": "ApoE \u03b54 allele", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 4}
{"article": "PMC4013077.txt", "subject": "ApoE \u03b54 allele", "relationship": "RELATED_TREATMENT", "object": "lower levels of CRP", "chunk": 4}
{"article": "PMC4013077.txt", "subject": "CRP", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "all-cause dementia", "chunk": 4}
{"article": "PMC4013077.txt", "subject": "Epstein-Barr virus immune response", "relationship": "RELATED_TREATMENT", "object": "viral load", "chunk": 4}
{"article": "PMC4013077.txt", "subject": "CMV serostatus", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "treatment of AD", "chunk": 4}
{"article": "PMC4021450.txt", "subject": "ADCS-ADL", "relationship": "RELATED_PROGNOSIS", "object": "Decline in ADCS-ADL score reflects progression of disease severity.", "chunk": 2}
{"article": "PMC4021450.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Decline in MMSE score reflects progression of disease severity.", "chunk": 2}
{"article": "PMC4021450.txt", "subject": "ADCS-ADL", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Items on the ADCS-ADL reflect various aspects of functional impairment and guide the selection of treatment strategies.", "chunk": 2}
{"article": "PMC4021450.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Disease severity over 2 years", "chunk": 4}
{"article": "PMC4021450.txt", "subject": "ADCS-ADL", "relationship": "RELATED_PROGNOSIS", "object": "Disease severity over 2 years", "chunk": 4}
{"article": "PMC4021450.txt", "subject": "BADL", "relationship": "RELATED_PROGNOSIS", "object": "Disease severity over 2 years", "chunk": 4}
{"article": "PMC4021450.txt", "subject": "IADL", "relationship": "RELATED_PROGNOSIS", "object": "Disease severity over 2 years", "chunk": 4}
{"article": "PMC4022276.txt", "subject": "Box and Block Test (B & B)", "relationship": "RELATED_TREATMENT", "object": "Training intervention using MusicGlove, IsoTrainer, or control (standard therapy)", "chunk": 4}
{"article": "PMC4022276.txt", "subject": "Box and Block Test (B & B)", "relationship": "INDICATES_PRESENCE_OF", "object": "Hand motor control", "chunk": 4}
{"article": "PMC4022276.txt", "subject": "Fugl-Meyer score (AMFM)", "relationship": "RELATED_TREATMENT", "object": "Training intervention using MusicGlove, IsoTrainer, or control (standard therapy)", "chunk": 4}
{"article": "PMC4022276.txt", "subject": "Action Research Arm Test (ARAT)", "relationship": "RELATED_TREATMENT", "object": "Training intervention using MusicGlove, IsoTrainer, or control (standard therapy)", "chunk": 4}
{"article": "PMC4022276.txt", "subject": "Wolf Motor Function test (WMFT)", "relationship": "RELATED_TREATMENT", "object": "Training intervention using MusicGlove, IsoTrainer, or control (standard therapy)", "chunk": 4}
{"article": "PMC4022276.txt", "subject": "9-hole peg test (NHPT)", "relationship": "RELATED_TREATMENT", "object": "Training intervention using MusicGlove, IsoTrainer, or control (standard therapy)", "chunk": 4}
{"article": "PMC4022276.txt", "subject": "Intrinsic Motivation Inventory (IMI)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Assessing Motivation level to guide training intervention type", "chunk": 4}
{"article": "PMC4022276.txt", "subject": "Dexeterity and Speed tests", "relationship": "RELATED_TREATMENT", "object": "Training intervention using MusicGlove, IsoTrainer, or control (standard therapy)", "chunk": 4}
{"article": "PMC4022276.txt", "subject": "B & B score", "relationship": "INDICATES_PRESENCE_OF", "object": "Improved hand function related to grasping small objects", "chunk": 6}
{"article": "PMC4022276.txt", "subject": "B & B score", "relationship": "RELATED_TREATMENT", "object": "MusicGlove training", "chunk": 6}
{"article": "PMC4022276.txt", "subject": "B & B score", "relationship": "RELATED_TREATMENT", "object": "Conventional tabletop exercises", "chunk": 6}
{"article": "PMC4022276.txt", "subject": "B & B score", "relationship": "RELATED_TREATMENT", "object": "Progress in hand motor control", "chunk": 7}
{"article": "PMC4022276.txt", "subject": "Percentage of total notes hit", "relationship": "CORRELATED_WITH", "object": "B & B score", "chunk": 7}
{"article": "PMC4022276.txt", "subject": "Percentage of notes hit for each grip type", "relationship": "CORRELATED_WITH", "object": "B & B score", "chunk": 7}
{"article": "PMC4027995.txt", "subject": "florbetapir F 18", "relationship": "DIAGNOSITC_OF", "object": "Amyloid Deposition in  AD and DLB patients", "chunk": 1}
{"article": "PMC4027995.txt", "subject": "florbenazine", "relationship": "INDICATES_PRESENCE_OF", "object": "Dopaminergic Deficits in PD and DLB patients", "chunk": 1}
{"article": "PMC4027995.txt", "subject": "florbenazine", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive impairment in DLB patients", "chunk": 1}
{"article": "PMC4027995.txt", "subject": "11C-labeled Pittsburgh compound B (11C-PiB)", "relationship": "INDICATES_PRESENCE_OF", "object": "\u03b2-amyloid visualization in living patients", "chunk": 1}
{"article": "PMC4027995.txt", "subject": "Florbetapir SUVr", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease (AD)", "chunk": 3}
{"article": "PMC4027995.txt", "subject": "Florbetapir SUVr", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia  (DLB)", "chunk": 3}
{"article": "PMC4027995.txt", "subject": "Florbenazine SUVr", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia  (DLB)", "chunk": 3}
{"article": "PMC4027995.txt", "subject": "Florbetapir mean cortical SUVr values", "relationship": "RELATED_PROGNOSIS", "object": "Diagnosis of Alzheimer's Disease and Dementia  ", "chunk": 3}
{"article": "PMC4027995.txt", "subject": "Florbenazine SUVr", "relationship": "INDICATES_PRESENCE_OF", "object": "Dopamine degeneration", "chunk": 3}
{"article": "PMC4027995.txt", "subject": "Posterior putamen florbenazine SUVr value", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "differentiation of Parkinson's Disease from Alzheimer's Disease patients and healthy controls", "chunk": 3}
{"article": "PMC4027995.txt", "subject": "florbetapir", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid deposition", "chunk": 4}
{"article": "PMC4027995.txt", "subject": "florbenazine", "relationship": "INDICATES_PRESENCE_OF", "object": "Dopamine abnormalities", "chunk": 4}
{"article": "PMC4027995.txt", "subject": "florbetapir", "relationship": "RELATED_TREATMENT", "object": "Fluorescence imaging", "chunk": 4}
{"article": "PMC4027995.txt", "subject": "florbenazine", "relationship": "RELATED_TREATMENT", "object": "Fluorescence imaging", "chunk": 4}
{"article": "PMC4027995.txt", "subject": "florbetapir SUVr", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline in patients with DLB", "chunk": 4}
{"article": "PMC4027995.txt", "subject": "VMAT2 binding", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline in patients with DLB", "chunk": 4}
{"article": "PMC4027995.txt", "subject": "florbenazine binding", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline in patients with DLB", "chunk": 4}
{"article": "PMC4027995.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive dysfunction", "chunk": 4}
{"article": "PMC4027995.txt", "subject": "florbetapir", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid", "chunk": 5}
{"article": "PMC4027995.txt", "subject": "florbetapir", "relationship": "RELATED_TO", "object": "Diagnostic reliability studies", "chunk": 5}
{"article": "PMC4027995.txt", "subject": "florbetapir", "relationship": "RELATED_TO", "object": "Published cut-off values", "chunk": 5}
{"article": "PMC4027995.txt", "subject": "florbetapir", "relationship": "RELATED_TO", "object": "Amyloid imaging", "chunk": 5}
{"article": "PMC4027995.txt", "subject": "dopa", "relationship": "RELATED_TO", "object": "Dopamine imaging", "chunk": 5}
{"article": "PMC4051660.txt", "subject": "QT interval", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosis and management of QT prolongation", "chunk": 2}
{"article": "PMC4051660.txt", "subject": "QTc interval", "relationship": "INDICATES_PRESENCE_OF", "object": "Prolonged QT syndrome", "chunk": 2}
{"article": "PMC4051660.txt", "subject": "QTc interval", "relationship": "RELATED_PROGNOSIS", "object": "Increased risk of Torsade de pointes and sudden cardiac death", "chunk": 2}
{"article": "PMC4051660.txt", "subject": "QTc interval", "relationship": "MONITORED_DURING_TREATMENT", "object": "Patients taking citalopram", "chunk": 2}
{"article": "PMC4051660.txt", "subject": "QT prolongation", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased risk of mortality", "chunk": 2}
{"article": "PMC4051660.txt", "subject": "QTc interval", "relationship": "MONITORED_DURING_TREATMENT", "object": "During the CitAD trial", "chunk": 3}
{"article": "PMC4051660.txt", "subject": "QTc interval", "relationship": "RELATED_TREATMENT", "object": "The CitAD Steering Committee (SC) decided to monitor QTc interval in participants following FDA warnings about citalopram and prolonged QT interval.", "chunk": 3}
{"article": "PMC4051660.txt", "subject": "QTc interval", "relationship": "INDICATES_PRESENCE_OF", "object": "A prolonged QTc interval (>450 ms for men and >470 ms for women) became an exclusion criterion for participation in the CitAD trial.", "chunk": 3}
{"article": "PMC4051660.txt", "subject": "QT interval", "relationship": "RELATED_PROGNOSIS", "object": "Prolonged QT interval during follow-up was associated with clinical events", "chunk": 5}
{"article": "PMC4051660.txt", "subject": "QT interval", "relationship": "MONITORED_DURING_TREATMENT", "object": "ECG monitoring began on 11", "chunk": 5}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease in a mouse model", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "Hypocretin receptor antagonist", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Decrease in levels under the effect of a hypocretin receptor antagonist", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "hypocretin-1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Dementia with Lewy bodies", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Increase in levels during hypocretin infusion", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "MONITORED_DURING_TREATMENT", "object": "In hourly cerebral spinal fluid samples", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Correlation with hypocretin-1 levels in advanced stage AD", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "hypocretin-1", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease/mild cognitive impairment", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer's disease in a mouse model", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Increased concentration during wakefulness", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Decreased concentration during sleep", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "PREDICT_SURVIVAL", "object": "May decline later in AD", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "A\u03b22", "relationship": "RELATED_PROGNOSIS", "object": "Levels found to be lower in the elderly patients with NC compared to aged controls", "chunk": 1}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "DIAGNOSITC_OF", "object": "Clinically discriminate AD from normal aging and other neurologic disorders", "chunk": 2}
{"article": "PMC4052448.txt", "subject": "total tau", "relationship": "DIAGNOSITC_OF", "object": "Clinically discriminate AD from normal aging and other neurologic disorders", "chunk": 2}
{"article": "PMC4052448.txt", "subject": "P-tau", "relationship": "DIAGNOSITC_OF", "object": "Clinically discriminate AD from normal aging and other neurologic disorders", "chunk": 2}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Calculated an Innotest\u00ae amyloid Tau Index (IATI) for each patient", "chunk": 2}
{"article": "PMC4052448.txt", "subject": "Hypocretin-1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Low cerebral cerebral cerebral cerebral spinal fluid hypocretin-1 levels (<110 pg/mL) were considered  clinically recognized as AD ", "chunk": 2}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4052448.txt", "subject": "Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4052448.txt", "subject": "Tau", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4052448.txt", "subject": "P-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4052448.txt", "subject": "P-tau", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4052448.txt", "subject": "IATI index", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4052448.txt", "subject": "IATI index", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4052448.txt", "subject": "A\u03b242 (pg/ml)", "relationship": "INDICATES_PRESENCE_OF", "object": "AD + mild cognitive impairment due to AD", "chunk": 4}
{"article": "PMC4052448.txt", "subject": "A\u03b242 (pg/ml)", "relationship": "RELATING_PROGNOSIS", "object": "advanced AD", "chunk": 4}
{"article": "PMC4052448.txt", "subject": "A\u03b242 (pg/ml)", "relationship": "RELATED_TREATMENT", "object": "diagnosing AD in atypical clinical forms", "chunk": 4}
{"article": "PMC4052448.txt", "subject": "P-tau (pg/ml)", "relationship": "RELATED_TREATMENT", "object": "diagnosing AD in atypical clinical forms", "chunk": 4}
{"article": "PMC4052448.txt", "subject": "tau (pg/ml)", "relationship": "RELATED_TREATMENT", "object": "diagnosing AD in atypical clinical forms", "chunk": 4}
{"article": "PMC4052448.txt", "subject": "hypocretin-1 (pg/ml)", "relationship": "INDICATES_PRESENCE_OF", "object": "demented patients", "chunk": 4}
{"article": "PMC4052448.txt", "subject": "hypocretin-1 (pg/ml)", "relationship": "GUIDE_TREATMENT_SELECTION", "object": "differentiating an AD + mild cognitive impairment due to AD diagnosis from other dementia diagnoses", "chunk": 4}
{"article": "PMC4052448.txt", "subject": "hypocretin-1 (pg/ml)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "demented patients", "chunk": 4}
{"article": "PMC4052448.txt", "subject": "hypocretin-1 (pg/ml)", "relationship": "RELATED_TREATMENT", "object": "diagnosing AD in atypical clinical forms", "chunk": 4}
{"article": "PMC4052448.txt", "subject": "A\u03b242 (pg/ml)", "relationship": "PREDICTS_SURVIVAL", "object": "advanced AD", "chunk": 4}
{"article": "PMC4052448.txt", "subject": "hypocretin-1 (pg/ml)", "relationship": "RELATED_TREATMENT", "object": "differentiating an AD + mild cognitive impairment due to AD diagnosis from other dementia diagnoses", "chunk": 4}
{"article": "PMC4052448.txt", "subject": "hypocretin-1 (pg/ml)", "relationship": "PREDICTED_STAY_DURATION", "object": "hospice enrollment", "chunk": 4}
{"article": "PMC4052448.txt", "subject": "hypocretin-1", "relationship": "DIAGNOSTIC_OF", "object": "Early-onset Alzheimer's Disease", "chunk": 5}
{"article": "PMC4052448.txt", "subject": "hypocretin-1", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimers Disease  ", "chunk": 5}
{"article": "PMC4052448.txt", "subject": "hypocretin-1", "relationship": "correlated with", "object": "A\u03b242", "chunk": 5}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Sleep quality", "chunk": 5}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid plaques", "chunk": 6}
{"article": "PMC4052448.txt", "subject": "A\u03b240", "relationship": "ASSOCIATED_WITH", "object": "A\u03b2 plaques", "chunk": 6}
{"article": "PMC4052448.txt", "subject": "APPs", "relationship": "ASSOCIATED_WITH", "object": "Synaptic plasticity", "chunk": 6}
{"article": "PMC4052448.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Cerebral spinal fluid", "chunk": 6}
{"article": "PMC4052448.txt", "subject": "tau", "relationship": "RELATED_PROGNOSIS", "object": "Cerebral spinal fluid", "chunk": 6}
{"article": "PMC4052448.txt", "subject": "P-tau", "relationship": "RELATED_PROGNOSIS", "object": "Cerebral spinal fluid", "chunk": 6}
{"article": "PMC4052448.txt", "subject": "IATI", "relationship": "RELATED_PROGNOSIS", "object": "Cerebral spinal fluid", "chunk": 6}
{"article": "PMC4052448.txt", "subject": "hypocretin-1", "relationship": "RELATED_PROGNOSIS", "object": "Cerebral spinal fluid", "chunk": 6}
{"article": "PMC4054967.txt", "subject": "amyloid-beta (A\u03b2)", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 1}
{"article": "PMC4054967.txt", "subject": "amyloid-beta (A\u03b2)", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Alzheimer\u2019s disease immunotherapy", "chunk": 1}
{"article": "PMC4054967.txt", "subject": "amyloid-beta protofibrils", "relationship": "RELATED_PROGNOSIS", "object": "Early-stage Alzheimer's Disease", "chunk": 1}
{"article": "PMC4054967.txt", "subject": "A\u03b2PP E693G (Arctic mutation)", "relationship": "ASSOCIATED_WITH", "object": "increase in soluble A\u03b2 oligomers", "chunk": 1}
{"article": "PMC4054967.txt", "subject": "A\u03b2 peptide", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "\u03b3-secretase inhibitors and \u03b2-secretase inhibitors", "chunk": 1}
{"article": "PMC4054967.txt", "subject": "A\u03b2 immunotherapy", "relationship": "RELATED_TREATMENT", "object": "Bapineuzumab", "chunk": 2}
{"article": "PMC4054967.txt", "subject": "Bapineuzumab", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "requires very adequate biomarkers", "chunk": 2}
{"article": "PMC4054967.txt", "subject": "AN1792", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "active vaccination", "chunk": 2}
{"article": "PMC4054967.txt", "subject": "Bapineuzumab", "relationship": "RELATED_TREATMENT", "object": "positive effect in the clinic", "chunk": 2}
{"article": "PMC4054967.txt", "subject": "Bapineuzumab", "relationship": "MONITORED_DURING_TREATMENT", "object": "levels of A\u03b2 in cerebral cerebral cerebral cerebral spinal fluid", "chunk": 2}
{"article": "PMC4054967.txt", "subject": "Bapineuzumab", "relationship": "RELATED_TREATMENT", "object": " vasogenic edema called amyloid-related imaging abnormalities with parenchymal edema as well as intracerebral microhemorrhages", "chunk": 2}
{"article": "PMC4054967.txt", "subject": "A\u03b21-6", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4054967.txt", "subject": "Soluble A\u03b2 protofibrils", "relationship": "IS_TARGET_OF_TREATMENT", "object": "BAN2401", "chunk": 3}
{"article": "PMC4054967.txt", "subject": "Altered A\u03b2 aggregation", "relationship": "RELATED_TREATMENT", "object": "Tau deposition", "chunk": 3}
{"article": "PMC4054967.txt", "subject": "A\u03b242 protofibrils", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Inflammatory response in microglia, in vitro", "chunk": 3}
{"article": "PMC4054967.txt", "subject": "A\u03b2 protofibrils", "relationship": "RELATED_PROGNOSIS", "object": "Spatial learning impairment in transgenic mice", "chunk": 3}
{"article": "PMC4054967.txt", "subject": "A\u03b2 protofibrils", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "AD immunotherapy", "chunk": 4}
{"article": "PMC4054967.txt", "subject": "A\u03b2 protofibrils", "relationship": "IS_TARGET_OF_TREATMENT", "object": "mAb158", "chunk": 4}
{"article": "PMC4054967.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "aid in refinement of clinical diagnosis", "chunk": 4}
{"article": "PMC4054967.txt", "subject": "tau", "relationship": "RELATED_TREATMENT", "object": "aid in refinement of clinical diagnosis", "chunk": 4}
{"article": "PMC4054967.txt", "subject": "amyloid PET", "relationship": "RELATED_TREATMENT", "object": "aid in refinement of clinical diagnosis", "chunk": 4}
{"article": "PMC4054967.txt", "subject": "A\u03b21\u201342", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 4}
{"article": "PMC4054967.txt", "subject": "amyloid PET", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 4}
{"article": "PMC4054967.txt", "subject": "A\u03b2 protofibrils", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "AD", "chunk": 4}
{"article": "PMC4054967.txt", "subject": "A\u03b2", "relationship": "DIAGNOSITC_OF", "object": "AD", "chunk": 4}
{"article": "PMC4054967.txt", "subject": "A\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "AD", "chunk": 4}
{"article": "PMC4054967.txt", "subject": "BAN2401", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "AD immunotherapy", "chunk": 4}
{"article": "PMC4054967.txt", "subject": "amyloid PET", "relationship": "USED_TO_DIAGNOSE", "object": "early patient population in the BAN2401 phase 2b trial", "chunk": 5}
{"article": "PMC4054967.txt", "subject": "A\u03b2", "relationship": "IS_TARGET_OF_TREATMENT", "object": "A\u03b2 immunotherapy", "chunk": 5}
{"article": "PMC4054967.txt", "subject": "soluble protofibrils", "relationship": "IS_TARGET_OF_TREATMENT", "object": "immunotherapy", "chunk": 5}
{"article": "PMC4054967.txt", "subject": "A\u03b2 neurotoxicity", "relationship": "RELATED_PROGNOSIS", "object": "disease intervention in AD", "chunk": 5}
{"article": "PMC4055052.txt", "subject": "A\u03b2", "relationship": "IS_TARGET_OF_TREATMENT", "object": "anti-amyloid therapies", "chunk": 1}
{"article": "PMC4055052.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s Disease brain pathology", "chunk": 1}
{"article": "PMC4055052.txt", "subject": "A\u03b2 Plaque", "relationship": "RELATED_PROGNOSIS", "object": "reduction of brain A\u03b2 levels", "chunk": 1}
{"article": "PMC4055052.txt", "subject": "A\u03b21\u201342", "relationship": "RELATED_TREATMENT", "object": "monoclonal antibodies directed against A\u03b2", "chunk": 1}
{"article": "PMC4055052.txt", "subject": "A\u03b21\u201342", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "passive immunisation", "chunk": 1}
{"article": "PMC4055052.txt", "subject": "GSK933776", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "immunotherapy during early clinical development", "chunk": 1}
{"article": "PMC4055052.txt", "subject": "Gantenerumab", "relationship": "RESPONDED_TO", "object": "reduction of brain A\u03b2 levels", "chunk": 1}
{"article": "PMC4055052.txt", "subject": "Solanezumab", "relationship": "MONITORED_DURING_TREATMENT", "object": "cerebral spinal fluid  A\u03b21\u201342", "chunk": 1}
{"article": "PMC4055052.txt", "subject": "A\u03b21\u201342", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment with GSK933776", "chunk": 3}
{"article": "PMC4055052.txt", "subject": "A\u03b21\u201342", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Treatment response to GSK933776", "chunk": 3}
{"article": "PMC4055052.txt", "subject": "total tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment with GSK933776", "chunk": 3}
{"article": "PMC4055052.txt", "subject": "total tau", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Treatment response to GSK933776", "chunk": 3}
{"article": "PMC4055052.txt", "subject": "phospho-tau 181", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment with GSK933776", "chunk": 3}
{"article": "PMC4055052.txt", "subject": "phospho-tau 181", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Treatment response to GSK933776", "chunk": 3}
{"article": "PMC4055052.txt", "subject": "GSK933776", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Thereapeutic intervention", "chunk": 3}
{"article": "PMC4055052.txt", "subject": "A\u03b21\u201342", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Treatment with GSK933776", "chunk": 3}
{"article": "PMC4055052.txt", "subject": "TotalTau", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Treatment with GSK933776", "chunk": 3}
{"article": "PMC4055052.txt", "subject": "phospho-tau 181", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Treatment with GSK933776", "chunk": 3}
{"article": "PMC4055052.txt", "subject": "A\u03b21\u201342", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC4055052.txt", "subject": "A\u03b21\u201342", "relationship": "RELATED_TREATMENT", "object": "Increased decreases in total cerebral cerebral cerebral cerebral spinal fluid A\u03b21\u201342 levels after administration of GSK933776", "chunk": 4}
{"article": "PMC4055052.txt", "subject": "tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease (relationship inferred by its measurement in cerebral cerebral cerebral cerebral spinal fluid and discussion of changes with treatment)", "chunk": 4}
{"article": "PMC4055052.txt", "subject": "phosphorylated tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease (relationship inferred by its measurement in cerebral cerebral cerebral cerebral spinal fluid and discussion of changes with treatment)", "chunk": 4}
{"article": "PMC4055052.txt", "subject": "APOE \u03f54 allele", "relationship": "DIAGNOSITC_OF", "object": "Early-onset Alzheimer's Disease", "chunk": 4}
{"article": "PMC4055052.txt", "subject": "A\u03b218\u201335", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnosis: Alzheimer's Disease", "chunk": 5}
{"article": "PMC4055052.txt", "subject": "A\u03b24228\u201342", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnosis: Alzheimer's Disease", "chunk": 5}
{"article": "PMC4055052.txt", "subject": "tau", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnosis: Alzheimer's Disease", "chunk": 5}
{"article": "PMC4055052.txt", "subject": "phosphorylate tau", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnosis: Alzheimer's Disease", "chunk": 5}
{"article": "PMC4055052.txt", "subject": "A\u03b21\u201342", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4055052.txt", "subject": "A\u03b21\u201342", "relationship": "RELATED_PROGNOSIS", "object": "Decreases in cerebral cerebral cerebral cerebral spinal fluid A\u03b21\u201342 after treatment with GSK933776", "chunk": 6}
{"article": "PMC4055052.txt", "subject": "A\u03b21\u201342", "relationship": "RELATED_TREATMENT", "object": "GSK933776", "chunk": 6}
{"article": "PMC4055052.txt", "subject": "A\u03b228\u201342", "relationship": "RELATED_TREATMENT", "object": "GSK933776", "chunk": 6}
{"article": "PMC4055052.txt", "subject": "A\u03b218\u201335", "relationship": "RELATED_TREATMENT", "object": "GSK933776", "chunk": 6}
{"article": "PMC4055052.txt", "subject": "A\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Assessing short-term A\u03b2 changes", "chunk": 7}
{"article": "PMC4055052.txt", "subject": "A\u03b2", "relationship": "IS_TARGET_OF_TREATMENT", "object": "GSK933776", "chunk": 7}
{"article": "PMC4055052.txt", "subject": "A\u03b2", "relationship": "MONITORED_DURING_TREATMENT", "object": "Continuous sampling method using a catheter", "chunk": 7}
{"article": "PMC4055052.txt", "subject": "A\u03b2", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Response to single-dose administration of an anti-A\u03b2 antibody", "chunk": 7}
{"article": "PMC4055052.txt", "subject": "APOE \u03f54", "relationship": "DIAGNOSTIC_OF", "object": "Reducing A\u03b2 and increasing tau levels in cerebral spinal fluid", "chunk": 7}
{"article": "PMC4055052.txt", "subject": "tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease (in conjunction with A\u03b2)", "chunk": 7}
{"article": "PMC4055052.txt", "subject": "Phosphorylated tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease (in conjunction with A\u03b2)", "chunk": 7}
{"article": "PMC4058849.txt", "subject": "personal-care dependency", "relationship": "PREDICTES_SURVIVAL", "object": "inpatient hospitalization", "chunk": 3}
{"article": "PMC4058849.txt", "subject": "Personal-care dependency", "relationship": "RELATED_PROGNOSIS", "object": "inpatient hospitalization", "chunk": 3}
{"article": "PMC4058849.txt", "subject": "Personal care dependency", "relationship": "RELATED_PROGNOSIS", "object": "Inpatient admission", "chunk": 6}
{"article": "PMC4058849.txt", "subject": "Behavior problems", "relationship": "RELATED_PROGNOSIS", "object": "Inpatient admission", "chunk": 6}
{"article": "PMC4066282.txt", "subject": "dementia screening", "relationship": "INDICATES_PRESENCE_OF", "object": "Reversible causes of cognitive impairment", "chunk": 1}
{"article": "PMC4066282.txt", "subject": "dementia screening", "relationship": "INDICATES_PRESENCE_OF", "object": "Opportunity for early pharmacological and non-pharmacological interventions", "chunk": 1}
{"article": "PMC4066282.txt", "subject": "dementia screening", "relationship": "INDICATES_PRESENCE_OF", "object": "Enhance patient and caregiver education and planning about the disease and its course", "chunk": 1}
{"article": "PMC4066282.txt", "subject": "dementia screening", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Induction of depression and anxiety once diagnosed", "chunk": 1}
{"article": "PMC4066282.txt", "subject": "dementia screening", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Patient stigmatization", "chunk": 1}
{"article": "PMC4066282.txt", "subject": "MIS-T", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 3}
{"article": "PMC4066282.txt", "subject": "MIS-T", "relationship": "RELATED_TREATMENT", "object": "Referral to the ABC MedHome program for co-management of dementia.", "chunk": 3}
{"article": "PMC4066282.txt", "subject": "PHQ-9", "relationship": "INDICATES_PRESENCE_OF", "object": "Suicidal thoughts", "chunk": 4}
{"article": "PMC4066282.txt", "subject": "PHQ-9", "relationship": "USED_TO_DIAGNOSE", "object": "Major depression", "chunk": 4}
{"article": "PMC4066282.txt", "subject": "GAD-7", "relationship": "USED_TO_DIAGNOSE", "object": "General anxiety disorders", "chunk": 4}
{"article": "PMC4066282.txt", "subject": "HUI", "relationship": "RELATED_PROGNOSIS", "object": "Patient health-related quality of life", "chunk": 4}
{"article": "PMC4066282.txt", "subject": "PHQ-9", "relationship": "RELATED_TREATMENT", "object": "Testing equivalence levels in treatment of mood", "chunk": 6}
{"article": "PMC4066282.txt", "subject": "GAD-7", "relationship": "RELATED_TREATMENT", "object": "Testing equivalence levels in treatment of anxiety", "chunk": 6}
{"article": "PMC4095696.txt", "subject": "N-methyl-D-aspartate (NMDA) receptor", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Currently FDA approved drug \"Memantine\"", "chunk": 1}
{"article": "PMC4095696.txt", "subject": "cholinesterase inhibitors", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Currently FDA approved drugs Tacrine, Donepezil, Rivastigmine, Galantamine", "chunk": 1}
{"article": "PMC4095696.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4095696.txt", "subject": "A\u03b2", "relationship": "RELATED_TREATMENT", "object": "Anti-A\u03b2 therapies", "chunk": 3}
{"article": "PMC4095696.txt", "subject": "tau-related", "relationship": "RELATED_TREATMENT", "object": "drugs", "chunk": 3}
{"article": "PMC4095696.txt", "subject": "memantine", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4095696.txt", "subject": "disease-modifying", "relationship": "RELATED_PROGNOSIS", "object": "compounds", "chunk": 3}
{"article": "PMC4107377.txt", "subject": "APOE \u03b54 allele", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC4107377.txt", "subject": "APOE \u03b54 variants", "relationship": "INDICATES_PRESENCE_OF", "object": "Substantially increased risk of dementia", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "APOE \u03b54 variants", "relationship": "RELATED_PROGNOSIS", "object": "Substantially increased risk of dementia", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "rs7412", "relationship": "RELATED_TO", "object": "APOE \u03b54 variants", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "rs429358", "relationship": "RELATED_TO", "object": "APOE \u03b54 variants", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "BIN1", "relationship": "RELATED_TO", "object": "Genome-wide significant predictors of AD", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "CLU", "relationship": "RELATED_TO", "object": "Genome-wide significant predictors of AD", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "ABCA7", "relationship": "RELATED_TO", "object": "Genome-wide significant predictors of AD", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "CR1", "relationship": "RELATED_TO", "object": "Genome-wide significant predictors of AD", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "PICALM", "relationship": "RELATED_TO", "object": "Genome-wide significant predictors of AD", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "MS4A6A", "relationship": "RELATED_TO", "object": "Genome-wide significant predictors of AD", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "CD33", "relationship": "RELATED_TO", "object": "Genome-wide significant predictors of AD", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "MS4A4E", "relationship": "RELATED_TO", "object": "Genome-wide significant predictors of AD", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "CD2AP", "relationship": "RELATED_TO", "object": "Genome-wide significant predictors of AD", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "AD-GRS", "relationship": "RELATED_TO", "object": "Probability of dementia", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "AD-GRS", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia risk", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "AD-GRS (excluding APOE)", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia risk", "chunk": 2}
{"article": "PMC4107377.txt", "subject": "AD-GRS", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia risk", "chunk": 3}
{"article": "PMC4107377.txt", "subject": "AD-GRS", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia risk (stronger association in NHW compared to NHB)", "chunk": 3}
{"article": "PMC4107377.txt", "subject": "APOE", "relationship": "IS_PART_OF", "object": "AD-GRS", "chunk": 3}
{"article": "PMC4107377.txt", "subject": "AD-GRS", "relationship": "RELATED_PROGNOSIS", "object": "Dementia probability", "chunk": 4}
{"article": "PMC4107377.txt", "subject": "AD-GRS", "relationship": "RELATED_PROGNOSIS", "object": "Memory score", "chunk": 4}
{"article": "PMC4107377.txt", "subject": "APOE-\u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "Higher dementia probability", "chunk": 4}
{"article": "PMC4107377.txt", "subject": "APOE-\u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "Lower memory score", "chunk": 4}
{"article": "PMC4107377.txt", "subject": "ABCA7 SNP rs115550680", "relationship": "NOT_ASSOCIATED_WITH", "object": "Dementia probability in NHB", "chunk": 4}
{"article": "PMC4107377.txt", "subject": "APOE \u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "Dementia risk", "chunk": 5}
{"article": "PMC4107377.txt", "subject": "AD-GRS including APOE", "relationship": "PREDICTING_SURVIVAL", "object": "Dementia risk in NHW", "chunk": 5}
{"article": "PMC4107377.txt", "subject": "AD-GRS including APOE", "relationship": "PREDICTING_SURVIVAL", "object": "Dementia risk in NHB", "chunk": 5}
{"article": "PMC4107377.txt", "subject": "AD-GRS excluding APOE", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Dementia risk in NHB males", "chunk": 5}
{"article": "PMC4107377.txt", "subject": "APOE", "relationship": "RELATED_TREATMENT", "object": "Genetic and social modifiers to explain divergent effects on dementia", "chunk": 5}
{"article": "PMC4107377.txt", "subject": "AD-GRS", "relationship": "RELATED_TREATMENT", "object": "Potential modifiers of APOE effects in different populations", "chunk": 5}
{"article": "PMC4107377.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TO_MORTALITY", "object": "Associated with mortality", "chunk": 6}
{"article": "PMC4107377.txt", "subject": "APOE \u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "De mentia risk", "chunk": 6}
{"article": "PMC4107377.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TREATMENT", "object": "Genetic determinants of chronic illnesses", "chunk": 6}
{"article": "PMC4107377.txt", "subject": "AD-GRS", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Dementia and memory", "chunk": 6}
{"article": "PMC4107377.txt", "subject": "AD-GRS", "relationship": "PREDICTS_SURVIVAL", "object": "Memory and dementia in NHW", "chunk": 6}
{"article": "PMC4107377.txt", "subject": "AD-GRS", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Genetic risk profiles by race and gender", "chunk": 6}
{"article": "PMC4109111.txt", "subject": "vitamin D receptor (VDR)", "relationship": "RELATED_TO_DISEASE", "object": "Sarcopenia", "chunk": 2}
{"article": "PMC4109111.txt", "subject": "androgen receptor (AR)", "relationship": "RELATED_TO_DISEASE", "object": "Sarcopenia", "chunk": 2}
{"article": "PMC4109111.txt", "subject": "ciliary neurotrophic factor (CNTF)", "relationship": "RELATED_TO_DISEASE", "object": "Sarcopenia", "chunk": 2}
{"article": "PMC4109111.txt", "subject": "myostatin (MSTN)", "relationship": "RELATED_TO_DISEASE", "object": "Sarcopenia", "chunk": 2}
{"article": "PMC4109111.txt", "subject": "insulin-like growth factor 1 (IGF1)", "relationship": "RELATED_TO_DISEASE", "object": "Sarcopenia", "chunk": 2}
{"article": "PMC4109111.txt", "subject": "angiotensin I converting enzyme 1 (ACE)", "relationship": "RELATED_TO_DISEASE", "object": "Sarcopenia", "chunk": 2}
{"article": "PMC4109111.txt", "subject": "alpha actinin 3 (ACTN3)", "relationship": "RELATED_TO_DISEASE", "object": "Sarcopenia", "chunk": 2}
{"article": "PMC4109111.txt", "subject": "interleukin 6 (IL-6)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Muscle mass and strength", "chunk": 2}
{"article": "PMC4109111.txt", "subject": "tumor necrosis factor (TNF)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Muscle mass and strength", "chunk": 2}
{"article": "PMC4109111.txt", "subject": "ROS", "relationship": "INDICATES_PRESENCE_OF", "object": "Oxidative Stress", "chunk": 3}
{"article": "PMC4109111.txt", "subject": "Catalase", "relationship": "DECREASED_IN", "object": "Elderly Individuals", "chunk": 3}
{"article": "PMC4109111.txt", "subject": "Glutathione Transferase", "relationship": "DECREASED_IN", "object": "Elderly Individuals", "chunk": 3}
{"article": "PMC4109111.txt", "subject": "Superoxide Dismutase (MnSOD)", "relationship": "INCREASED_IN", "object": "Old Individuals", "chunk": 3}
{"article": "PMC4109111.txt", "subject": "Catalase", "relationship": "INCREASED_IN", "object": "Old Individuals", "chunk": 3}
{"article": "PMC4109111.txt", "subject": "TNF-\u03b1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "muscle wasting and sarcopenia", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "TNF-\u03b1", "relationship": "IS_CAUSE_OF", "object": "ROS production, mitochondrial dysfunction, and inflammation", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "NF-\u03baB", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "muscle atrophy", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "NF-\u03baB", "relationship": "INDUCED_BY", "object": "ROS and RNS", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "NF-\u03baB", "relationship": "REGULATES", "object": "Ubiquitin-proteasome pathway (UPS)", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "p38", "relationship": "REGULATES", "object": "expression of E3 ubiquitin ligases (atrogin-1)", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "MuRF-1", "relationship": "ASSOCIATED_WITH", "object": "muscle atrophy", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "atrogin-1", "relationship": "ASSOCIATED_WITH", "object": "muscle atrophy", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "Apoptosis", "relationship": "ASSOCIATED_WITH", "object": "Muscle atrophy and sarcopenia", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "p53", "relationship": "ASSOCIATED_WITH", "object": "Apoptosis", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "Bax", "relationship": "ASSOCIATED_WITH", "object": "Apoptosis", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "Caspase 3", "relationship": "ASSOCIATED_WITH", "object": "Apoptosis", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "EndoG", "relationship": "ASSOCIATED_WITH", "object": "Apoptosis", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "MAPK", "relationship": "ASSOCIATED_WITH", "object": "Cell death", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "Calpains", "relationship": "ASSOCIATED_WITH", "object": "Muscle wasting and sarcopenia", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "RyR1", "relationship": "ASSOCIATED_WITH", "object": "Proteolytic pathway and muscle wasting", "chunk": 4}
{"article": "PMC4109111.txt", "subject": "AGEs", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Lower muscle strength", "chunk": 6}
{"article": "PMC4109111.txt", "subject": "8-OHdG", "relationship": "USED_TO_DIAGNOSE", "object": "DNA damage", "chunk": 6}
{"article": "PMC4109111.txt", "subject": "vitamin E", "relationship": "RELATED_TREATMENT", "object": "Delaying or preventing muscle wasting in the elderly", "chunk": 6}
{"article": "PMC4109111.txt", "subject": "\u03b3-tocopherol", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Muscle strength", "chunk": 6}
{"article": "PMC4109111.txt", "subject": "\u03b1-tocopherol", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Muscle strength", "chunk": 6}
{"article": "PMC4109111.txt", "subject": "vitamin E", "relationship": "REDUCED_MORTALITY", "object": " Attenuation of the early onset of muscle weakness in the elderly", "chunk": 7}
{"article": "PMC4109111.txt", "subject": "vitamin E", "relationship": "RELATED_PROGNOSIS", "object": "improved physical performance and oxidative status", "chunk": 8}
{"article": "PMC4109111.txt", "subject": "vitamin E", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "attenuated unfavorable elevations", "chunk": 8}
{"article": "PMC4109111.txt", "subject": "vitamin E", "relationship": "RELATED_TREATMENT", "object": "repair of oxidative damaged proteins", "chunk": 8}
{"article": "PMC4109111.txt", "subject": "vitamin E", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "provide a stable antioxidant supply", "chunk": 8}
{"article": "PMC4109111.txt", "subject": "vitamin E", "relationship": "RELATED_TREATMENT", "object": "prevention and treatment for sarcopenia", "chunk": 9}
{"article": "PMC4109111.txt", "subject": "vitamin E", "relationship": "RELATED_TREATMENT", "object": "antiaging intervention for the muscle", "chunk": 9}
{"article": "PMC4109111.txt", "subject": "vitamin E", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Reducing oxidative stress in aging", "chunk": 9}
{"article": "PMC4109111.txt", "subject": "vitamin E", "relationship": "MONITORED_DURING_TREATMENT", "object": "repair of cell membrane injury", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid amyloid-\u03b21\u201342", "relationship": "DIAGNOSITC_OF", "object": "Diagnosis: Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4132648.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid amyloid-\u03b21\u201342", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosis of Alzheimer's disease", "chunk": 1}
{"article": "PMC4132648.txt", "subject": "amyloid-\u03b21\u201342", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosis of Alzheimer's disease", "chunk": 1}
{"article": "PMC4132648.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid phosphorylated tau", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnosis: Alzheimer's disease", "chunk": 1}
{"article": "PMC4132648.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid phosphorylated tau", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosis of Alzheimer's disease ", "chunk": 1}
{"article": "PMC4132648.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid total tau", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnosis: Alzheimer's disease", "chunk": 1}
{"article": "PMC4132648.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid total tau", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosis of Alzheimer's disease", "chunk": 1}
{"article": "PMC4132648.txt", "subject": "APOE4", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC4132648.txt", "subject": "cerebral spinal fluid amyloid-\u03b21\u201342", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC4132648.txt", "subject": "cerebral spinal fluid total tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC4132648.txt", "subject": "hippocampal volume", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC4132648.txt", "subject": "FDG-PET hypometabolism", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC4132648.txt", "subject": "atrophy rate measured from structural MRI", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC4132648.txt", "subject": "Biomarker evidence", "relationship": "INDICATES_PRESENCE_OF", "object": "presymptomatic Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC4132648.txt", "subject": "impaired cognitive function", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC4132648.txt", "subject": "amyloid-\u03b21\u201342", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "phosphorylated tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "total tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "ADAS-Cog", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "Rey Auditory Verbal Learning Test", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "Mini-Mental State Examination", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "brain", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "ventricles", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "hippocampus", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "entorhinal", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "mid temporal", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "fusiform", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "hippocampal atrophy", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "brain atrophy", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "APOE4", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4132648.txt", "subject": "amyloid", "relationship": "RELATED_TO", "object": "Staging of 285 subjects: 189 were amyloid+", "chunk": 4}
{"article": "PMC4132648.txt", "subject": "APOE", "relationship": "RELATED_TO", "object": "Staging of 285 subjects: 139 were APOE+", "chunk": 4}
{"article": "PMC4132648.txt", "subject": "amyloid", "relationship": "RELATED_TO", "object": "Staging of 285 subjects: 123 were amyloid+APOE+", "chunk": 4}
{"article": "PMC4132648.txt", "subject": "APOE +/\u2212", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 5}
{"article": "PMC4132648.txt", "subject": "amyloid+ ", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 5}
{"article": "PMC4132648.txt", "subject": "total tau", "relationship": "RELATED_TO", "object": "Alzheimer's disease", "chunk": 5}
{"article": "PMC4132648.txt", "subject": "phosphorylated tau", "relationship": "RELATED_TO", "object": "Alzheimer's disease", "chunk": 5}
{"article": "PMC4132648.txt", "subject": "amyloid-\u03b21\u201342", "relationship": "RELATED_TO", "object": "Alzheimer's disease", "chunk": 5}
{"article": "PMC4132648.txt", "subject": "total tau", "relationship": "RELATED_TREATMENT", "object": "cerebral spinal fluid total tau assays", "chunk": 8}
{"article": "PMC4132648.txt", "subject": "phosphorylated tau", "relationship": "RELATED_TREATMENT", "object": "cerebral spinal fluid total tau and phosphorylated tau assays", "chunk": 8}
{"article": "PMC4132648.txt", "subject": "amyloid-\u03b21\u201342", "relationship": "RELATED_TREATMENT", "object": "cerebral cerebral cerebral cerebral spinal fluid amyloid-\u03b21\u201342 assays", "chunk": 8}
{"article": "PMC4132648.txt", "subject": "amyloid-\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "Predict abnormal amyloid levels", "chunk": 8}
{"article": "PMC4132648.txt", "subject": "hippocampal atrophy rate", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 8}
{"article": "PMC4132648.txt", "subject": "entorhinal volume loss", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 8}
{"article": "PMC4132648.txt", "subject": "whole brain atrophy rate", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer\u2019s disease", "chunk": 8}
{"article": "PMC4132648.txt", "subject": "Mini-Mental State Examination reduction", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s disease", "chunk": 8}
{"article": "PMC4132648.txt", "subject": "vascular disease", "relationship": "RELATED_TREATMENT", "object": "contribute to brain atrophy rate", "chunk": 8}
{"article": "PMC4132648.txt", "subject": "amyloid-\u03b2", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Abnormal levels indicate Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "Phosphorylated tau", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Abnormal levels indicate Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "Total tau", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Abnormal levels indicate Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "Hippocampal atrophy", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Measured in ml/year, abnormal levels indicate Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "Brain atrophy", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Measured in ml/year, abnormal levels indicate Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "RAVLT", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "ADAS-Cog", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "MMSE", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "Hippocampus (% TIV)", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Abnormal levels indicate Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "Entorhinal (% TIV)", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Abnormal levels indicate Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "Mid temporal (% TIV)", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Abnormal levels indicate Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "Whole brain (% TIV)", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Abnormal levels indicate Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "Fusiform (% TIV)", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Abnormal levels indicate Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "Ventricles (% TIV)", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Abnormal levels indicate Alzheimer's disease", "chunk": 9}
{"article": "PMC4132648.txt", "subject": "FDG", "relationship": "RELATED_TO_DIAGNOSTIC", "object": "Mild Cognitive Impairment subtypes", "chunk": 10}
{"article": "PMC4132648.txt", "subject": "Amyloid PET biomarkers", "relationship": "RELATED_TO_DIAGNOSTIC", "object": "Mild Cognitive Impairment subtypes", "chunk": 10}
{"article": "PMC4132648.txt", "subject": "Tau-PET", "relationship": "RELATED_TO_DIAGNOSTIC", "object": "Alzheimer's Disease", "chunk": 10}
{"article": "PMC4132648.txt", "subject": "APOE", "relationship": "RELATED_TO_DIAGNOSTIC", "object": "Alzheimer's Disease", "chunk": 10}
{"article": "PMC4150993.txt", "subject": "amyloid deposits", "relationship": "RELATED TO", "object": "neurophysiological status", "chunk": 1}
{"article": "PMC4150993.txt", "subject": "white matter pathways", "relationship": "RELATED TO", "object": "neurophysiological status", "chunk": 1}
{"article": "PMC4150993.txt", "subject": "genetic, pharmacological and other biomarkers ", "relationship": "RELATED TO", "object": "neurophysiological status", "chunk": 1}
{"article": "PMC4150993.txt", "subject": "high level of cardiovascular fitness", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "cognitive aging and protection against risk", "chunk": 5}
{"article": "PMC4150993.txt", "subject": "high level of cardiovascular fitness", "relationship": "RELATED_TO", "object": "modest enhancement of brain health directly, most likely through increased secretion of brain-derived neurotrophic factor (BDNF)", "chunk": 5}
{"article": "PMC4150993.txt", "subject": "high level of cardiovascular fitness", "relationship": "RELATED_TO", "object": "improved vasculature", "chunk": 5}
{"article": "PMC4150993.txt", "subject": "intellectual and social activities in middle and late adulthood", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "better cognitive ability in middle-aged and older adults, less age-related cognitive decline", "chunk": 5}
{"article": "PMC4150993.txt", "subject": "highly educated individuals", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "diagnosed with dementia at later ages", "chunk": 5}
{"article": "PMC4150993.txt", "subject": "APOE-4 gene", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s diagnosis", "chunk": 6}
{"article": "PMC4150993.txt", "subject": "APOE-4 gene", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Substantially increases the risk of Alzheimer\u2019s diagnosis", "chunk": 6}
{"article": "PMC4150993.txt", "subject": "amyloid and tau deposition", "relationship": "RELATED_TO", "object": "Alzheimer\u2019s disease", "chunk": 6}
{"article": "PMC4150993.txt", "subject": "amyloid and tau deposition", "relationship": "RELATED_TREATMENT", "object": "Used in amyloid imaging techniques", "chunk": 6}
{"article": "PMC4150993.txt", "subject": "amyloid", "relationship": "INDICATES_PRESENCE_OF", "object": "preclinical AD ", "chunk": 6}
{"article": "PMC4150993.txt", "subject": "high amyloid burden", "relationship": "INDICATES_PRESENCE_OF", "object": "preclinical AD", "chunk": 6}
{"article": "PMC4150993.txt", "subject": "amyloid deposition", "relationship": "INDICATES_PRESENCE_OF", "object": "Preclinical AD", "chunk": 7}
{"article": "PMC4150993.txt", "subject": "tau protein", "relationship": "INDICATES_PRESENCE_OF", "object": "Preclinical AD", "chunk": 7}
{"article": "PMC4150993.txt", "subject": "hippocampal volume", "relationship": "RELATED_PROGNOSIS", "object": "Decline in AD", "chunk": 7}
{"article": "PMC4153626.txt", "subject": "Gait Speed", "relationship": "RELATED_PROGNOSIS", "object": "Faster gait speed is predictor of Cluster Falls trajectory.", "chunk": 4}
{"article": "PMC4153626.txt", "subject": "Diabetes Mellitus (DM)", "relationship": "RELATED_PROGNOSIS", "object": "Diabetes Mellitus is a predictor of Increasing Falls trajectory.", "chunk": 4}
{"article": "PMC4153626.txt", "subject": "Cognitive Impairment", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive impairment is a predictor of Increasing Falls trajectory.", "chunk": 4}
{"article": "PMC4153626.txt", "subject": "Comorbidities (2 or more)", "relationship": "RELATED_PROGNOSIS", "object": "2 or more comorbidities is a predictor of Chronic Recurring Falls trajectory.", "chunk": 4}
{"article": "PMC4153626.txt", "subject": "Falls in past year", "relationship": "RELATED_PROGNOSIS", "object": "Falls in the past year are predictors of Cluster Falls and Chronic Recurring Falls trajectories.", "chunk": 4}
{"article": "PMC4153626.txt", "subject": "Symptoms of Depression", "relationship": "RELATED_PROGNOSIS", "object": "Symptoms of depression are predictive of all faller trajectory groups.", "chunk": 4}
{"article": "PMC4159858.txt", "subject": "Aluminum", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer-like lesions in the brain", "chunk": 1}
{"article": "PMC4159858.txt", "subject": "Sulforaphane", "relationship": "PREDICTS_SURVIVAL", "object": "Lower aluminum levels in the brain of AD-like mice", "chunk": 1}
{"article": "PMC4159858.txt", "subject": "Sulforaphane", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Potential application in AD therapeutics", "chunk": 1}
{"article": "PMC4159858.txt", "subject": "Cholinergic neurons", "relationship": "RELATED_PROGNOSIS", "object": "Decreased numbers were observed in the medial septal (MS) and hippocampal CA1 regions of AD-like mice compared with controls and AD-like mice treated with SFN", "chunk": 2}
{"article": "PMC4159858.txt", "subject": "Cholinergic neurons", "relationship": "RELATED_TREATMENT", "object": "SFN treatment  increased the numbers in these regions", "chunk": 2}
{"article": "PMC4159858.txt", "subject": "BrdU-positive neurons", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "SFN significantly increased the numbers of BrdU-positive neurons in the SVZ and SGZ of AD-like mice", "chunk": 2}
{"article": "PMC4159858.txt", "subject": "BrdU-positive neurons", "relationship": "INDICATES_PRESENCE_OF", "object": "proliferation, a marker of neurogenesis", "chunk": 2}
{"article": "PMC4159858.txt", "subject": "Cholinergic neurons", "relationship": "INDICATES_PRESENCE_OF", "object": "The presence of cholinergic neurons was indicated by the presence of brown immunoreactive cells", "chunk": 2}
{"article": "PMC4159858.txt", "subject": "ChAT", "relationship": "INDICATES_PRESENCE_OF", "object": "Cholinergic neurons", "chunk": 3}
{"article": "PMC4159858.txt", "subject": "ChAT", "relationship": "RELATED_TREATMENT", "object": "Treating AD-like mice with SFN could lead to the increase of cholinergic neurons", "chunk": 3}
{"article": "PMC4159858.txt", "subject": "ChAT", "relationship": "MONITORED_DURING_TREATMENT", "object": "Changes in the cholinergic system (ACh level and ChAT and AChE activities) in the cerebral cortex", "chunk": 3}
{"article": "PMC4159858.txt", "subject": "AChE", "relationship": "MONITORED_DURING_TREATMENT", "object": "Changes in the cholinergic system (ACh level and ChAT and AChE activities) in the cerebral cortex", "chunk": 3}
{"article": "PMC4159858.txt", "subject": "ACh", "relationship": "MONITORED_DURING_TREATMENT", "object": "Changes in the cholinergic system (ACh level and ChAT and AChE activities) in the cerebral cortex", "chunk": 3}
{"article": "PMC4159858.txt", "subject": "ChAT", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Cholinergic neuron loss in the MS and hippocampal CA1 regions", "chunk": 3}
{"article": "PMC4159858.txt", "subject": "SFN", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "SFN is a promising compound with neuroprotective properties, which is expected to be useful in the prevention of AD.", "chunk": 3}
{"article": "PMC4159858.txt", "subject": "BrdU", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "can be incorporated into DNA only during the S-phase of the mitotic process", "chunk": 3}
{"article": "PMC4159858.txt", "subject": "Ki-67", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Another marker, such as Ki-67, which is fully positive for its whole duration", "chunk": 3}
{"article": "PMC4159858.txt", "subject": "TUNEL", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "A Terminal-deoxynucleoitidyl Transferase Mediated Nick End Labeling (TUNEL) test", "chunk": 3}
{"article": "PMC4159858.txt", "subject": "Aluminum", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Aluminum load reduction may be implicated in SFN-mediated neuroprotective effects in AD-like mice", "chunk": 3}
{"article": "PMC4159858.txt", "subject": "Aluminum", "relationship": "RELATED_TREATMENT", "object": "SFN may reduce aluminum load", "chunk": 5}
{"article": "PMC4159858.txt", "subject": "AChE", "relationship": "MONITORED_DURING_TREATMENT", "object": "Activities were described in units per milligram fresh tissue protein", "chunk": 5}
{"article": "PMC4159858.txt", "subject": "ChAT", "relationship": "MONITORED_DURING_TREATMENT", "object": "Activities were described in units per milligram fresh tissue protein", "chunk": 5}
{"article": "PMC4159858.txt", "subject": "ACh", "relationship": "MONITORED_DURING_TREATMENT", "object": "Level was expressed as micrograms per milligram fresh tissue protein", "chunk": 5}
{"article": "PMC4174765.txt", "subject": "Amyloid (A\u03b2) oligomers", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurotransmission pathways dysfunction", "chunk": 1}
{"article": "PMC4174765.txt", "subject": "Amyloid (A\u03b2) oligomers", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cell dysfunction, neurotransmitters signalling imbalance and neurological signs", "chunk": 1}
{"article": "PMC4174765.txt", "subject": "Amyloid precursor protein (APP)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Amyloid hypothesis postulates that APP undergoes impairment of physiological cleavage system due to unknown trigger(s), producing oligomeric toxic species", "chunk": 1}
{"article": "PMC4174765.txt", "subject": "APP oligomers", "relationship": "RELATED_PROGNOSIS", "object": "Impairment of synaptic plasticity mechanisms, neuronal network disarrangement and cell death", "chunk": 1}
{"article": "PMC4174765.txt", "subject": "Oligomers", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alteration in stoichiometry could be responsible for cell degeneration and death", "chunk": 1}
{"article": "PMC4174765.txt", "subject": "Extrapyramidal signs", "relationship": "INDICATES_PRESENCE_OF", "object": "Dopamine (DA) containing neurons undergo degenerative changes", "chunk": 1}
{"article": "PMC4174765.txt", "subject": "Dopamine (DA) containing neurons", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cognitive decline and non-cognitive symptoms of AD", "chunk": 1}
{"article": "PMC4174765.txt", "subject": "A\u03b2 oligomers", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurodegeneration", "chunk": 3}
{"article": "PMC4174765.txt", "subject": "A\u03b2 oligomers", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Rapid progression of cognitive decline", "chunk": 3}
{"article": "PMC4174765.txt", "subject": " \u03b17 nAChRs", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment targeting A\u03b2 oligomers", "chunk": 3}
{"article": "PMC4174765.txt", "subject": "\u03b5 -syn", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Prevention of aggregation", "chunk": 3}
{"article": "PMC4179179.txt", "subject": "Hcy", "relationship": "RELATED_TREATMENT", "object": "n-3 PUFAs have demonstrated their ability to reduce Hcy levels", "chunk": 1}
{"article": "PMC4179179.txt", "subject": "DHA", "relationship": "RELATED_TREATMENT", "object": "daily administration of oils rich in DHA and LA to rats significantly decreased the plasma Hcy concentration", "chunk": 1}
{"article": "PMC4179179.txt", "subject": "n-3 PUFAs", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "cardiovascular diseases are risk factors for both vascular and degenerative dementia", "chunk": 1}
{"article": "PMC4179179.txt", "subject": "n-3 PUFAs", "relationship": "RELATED_PROGNOSIS", "object": "reduce the risk of cognitive decline", "chunk": 1}
{"article": "PMC4179179.txt", "subject": "n-3 PUFAs, particularly DHA", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "associated with reduced cognitive decline during aging", "chunk": 1}
{"article": "PMC4179179.txt", "subject": "n-3 PUFAs", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "an important mechanism to reduce the risk of cognitive decline", "chunk": 1}
{"article": "PMC4179179.txt", "subject": "hs-CRP", "relationship": "INDICATES_PRESENCE_OF", "object": "inflammation", "chunk": 2}
{"article": "PMC4179179.txt", "subject": "homocysteine (Hcy)", "relationship": "RELATED_TO", "object": "cardiovascular risk", "chunk": 2}
{"article": "PMC4179179.txt", "subject": "homocysteine (Hcy)", "relationship": "PREDICTED_BY", "object": "the clinical assessments of cognitive function", "chunk": 2}
{"article": "PMC4179179.txt", "subject": "Total cholesterol", "relationship": "RELATED_TO_DISEASE_STATE", "object": "Increased in the case group (with cognitive impairment) compared to the control group", "chunk": 3}
{"article": "PMC4179179.txt", "subject": "LDL cholesterol", "relationship": "RELATED_TO_DISEASE_STATE", "object": "Increased in the case group (with cognitive impairment) compared to the control group", "chunk": 3}
{"article": "PMC4179179.txt", "subject": "Triglycerides", "relationship": "RELATED_TO_DISEASE_STATE", "object": "Increased in the case group (with cognitive impairment) compared to the control group", "chunk": 3}
{"article": "PMC4179179.txt", "subject": "Total cholesterol/HDL-C ratio", "relationship": "RELATED_TO_DISEASE_STATE", "object": "Increased in the case group (with cognitive impairment) compared to the control group", "chunk": 3}
{"article": "PMC4179179.txt", "subject": "14:0", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment", "chunk": 3}
{"article": "PMC4179179.txt", "subject": "16:0", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment", "chunk": 3}
{"article": "PMC4179179.txt", "subject": "22:0", "relationship": "INDICATES_ABSENCE_OF", "object": "Cognitive impairment", "chunk": 3}
{"article": "PMC4179179.txt", "subject": "24:1n-9", "relationship": "INDICATES_ABSENCE_OF", "object": "Cognitive impairment", "chunk": 3}
{"article": "PMC4179179.txt", "subject": "16:1n-7", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment", "chunk": 3}
{"article": "PMC4179179.txt", "subject": "22:6n-3 (DHA)", "relationship": "RELATED_TO_DISEASE_STATE", "object": "Decreased in the case group (with cognitive impairment) compared to the control group", "chunk": 3}
{"article": "PMC4179179.txt", "subject": "Total Polyunsaturated fatty acids", "relationship": "RELATED_TO_DISEASE_STATE", "object": "Decreased in the case group (with cognitive impairment) compared to the control group", "chunk": 3}
{"article": "PMC4179179.txt", "subject": "Hcy", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive impairment", "chunk": 4}
{"article": "PMC4179179.txt", "subject": "Hcy", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cognitive decline (negative correlation with cognitive performance)", "chunk": 4}
{"article": "PMC4179179.txt", "subject": "Hcy", "relationship": "RELATED_TREATMENT", "object": "Management of cognitive impairment", "chunk": 4}
{"article": "PMC4179179.txt", "subject": "22:6n-3", "relationship": "RELATED_TREATMENT", "object": "Brain health (specifically memory formation)", "chunk": 4}
{"article": "PMC4179179.txt", "subject": "22:6n-3", "relationship": "RELATED_TREATMENT", "object": "Neurological function", "chunk": 4}
{"article": "PMC4179179.txt", "subject": "n-6/n-3 ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased risk for chronic diseases", "chunk": 4}
{"article": "PMC4179179.txt", "subject": "20:4n-6", "relationship": "RELATED_PROGNOSIS", "object": "Inflammation", "chunk": 4}
{"article": "PMC4179179.txt", "subject": "EPA and DHA", "relationship": "INDICATES_PRESENCE_OF", "object": "Anti-inflammatory effects", "chunk": 4}
{"article": "PMC4179179.txt", "subject": "hs-CRP", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Managing inflammation", "chunk": 4}
{"article": "PMC4179179.txt", "subject": "n-3 PUFAs", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Better cognitive performance", "chunk": 5}
{"article": "PMC4179179.txt", "subject": "DHA", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Better cognitive performance", "chunk": 5}
{"article": "PMC4179179.txt", "subject": "DHA", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": " Suppressing A\u03b2 peptide production and amyloid plaque formation", "chunk": 5}
{"article": "PMC4179179.txt", "subject": "myristic acid (14:0)", "relationship": "RELATED_TO", "object": "Cognitive decline", "chunk": 5}
{"article": "PMC4179179.txt", "subject": "palmitic acid (16:0)", "relationship": "RELATED_TO", "object": "Cognitive decline", "chunk": 5}
{"article": "PMC4179179.txt", "subject": "palmitoleic acid (16:1n-7)", "relationship": "RELATED_TO", "object": "Cognitive decline", "chunk": 5}
{"article": "PMC4179179.txt", "subject": "n-6/n-3 ratio", "relationship": "RELATED_TO", "object": "Cognitive decline", "chunk": 5}
{"article": "PMC4181752.txt", "subject": "Geriatric Depression Scale (GDS)", "relationship": "RELATED_PROGNOSIS", "object": "Assessment of progression of dementia", "chunk": 1}
{"article": "PMC4181752.txt", "subject": "Geriatric Depression Scale (GDS)", "relationship": "INDICATES_PRESENCE_OF", "object": "Depression in elderly patients", "chunk": 3}
{"article": "PMC4195286.txt", "subject": "CNV amplitude", "relationship": "INDICATES_PRESENCE_OF", "object": "Modulations in the P1 and N1 components", "chunk": 5}
{"article": "PMC4195286.txt", "subject": "SC condition", "relationship": "RELATED_TO", "object": "Higher amplitude (more negative) of the CNV", "chunk": 5}
{"article": "PMC4195286.txt", "subject": "SC condition", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Stimuli presentation and targets", "chunk": 5}
{"article": "PMC4195286.txt", "subject": "N1 amplitude", "relationship": "INDICATES_PRESENCE_OF", "object": "Congruent target condition", "chunk": 7}
{"article": "PMC4195286.txt", "subject": "BA 19", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "P1 generator", "chunk": 10}
{"article": "PMC4200223.txt", "subject": "frontal structural abnormalities", "relationship": "RELATED_TO", "object": "neuropsychiatric symptoms observed in AD patients", "chunk": 2}
{"article": "PMC4200223.txt", "subject": "apathy", "relationship": "ASSOCIATED_WITH", "object": "frontal structures", "chunk": 2}
{"article": "PMC4200223.txt", "subject": "delusions", "relationship": "CORRELATED_WITH", "object": "frontal, parietal, and temporal structures", "chunk": 2}
{"article": "PMC4200223.txt", "subject": "depressive symptoms", "relationship": "ASSOCIATED_WITH", "object": "thalamus, lentiform nucleus, and medial temporal cortex", "chunk": 2}
{"article": "PMC4200223.txt", "subject": "agitation", "relationship": "ASSOCIATED_WITH", "object": "temporal and frontal structures", "chunk": 2}
{"article": "PMC4200223.txt", "subject": "amygdale atrophy", "relationship": "RELATED_TO", "object": "aberrant motor behaviour", "chunk": 2}
{"article": "PMC4200223.txt", "subject": "amygdale atrophy", "relationship": "POTENTIALLY_RELATED_TO", "object": "anxiety and irritability", "chunk": 2}
{"article": "PMC4200223.txt", "subject": "Mini-Zarit test", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Caregiver health", "chunk": 3}
{"article": "PMC4200223.txt", "subject": "Geriatric Depression Scale (GDS)", "relationship": "INDICATES_PRESENCE_OF", "object": "Depression", "chunk": 3}
{"article": "PMC4200223.txt", "subject": "MINI", "relationship": "INDICATES_PRESENCE_OF", "object": "Previous instances of depression", "chunk": 3}
{"article": "PMC4202787.txt", "subject": "F2-isoprostane levels", "relationship": "INDICATES_PRESENCE_OF", "object": "Oxidative stress", "chunk": 2}
{"article": "PMC4202787.txt", "subject": "\u03b2-OHB levels", "relationship": "INDICATES_PRESENCE_OF", "object": "Paragraph recall improvement with MCT administration", "chunk": 3}
{"article": "PMC4202787.txt", "subject": "ADAS-cog", "relationship": "RELATED_PROGNOSIS", "object": "Treatment effect of AC-1202", "chunk": 3}
{"article": "PMC4202787.txt", "subject": "ADAS-cog", "relationship": "MONITORED_DURING_TREATMENT", "object": "Ginkgo Biloba treatment", "chunk": 3}
{"article": "PMC4202787.txt", "subject": "3MSE", "relationship": "MONITORED_DURING_TREATMENT", "object": "Ginkgo Biloba treatment", "chunk": 3}
{"article": "PMC4202787.txt", "subject": "vitamin E (\u03b1-tocopherol)", "relationship": "USED_TO_DIAGNOSE", "object": "Slowing the progression of AD", "chunk": 3}
{"article": "PMC4202787.txt", "subject": "\u03b1-tocopherol", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "AD treatment", "chunk": 3}
{"article": "PMC4202787.txt", "subject": "\u03b1-tocopherol", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "AD progression slowing", "chunk": 3}
{"article": "PMC4202787.txt", "subject": "\u03b1-tocopherol", "relationship": "IS_TARGET_OF_TREATMENT", "object": "AD progression slowing", "chunk": 3}
{"article": "PMC4202787.txt", "subject": "vitamin C (ascorbic acid)", "relationship": "RELATED_PROGNOSIS", "object": "Prevention and treatment of AD", "chunk": 3}
{"article": "PMC4202787.txt", "subject": "vitamin C (ascorbic acid)", "relationship": "INDICATES_PRESENCE_OF", "object": "Essential vitamin for human health", "chunk": 3}
{"article": "PMC4202787.txt", "subject": "Vitamin C", "relationship": "INDICATES_PRESENCE_OF", "object": "AD and cognitive impairment", "chunk": 4}
{"article": "PMC4202787.txt", "subject": "vitamin C", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "AD and cognitive impairment", "chunk": 4}
{"article": "PMC4202787.txt", "subject": "CoQ10", "relationship": "IS_TARGET_OF_TREATMENT", "object": "reduce amyloid plaque deposition", "chunk": 4}
{"article": "PMC4202787.txt", "subject": "CoQ10", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "antioxidant therapy", "chunk": 4}
{"article": "PMC4202787.txt", "subject": "Latreperdine", "relationship": "is_basis_for_therapy_choice", "object": "treatment of AD", "chunk": 4}
{"article": "PMC4202787.txt", "subject": "Omage-3 fatty acids", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "prevention or slow AD progression", "chunk": 4}
{"article": "PMC4202787.txt", "subject": "Docosahexaenoic acid (DHA)", "relationship": "RELATED_TREATMENT", "object": " prevention or slow AD progression", "chunk": 4}
{"article": "PMC4202787.txt", "subject": "Eicosapentaenoic acid (EPA)", "relationship": "RELATED_TREATMENT", "object": " prevention or slow AD progression", "chunk": 4}
{"article": "PMC4202787.txt", "subject": "ApoE \u03b54", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Negating the beneficial effects of omega-3 fatty acids", "chunk": 5}
{"article": "PMC4202787.txt", "subject": "ApoE \u03b54", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer's disease", "chunk": 5}
{"article": "PMC4202787.txt", "subject": "omega-3 fatty acids", "relationship": "INDICATES_PRESENCE_OF", "object": "cognitive decline in association with AD", "chunk": 5}
{"article": "PMC4202787.txt", "subject": "vitamin B12", "relationship": "RELATED_PROGNOSIS", "object": "increased risk of AD", "chunk": 5}
{"article": "PMC4202787.txt", "subject": "serum homocysteine levels", "relationship": "RELATED_PROGNOSIS", "object": "increased risk of AD", "chunk": 5}
{"article": "PMC4202787.txt", "subject": "folate", "relationship": "RELATED_TREATMENT", "object": "slowing the onset or progression of AD in cerebral gray matter", "chunk": 5}
{"article": "PMC4202787.txt", "subject": "Cerefolin NAC", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "treating vitamin deficiencies associated with memory loss", "chunk": 5}
{"article": "PMC4202787.txt", "subject": "B complex vitamins", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "routine laboratory analysis of such vitamin levels, and repletion if found to be deficient", "chunk": 5}
{"article": "PMC4202787.txt", "subject": "\u03b2-hydroxybutyrate", "relationship": "INDICATES_PRESENCE_OF", "object": "Higher ketone levels", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "\u03b2-hydroxybutyrate", "relationship": "RELATED_TREATMENT", "object": "Possible strategy for treatment of AD", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "Medium chain triglycerides (MCTs)", "relationship": "RELATED_TREATMENT", "object": "Possible strategy for treatment of AD", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "MCTs", "relationship": "RELATED_TREATMENT", "object": "Produce higher ketone levels in the blood", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "Coconut oil", "relationship": "RELATED_TREATMENT", "object": "Treatment for AD", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "Caprylic acid", "relationship": "RELATED_TREATMENT", "object": "Restore brain function", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "Axona\u00ae", "relationship": "RELATED_TREATMENT", "object": "Improve cognition", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "Souvenaid\u00ae", "relationship": "RELATED_TREATMENT", "object": "Promote synaptic formation and function", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "Souvenaid\u00ae", "relationship": "RELATED_TREATMENT", "object": "Cognitive improvement", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "Souvenaid\u00ae", "relationship": "RELATED_TREATMENT", "object": "Enhance synaptic health and neuronal stability", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "uridine monophosphate", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Target underlying process in AD", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "choline", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Target underlying process in AD", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "phospholipids", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Target underlying process in AD", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "EPA", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Target underlying process in AD", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "DHA", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Target underlying process in AD", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "vitamins E, C, B12, and B6", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Target underlying process in AD", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "folic acid", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Target underlying process in AD", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "selenium", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Target underlying process in AD", "chunk": 6}
{"article": "PMC4202787.txt", "subject": "Mediterranean diet", "relationship": "RELATED_PROGNOSIS", "object": "reduced mortality in patients with AD", "chunk": 7}
{"article": "PMC4202787.txt", "subject": "Mediterranean diet", "relationship": "RELATED_PROGNOSIS", "object": "lower risk of AD (primary prevention)", "chunk": 7}
{"article": "PMC4202787.txt", "subject": "Mediterranean diet", "relationship": "RELATED_PROGNOSIS", "object": "slower progression of symptoms of mild cognitive decline into AD", "chunk": 7}
{"article": "PMC4202787.txt", "subject": "Mediterranean diet", "relationship": "RELATED_TREATMENT", "object": "preventive measure for AD and cognitive impairment", "chunk": 7}
{"article": "PMC4202787.txt", "subject": "Mediterranean diet", "relationship": "RELATED_PROGNOSIS", "object": "greater compliance and dosage being associated with greater benefits", "chunk": 7}
{"article": "PMC4202787.txt", "subject": "olive oil", "relationship": "RELATED_TREATMENT", "object": "inhibitory properties on fibrillization of tau protein", "chunk": 7}
{"article": "PMC4202787.txt", "subject": "monounsaturated fatty acids (MUFAs)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "promotes neuronal health", "chunk": 7}
{"article": "PMC4202787.txt", "subject": "polyunsaturated fatty acids (PUFAs)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "promotes neuronal health", "chunk": 7}
{"article": "PMC4202787.txt", "subject": "micronutrients", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "promotes neuronal health", "chunk": 7}
{"article": "PMC4202787.txt", "subject": "macronutrients", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "promotes neuronal health", "chunk": 7}
{"article": "PMC4202787.txt", "subject": "Huperzine A", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": " Treatment of AD patients", "chunk": 8}
{"article": "PMC4202787.txt", "subject": "Huperzine A", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Drug-na\u00efve populations", "chunk": 8}
{"article": "PMC4202787.txt", "subject": "Gingko biloba", "relationship": "RELATED_TREATMENT", "object": "Preventing the development of or slowing progression of mild cognitive impairment into AD", "chunk": 8}
{"article": "PMC4202787.txt", "subject": "Resveratrol", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Mild to moderate AD patients", "chunk": 8}
{"article": "PMC4202787.txt", "subject": "Curcumin", "relationship": "RELATED_TREATMENT", "object": "Treat or preventing cancer, aging and AD", "chunk": 8}
{"article": "PMC4221919.txt", "subject": "VO2max", "relationship": "RELATED_PROGNOSIS", "object": "Aerobic exercise capacity", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "HRV", "relationship": "RELATED_PROGNOSIS", "object": "Autonomic nervous system", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "SNS activity", "relationship": "RELATED_PROGNOSIS", "object": "Autonomic nervous system", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "BP", "relationship": "RELATED_PROGNOSIS", "object": "Cardiovascular", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "pulse wave velocity", "relationship": "RELATED_PROGNOSIS", "object": "Cardiovascular", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "endothelial function", "relationship": "RELATED_PROGNOSIS", "object": "Cardiovascular", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "cardiac-echocardiography", "relationship": "RELATED_PROGNOSIS", "object": "Cardiovascular", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "executive function", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive function", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "memory", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive function", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "Glucose tolerance", "relationship": "RELATED_PROGNOSIS", "object": "glucose", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "insulin sensitivity", "relationship": "RELATED_PROGNOSIS", "object": "glucose", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "superoxide production", "relationship": "RELATED_PROGNOSIS", "object": "Inflammation/oxidative stress", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "cytokines", "relationship": "RELATED_PROGNOSIS", "object": "Inflammation/oxidative stress", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "antioxidants", "relationship": "RELATED_PROGNOSIS", "object": "Inflammation/oxidative stress", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "GFR", "relationship": "RELATED_PROGNOSIS", "object": "Kidney function", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "BUN", "relationship": "RELATED_PROGNOSIS", "object": "Kidney function", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "urinary protein", "relationship": "RELATED_PROGNOSIS", "object": "Kidney function", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "strength", "relationship": "RELATED_PROGNOSIS", "object": "Motor/physical function", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "endurance", "relationship": "RELATED_PROGNOSIS", "object": "Motor/physical function", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "balance", "relationship": "RELATED_PROGNOSIS", "object": "Motor/physical function", "chunk": 4}
{"article": "PMC4221919.txt", "subject": "coordination", "relationship": "RELATED_PROGNOSIS", "object": "Motor/physical function", "chunk": 4}
{"article": "PMC4227681.txt", "subject": "Amyloid peptides (A\u03b2)", "relationship": "DIAGNOSITC_OF", "object": "Senile plaques, hallmark of Alzheimer's disease", "chunk": 1}
{"article": "PMC4227681.txt", "subject": "A\u03b2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Amyloid-related locomotor dysfunction and premature death", "chunk": 1}
{"article": "PMC4227681.txt", "subject": "A\u03b2", "relationship": "RELATED_TO", "object": "Neuronal death and brain shrinkage", "chunk": 1}
{"article": "PMC4227681.txt", "subject": "A\u03b2", "relationship": "RELATED_TREATMENT", "object": "SmartSoup reduces A\u03b2 levels and amyloid associated pathology in AD transgenic mice", "chunk": 1}
{"article": "PMC4227681.txt", "subject": "Tau protein", "relationship": "DIAGNOSITC_OF", "object": "Neurofibrillary tangles, a hallmark of Alzheimer's disease", "chunk": 1}
{"article": "PMC4227681.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloidosis", "chunk": 1}
{"article": "PMC4227681.txt", "subject": "Radix Polygalae (RP)", "relationship": "RELATED_TREATMENT", "object": "Reduces A\u03b2 generation", "chunk": 1}
{"article": "PMC4227681.txt", "subject": "Rhizoma Acori Tatarinowii (AT)", "relationship": "RELATED_TREATMENT", "object": "Exerts neuroprotective effects against A\u03b2", "chunk": 1}
{"article": "PMC4227681.txt", "subject": "Poria cum Radix Pini (PRP)", "relationship": "RELATED_TREATMENT", "object": "Exerts neuroprotective effects against A\u03b2", "chunk": 1}
{"article": "PMC4227681.txt", "subject": "A\u03b240", "relationship": "RELATED_TREATEMENT", "object": "SS was administered to assess its efficacy against AD.", "chunk": 2}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATEMENT", "object": "SS was administered to assess its efficacy against AD.", "chunk": 2}
{"article": "PMC4227681.txt", "subject": "A\u03b2", "relationship": "MONITORED_DURING_TREATMENT", "object": "A\u03b2 plaque deposition was monitored using immunohistochemistry.", "chunk": 2}
{"article": "PMC4227681.txt", "subject": "A\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "The efficacy of SS was assessed relative to its effect on A\u03b2 plaque deposition.", "chunk": 2}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid fibril formation", "chunk": 3}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "RELATED_TO", "object": "Oligomeric  A\u03b2 peptides", "chunk": 3}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "RELATED_TO", "object": "Amyloid peptides", "chunk": 3}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "RELATED_TO", "object": "Fibrils", "chunk": 3}
{"article": "PMC4227681.txt", "subject": "A\u03b240", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid fibril formation", "chunk": 3}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "USED_TO_DIAGNOSE", "object": "A\u00df42 amyloid fibril formation", "chunk": 3}
{"article": "PMC4227681.txt", "subject": "APP", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnose: Early-onset Alzheimer's Disease", "chunk": 3}
{"article": "PMC4227681.txt", "subject": "A\u03b2 levels", "relationship": "RELATED_TO_TREATMENT", "object": "reduced by SS treatment", "chunk": 4}
{"article": "PMC4227681.txt", "subject": "A\u03b2 deposits", "relationship": "INDICATES_PRESENCE_OF", "object": "Cerebral amyloidosis", "chunk": 4}
{"article": "PMC4227681.txt", "subject": "A\u03b2 plaques", "relationship": "ASSOCIATED_WITH", "object": "amyloidosis", "chunk": 4}
{"article": "PMC4227681.txt", "subject": "amyloid plaques", "relationship": "PREDICTS_SURVIVAL", "object": "formation prevented or clearance enhanced by SS treatment", "chunk": 4}
{"article": "PMC4227681.txt", "subject": "A\u03b2 plaque burden", "relationship": "REDUCED_BY", "object": "SS treatment", "chunk": 4}
{"article": "PMC4227681.txt", "subject": "A\u03b240", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "A\u03b240 levels in the culture medium of cells treated with SS were reduced in a dose-dependent manner", "chunk": 6}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "A\u03b242 levels in the culture medium of cells treated with SS were reduced in a dose-dependent manner.", "chunk": 6}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "A\u03b2-induced premature death", "chunk": 6}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b2 transgenic flies", "chunk": 6}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "RELATED_TO", "object": "Toxicity", "chunk": 7}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "TARGET_OF_TREATMENT", "object": "SS", "chunk": 7}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "ASSOCIATED_WITH", "object": "Amyloidosis", "chunk": 7}
{"article": "PMC4227681.txt", "subject": "A\u03b240", "relationship": "TARGET_OF_TREATMENT", "object": "RP", "chunk": 7}
{"article": "PMC4227681.txt", "subject": "AT", "relationship": "PROTECTS_AGAINST", "object": "A\u03b242 induced toxicity", "chunk": 7}
{"article": "PMC4227681.txt", "subject": "PRP", "relationship": "PROTECTS_AGAINST", "object": "A\u03b242 induced toxicity", "chunk": 7}
{"article": "PMC4227681.txt", "subject": "SS", "relationship": "AMELIORATED", "object": "AD-related pathological symptoms", "chunk": 7}
{"article": "PMC4227681.txt", "subject": "SS", "relationship": "REDUCES", "object": "A\u03b2 levels", "chunk": 7}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "RP reduces the A\u03b2 generation", "chunk": 8}
{"article": "PMC4227681.txt", "subject": "A\u03b240", "relationship": "RELATED_TREATMENT", "object": "RP reduces the A\u03b2 generation", "chunk": 8}
{"article": "PMC4227681.txt", "subject": "A\u03b242", "relationship": "MONITORED_DURING_TREATMENT", "object": "Representative Western blots and Atomic Force Microscope (AFM) for A\u03b242 oligomers", "chunk": 8}
{"article": "PMC4227681.txt", "subject": "A\u03b242 oligomers", "relationship": "MONITORED_DURING_TREATMENT", "object": "Representative Western blots and Atomic Force Microscope (AFM) for A\u03b242 oligomers", "chunk": 8}
{"article": "PMC4233234.txt", "subject": "BACbche gene gene", "relationship": "IS_TARGET_OF_TREATMENT", "object": "disease-modifying treatment of Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4233234.txt", "subject": "BACbche gene gene", "relationship": "RELATED_TREATMENT", "object": "Alzheimer\u2019s disease treatment", "chunk": 1}
{"article": "PMC4233234.txt", "subject": "A\u03b21-34", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Monitoring target engagement of BACbche gene gene inhibitors", "chunk": 1}
{"article": "PMC4233234.txt", "subject": "A\u03b21-34", "relationship": "MONITORED_DURING_TREATMENT", "object": "BACbche gene gene inhibition", "chunk": 1}
{"article": "PMC4233234.txt", "subject": "A\u03b25-40", "relationship": "MONITORED_DURING_TREATMENT", "object": "BACbche gene gene inhibition", "chunk": 1}
{"article": "PMC4233234.txt", "subject": "A\u03b21-34", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "BACbche gene gene inhibition resulted in decreased levels of", "chunk": 1}
{"article": "PMC4233234.txt", "subject": "A\u03b25-40", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "BACbche gene gene inhibition resulted in increased levels of", "chunk": 1}
{"article": "PMC4233234.txt", "subject": "A\u03b25-X", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "BACbche gene gene inhibition resulted in increased levels of", "chunk": 1}
{"article": "PMC4233234.txt", "subject": "A\u03b21-40", "relationship": "RELATED_TO_TREATMENT", "object": "LY2811376 reduced the levels of A\u03b21-40.", "chunk": 2}
{"article": "PMC4233234.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TO_TREATMENT", "object": "LY2811376 reduced the levels of A\u03b21-42.", "chunk": 2}
{"article": "PMC4233234.txt", "subject": "A\u03b25-40", "relationship": "RELATED_TO_TREATMENT", "object": "LY2811376 increased relative levels of A\u03b25-40 compared to vehicle-treated cells.", "chunk": 2}
{"article": "PMC4233234.txt", "subject": "\u00df-amyloid", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b2 concentration in cerebral spinal fluid indicates the presence of \u00df-amyloid.", "chunk": 2}
{"article": "PMC4233234.txt", "subject": "A\u03b25-40", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b2 production via a  BACE1-independent APP processing pathway", "chunk": 3}
{"article": "PMC4233234.txt", "subject": "A\u03b25-40", "relationship": "RELATED_PROGNOSIS", "object": "Positive effect with a BACE1 inhibitor", "chunk": 3}
{"article": "PMC4233234.txt", "subject": "A\u03b21-34", "relationship": "RELATED_TREATMENT", "object": "Decreased by a BACE1 inhibitor like LY2811376", "chunk": 3}
{"article": "PMC4233234.txt", "subject": "A\u03b21-34", "relationship": "MONITORED_DURING_TREATMENT", "object": "Effects of a BACE1 inhibitor", "chunk": 3}
{"article": "PMC4233234.txt", "subject": "LY2811376", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Monitoring changes in A\u03b21-34 levels", "chunk": 3}
{"article": "PMC4233234.txt", "subject": "A\u03b25-40", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Suitable for the use of a BACE1 inhibitor", "chunk": 3}
{"article": "PMC4233234.txt", "subject": "sAPP\u03b1", "relationship": "RELATED_PROGNOSIS", "object": "Increased with LY2811376", "chunk": 3}
{"article": "PMC4233234.txt", "subject": "A\u03b21-34", "relationship": "INDICATES_PRESENCE_OF", "object": "BACbche gene gene inhibition", "chunk": 4}
{"article": "PMC4233234.txt", "subject": "A\u03b21-34", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "BACbche gene gene inhibitors", "chunk": 4}
{"article": "PMC4233234.txt", "subject": "A\u03b21-34", "relationship": "MONITORED_DURING_TREATMENT", "object": "BACbche gene gene inhibition", "chunk": 4}
{"article": "PMC4233234.txt", "subject": "A\u03b21-40", "relationship": "PREDICTED_SURVIVAL", "object": "LY2811376 treatment", "chunk": 4}
{"article": "PMC4233234.txt", "subject": "A\u03b25-40", "relationship": "INDICATES_PRESENCE_OF", "object": "BACbche gene gene inhibition", "chunk": 4}
{"article": "PMC4233234.txt", "subject": "A\u03b25-40", "relationship": "RELATED_TO", "object": "Inhibition of BACbche gene gene", "chunk": 4}
{"article": "PMC4233234.txt", "subject": "A\u03b25-X", "relationship": "correlated_to", "object": "sAPP\u03b1", "chunk": 4}
{"article": "PMC4233234.txt", "subject": "A\u03b25-X", "relationship": "correlated_to", "object": "sAPP\u03b2", "chunk": 4}
{"article": "PMC4233234.txt", "subject": "A\u03b25-X", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "inhibition of BACbche gene gene", "chunk": 4}
{"article": "PMC4239389.txt", "subject": "Neuropsychiatric Inventory (NPI)", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuropsychiatric problems", "chunk": 2}
{"article": "PMC4239389.txt", "subject": "Neuropsychiatric Inventory (NPI)", "relationship": "RELATED_TREATMENT", "object": "Assessment of behavioral disorders", "chunk": 2}
{"article": "PMC4239389.txt", "subject": "Neuropsychiatric Inventory (NPI-Q)", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment for behavioral disorders", "chunk": 2}
{"article": "PMC4239389.txt", "subject": "Mini Mental State Examination (MMSE)", "relationship": "USED_TO_DIAGNOSE", "object": "Global cognitive function", "chunk": 2}
{"article": "PMC4239389.txt", "subject": "EuroQuol EQ-5D", "relationship": "RELATED_PROGNOSIS", "object": "Patients' quality of life", "chunk": 2}
{"article": "PMC4239389.txt", "subject": "Caregiver\u2019s Quality of Life (QDVA)", "relationship": "RELATED_PROGNOSIS", "object": "Caregivers' quality of life", "chunk": 2}
{"article": "PMC4239389.txt", "subject": "mini-Zarit", "relationship": "RELATED_PROGNOSIS", "object": "Caregiver\u2019s burden", "chunk": 2}
{"article": "PMC4239389.txt", "subject": "BPSD", "relationship": "INDICATES_PRESENCE_OF", "object": "Requires hospitalization in a specific unit", "chunk": 3}
{"article": "PMC4239389.txt", "subject": "BPSD", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Negative impact on both patients\u2019 and caregivers\u2019 quality of life", "chunk": 3}
{"article": "PMC4239389.txt", "subject": "BPSD", "relationship": "RELATED_TREATMENT", "object": "Specific pharmacological or non drug therapy ", "chunk": 3}
{"article": "PMC4239389.txt", "subject": "BPSD", "relationship": "RELATED_TREATMENT", "object": "Management in CBUs", "chunk": 3}
{"article": "PMC4239389.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Global cognitive performance", "chunk": 3}
{"article": "PMC4239389.txt", "subject": "EQ-5D", "relationship": "RELATED_TREATMENT", "object": "Patients\u2019 and caregivers\u2019 QoL", "chunk": 3}
{"article": "PMC4239389.txt", "subject": "NPI", "relationship": "RELATED_TREATMENT", "object": "BPSD", "chunk": 3}
{"article": "PMC4239389.txt", "subject": "NPI-ES", "relationship": "RELATED_TREATMENT", "object": "BPSD", "chunk": 3}
{"article": "PMC4239389.txt", "subject": "mini-Zarit", "relationship": "RELATED_TREATMENT", "object": "Caregivers\u2019 burden", "chunk": 3}
{"article": "PMC4239389.txt", "subject": "QDVA", "relationship": "RELATED_TREATMENT", "object": "Patients\u2019 and caregivers\u2019 QoL", "chunk": 3}
{"article": "PMC4247762.txt", "subject": "Tau", "relationship": "RELATED_PROGNOSIS", "object": "Neurodegeneration and cognitive decline", "chunk": 1}
{"article": "PMC4247762.txt", "subject": "Tau", "relationship": "RELATED_PROGNOSIS", "object": "Dementia", "chunk": 1}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Neurodegeneration", "chunk": 1}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Extracellular plaque", "chunk": 1}
{"article": "PMC4247762.txt", "subject": "Tau", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Nilotinib", "chunk": 1}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 2}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TREATMENT", "object": "Nilotinib partially cleared", "chunk": 2}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TREATMENT", "object": "proteasome inhibition", "chunk": 2}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TREATMENT", "object": "autophagy blockade", "chunk": 2}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "MONITORIED_DURING_TREATMENT", "object": "Nilotinib treatment", "chunk": 2}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TREATMENT", "object": "Bafilomycin-A1 blocking autophagy", "chunk": 2}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "accumulation", "chunk": 2}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "RELATED_TREATMENT", "object": "Ilotinib prevented accumulation", "chunk": 2}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "RELATED_TREATMENT", "object": "MG132 increasing levels", "chunk": 2}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "RELATED_TREATMENT", "object": "Bafilomycin-A1 increasing levels", "chunk": 2}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Nilotinib was used to modulate A\u03b21-42 levels", "chunk": 3}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "INDICATES_PRESENCE_OF", "object": "detected in AV10 and AV20  but not in the lysosome in WT mice expressing A\u03b21-42", "chunk": 3}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TREATMENT", "object": "Nilotinib reduced A\u03b21-42 levels in AV10 and increased it in the lysosome,", "chunk": 3}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Nilotinib significantly reduced A\u03b21-42 in AV10 and increased it in the lysosome,", "chunk": 3}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RESPONDED_TO", "object": "Nilotinib", "chunk": 3}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "RELATED_TREATMENT", "object": "Nilotinib reduced p-Tau", "chunk": 3}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "RELATED_TREATMENT", "object": "Nilotinib reduced p-Tau ", "chunk": 3}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "p-Tau clearance was examined", "chunk": 3}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Nilotinib reduced p-Tau  ", "chunk": 3}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RELATED_PROGNOSIS", "object": "Nilotinib decreased A\u03b21-42 in AV20 and increased it in the lysosomes", "chunk": 4}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TREATMENT", "object": "Nilotinib did not alter A\u03b21-42 levels in AVs", "chunk": 4}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RESPONDED_TO", "object": "Nilotinib", "chunk": 4}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "RELATED_PROGNOSIS", "object": "Nilotinib reduced p-Tau", "chunk": 4}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "RELATED_TREATMENT", "object": "Parkin and Nilotinib decreased p-Tau", "chunk": 4}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "Nilotinib and parkin", "chunk": 4}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "RESPONDED_TO", "object": "Neilotinib", "chunk": 4}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RELATED_PROGNOSIS", "object": "Boosting autophagy leads to A\u03b21-42 clearance in WT but not Tau\u2212/\u2212 mice", "chunk": 4}
{"article": "PMC4247762.txt", "subject": "Beclin-1", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Nilotinib and parkin", "chunk": 4}
{"article": "PMC4247762.txt", "subject": "LC3-II", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Nilotinib and parkin", "chunk": 4}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "RELATED_TO", "object": "Nilotinib treatment", "chunk": 5}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzhiemer's Disease", "chunk": 5}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "RELATED_TO", "object": "Tau expression", "chunk": 5}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TO", "object": "Tau expression", "chunk": 5}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RELATED_PROGNOSIS", "object": "plaque deposition", "chunk": 6}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Nilotinib", "chunk": 6}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "MONITORED_DURING_TREATMENT", "object": "Autophagic intracellular clearance", "chunk": 6}
{"article": "PMC4247762.txt", "subject": "Tau", "relationship": "RELATED_TREATMENT", "object": "Treatment of neurodegeneration using Nilotinib", "chunk": 7}
{"article": "PMC4247762.txt", "subject": "Tau", "relationship": "RELATED_TREATMENT", "object": "Management of neurodegeneration through autophagic clearance", "chunk": 7}
{"article": "PMC4247762.txt", "subject": "Tau", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Determining treatment strategies based on Tau status", "chunk": 7}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TREATMENT", "object": "Treatment of neurodegeneration by influencing A\u03b21-42 levels", "chunk": 7}
{"article": "PMC4247762.txt", "subject": "LC3-B", "relationship": "MONITORED_DURING_TREATMENT", "object": "Monitoring of autophagy activity during treatment interventions", "chunk": 7}
{"article": "PMC4247762.txt", "subject": "Beclin-1", "relationship": "MONITORED_DURING_TREATMENT", "object": "Monitoring of autophagy activity during treatment interventions", "chunk": 7}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Evaluation of A\u03b21-42 dynamics in response to treatment", "chunk": 7}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "RESPONDED_TO", "object": "Reduction in free unbound p-Tau in response to boosting autophagy", "chunk": 7}
{"article": "PMC4247762.txt", "subject": "Tau", "relationship": " relacionada con", "object": "Neurodegeneration", "chunk": 7}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 8}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TREATMENT", "object": "Nilotinib treatment", "chunk": 8}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Increased Beclin-1 and LC3-II levels", "chunk": 8}
{"article": "PMC4247762.txt", "subject": "A\u03b21-42", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Decreased p-Tau levels", "chunk": 8}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 8}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 8}
{"article": "PMC4247762.txt", "subject": "p-Tau", "relationship": "RELATED_PROGNOSIS", "object": "Disease severity", "chunk": 8}
{"article": "PMC4247762.txt", "subject": "Caspase-3 activity", "relationship": "INDICATES_PRESENCE_OF", "object": "Apoptosis", "chunk": 8}
{"article": "PMC4255368.txt", "subject": "tau protein", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Immunotherapy targeting structural determinants on tau", "chunk": 1}
{"article": "PMC4255368.txt", "subject": "phospho-tau epitopes", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Proposed tau immunotherapeutic approaches", "chunk": 1}
{"article": "PMC4255368.txt", "subject": "phospho-Ser396/phospho-Ser404 ", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Immunotherapeutic approaches", "chunk": 1}
{"article": "PMC4255368.txt", "subject": "phospho-Thr231/phospho-Ser235", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Immunotherapeutic approaches", "chunk": 1}
{"article": "PMC4255368.txt", "subject": "phospho-Ser422", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Immunotherapeutic approaches", "chunk": 1}
{"article": "PMC4255368.txt", "subject": "AT8", "relationship": "INDICATES_PRESENCE_OF", "object": "pSer202/pThr205 phosphorylation", "chunk": 2}
{"article": "PMC4255368.txt", "subject": "DC209", "relationship": "INDICATES_PRESENCE_OF", "object": "pThr231 phosphorylation", "chunk": 2}
{"article": "PMC4255368.txt", "subject": "DC217", "relationship": "INDICATES_PRESENCE_OF", "object": "pThr217 phosphorylation", "chunk": 2}
{"article": "PMC4255368.txt", "subject": "DC179", "relationship": "INDICATES_PRESENCE_OF", "object": "pThr181 phosphorylation", "chunk": 2}
{"article": "PMC4255368.txt", "subject": "DC25", "relationship": "INDICATES_PRESENCE_OF", "object": "All forms of physiological and pathological tau protein", "chunk": 2}
{"article": "PMC4255368.txt", "subject": "tau peptide sequence 294KDNIKHVPGGGS305", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Development of immunotherapeutic approach against diseased forms of tau", "chunk": 2}
{"article": "PMC4255368.txt", "subject": "AT8", "relationship": "INDICATES_PRESENCE_OF", "object": "Tau pathology", "chunk": 3}
{"article": "PMC4255368.txt", "subject": "pT212", "relationship": "INDICATES_PRESENCE_OF", "object": "Tau pathology", "chunk": 3}
{"article": "PMC4255368.txt", "subject": "pS214", "relationship": "INDICATES_PRESENCE_OF", "object": "Tau pathology", "chunk": 3}
{"article": "PMC4255368.txt", "subject": "Tau5", "relationship": "INDICATES_PRESENCE_OF", "object": "Tau pathology", "chunk": 3}
{"article": "PMC4255368.txt", "subject": "HT7", "relationship": "INDICATES_PRESENCE_OF", "object": "Tau pathology", "chunk": 3}
{"article": "PMC4255368.txt", "subject": "tau peptide vaccine", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment of AD and related tauopathies.", "chunk": 4}
{"article": "PMC4255368.txt", "subject": "tau peptide vaccine", "relationship": "RELATED_TREATMENT", "object": "Therapeutic efficacy studies in a transgenic rat model of AD.", "chunk": 4}
{"article": "PMC4255368.txt", "subject": "DC8E8", "relationship": "INDICATES_PRESENCE_OF", "object": "Structural determinants of the tau protein important for pathological tau\u2013tau interaction", "chunk": 4}
{"article": "PMC4255368.txt", "subject": "DC8E8", "relationship": "RELATED_PROGNOSIS", "object": "Could lead to successful treatment of AD and related tauopathies.", "chunk": 4}
{"article": "PMC4255368.txt", "subject": "tau oligomers", "relationship": "MONITORED_DURING_TREATMENT", "object": "Analysis of the impact of tau vaccine treatment.", "chunk": 4}
{"article": "PMC4255368.txt", "subject": "highly phosphorylated forms of truncated tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "Analysis of the impact of tau vaccine treatment.", "chunk": 4}
{"article": "PMC4255368.txt", "subject": "full-length tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "Analysis of the impact of tau vaccine treatment.", "chunk": 4}
{"article": "PMC4255368.txt", "subject": "pThr217", "relationship": "MONITORED_DURING_TREATMENT", "object": "Analysis of the impact of tau vaccine treatment.", "chunk": 4}
{"article": "PMC4255368.txt", "subject": "pThr231", "relationship": "MONITORED_DURING_TREATMENT", "object": "Analysis of the impact of tau vaccine treatment.", "chunk": 4}
{"article": "PMC4255368.txt", "subject": "pSer202/pThr205", "relationship": "MONITORED_DURING_TREATMENT", "object": "Analysis of the impact of tau vaccine treatment.", "chunk": 4}
{"article": "PMC4255368.txt", "subject": "pThr181", "relationship": "MONITORED_DURING_TREATMENT", "object": "Analysis of the impact of tau vaccine treatment.", "chunk": 4}
{"article": "PMC4255368.txt", "subject": "tau oligomers", "relationship": "INDICATES_PRESENCE_OF", "object": "Pathological tau", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "Neurofibrillary tangles (PHFs)", "relationship": "INDICATES_PRESENCE_OF", "object": "Late forms of pathological tau", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "Thr217 phosphorylated tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Hyperphosphorylated tau species", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "pThr231 tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Hyperphosphorylated tau species", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "pS202/pThr205 tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Hyperphosphorylated tau species", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "pThr181 tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Hyperphosphorylated tau species", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "Neurofibrillary tangles", "relationship": "INDICATES_PRESENCE_OF", "object": "Extensive neurofibrillary degeneration", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "AT8 antibody staining", "relationship": "RELATED_PROGNOSIS", "object": "Reduced number of Neurofibrillary tangles", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "pS214 antibody staining", "relationship": "RELATED_PROGNOSIS", "object": "Reduced number of Neurofibrillary tangles", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "pT212 antibody staining", "relationship": "RELATED_PROGNOSIS", "object": "Reduced number of Neurofibrillary tangles", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "Active tau peptide vaccine", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Improved sensorimotor functions, neurofibrillary degeneration reduction", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "Reduced escape latency", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Improved sensorimotor functions", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "Reduced hindlimb slips", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Improved sensorimotor functions", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "Decreased NeuroScale score", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Improved sensorimotor functions", "chunk": 5}
{"article": "PMC4255368.txt", "subject": "Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurofibrillary pathology", "chunk": 6}
{"article": "PMC4255368.txt", "subject": "Tau", "relationship": "RELATED_BYOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Reduction of tau hyperphosphorylation, prevention of tau aggregation or clearance of tau oligomers", "chunk": 6}
{"article": "PMC4255368.txt", "subject": "Tau phosphorylation", "relationship": "RELATED_TREATMENT", "object": "Tau immunotherapy", "chunk": 6}
{"article": "PMC4255368.txt", "subject": "Tau oligomers", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Tau peptide vaccine", "chunk": 6}
{"article": "PMC4255368.txt", "subject": "Tau pathology", "relationship": "RELATES_TO_INDICATION_OF_TREATMENT", "object": "Tau peptide vaccine", "chunk": 6}
{"article": "PMC4255368.txt", "subject": "tau pathology", "relationship": "DIAGNOSITC_OF", "object": "Cognitive decline and Memory impairment", "chunk": 6}
{"article": "PMC4255368.txt", "subject": "Neurofibrillary tangles", "relationship": "RELATED_PROGNOSIS", "object": "Disease Duration & Cognitive Impairment in AD", "chunk": 6}
{"article": "PMC4255368.txt", "subject": "tau phosphorylation", "relationship": "RELATED_TO", "object": "Therapeutic effect of the active tau vaccine", "chunk": 7}
{"article": "PMC4255368.txt", "subject": "tau oligomers", "relationship": "RELATED_TO", "object": "Therapeutic effect of the active tau vaccine", "chunk": 7}
{"article": "PMC4255368.txt", "subject": "Neurofibrillary tangles", "relationship": "TARGETED_BY", "object": "TAU5, HT7, pT212 and pS214", "chunk": 7}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "RELATED_TREATMENT", "object": "Treatment of Alzheimer's Disease", "chunk": 1}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Tau immunotherapy", "chunk": 1}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Immunotherapy for Alzheimer's Disease", "chunk": 1}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Tau immunotherapy", "chunk": 1}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "RESPONDED_TO", "object": "Disease-modifying Therapy", "chunk": 1}
{"article": "PMC4255369.txt", "subject": "phospho-Ser396/phospho-Ser404", "relationship": "RELATED_TREATMENT", "object": "Tau immunotherapy strategy", "chunk": 1}
{"article": "PMC4255369.txt", "subject": "phospho-Thr231/phospho-Ser235", "relationship": "RELATED_TREATMENT", "object": "Tau immunotherapy strategy", "chunk": 1}
{"article": "PMC4255369.txt", "subject": "phospho-Ser422", "relationship": "RELATED_TREATMENT", "object": "Tau immunotherapy strategy", "chunk": 1}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Crystallisation of Fab was performed", "chunk": 2}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "RELATED_TREATMENT", "object": "This study", "chunk": 2}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "RELATED_TO_TREATMENT", "object": "candidate therapeutic antibody", "chunk": 4}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "IS_TARGET_OF_TREATMENT", "object": "an in vitro pathological tau\u2013tau interaction assay", "chunk": 4}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "RELATED_PROGNOSIS", "object": " enables the detection of early stages of pathological tau in human preclinical AD", "chunk": 4}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "RELATED_PROGNOSIS", "object": "recognised both the stage of pathological tau oligomers and the stage of pathological tau polymers (tangles)", "chunk": 4}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "RELATED_PROGNOSIS", "object": "recognised mainly pathological tau polymers in the form of Neurofibrillary tangles, neuritic plaques and neuropil threads", "chunk": 4}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Immunotherapy", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "MONITORED_DURING_TREATMENT", "object": "Immunotherapy", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "RESPONDED_TO", "object": "Immunotherapy", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "tau protein", "relationship": "IS_TARGET_OF_TREATMENT", "object": "DC8E8 immunotherapy", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "Neurofibrillary tangles", "relationship": "PREDICTED_SURVIVAL", "object": "Transgenic mice treated with DC8E8 reduced neurofibrillary tangles and lived longer", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "sarcosyl-insoluble tau oligomers", "relationship": "MONITORED_DURING_TREATMENT", "object": "DC8E8 immunotherapy", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "  targeting tau protein", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "tau protein", "relationship": "RELATED_PROGNOSIS", "object": "Misordered tau protein is associated with Neurofibrillary tangles and disease progression", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "truncated tau protein", "relationship": "RELATED_PROGNOSIS", "object": "DC8E8 recognizes truncated tau protein, a possible indicator of disease progression", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "full-length tau protein", "relationship": "RELATED_PROGNOSIS", "object": "DC8E8 recognizes full-length tau protein, potentially indicating disease progression", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "assembled tau protein", "relationship": "RELATED_PROGNOSIS", "object": "DC8E8 recognizes assembled tau protein, potentially indicating disease progression", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "soluble tau", "relationship": "RELATED_PROGNOSIS", "object": "DC8E8 recognizes soluble tau, potentially indicating disease progression", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "sarcosyl-insoluble tau", "relationship": "RELATED_PROGNOSIS", "object": "DC8E8 recognizes sarcosyl-insoluble tau, a marker of pathology", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "alphabeta amyloid", "relationship": "RELATED_PROGNOSIS", "object": "alphabeta amyloid is a hallmark of Alzheimer's disease", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "Neurofibrillary tangles", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "tau protein", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Targeting tau protein with DC8E8 immunotherapy", "chunk": 5}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "INDICATES_PRESENCE_OF", "object": "Mis-disordered tau", "chunk": 7}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "RELATED_PROGNOSIS", "object": "Distinguishes between pathological and physiological \u2018healthy\u2019 tau", "chunk": 7}
{"article": "PMC4255369.txt", "subject": "Truncated mis-disordered tau protein", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Immunotherapy targeting various tau species", "chunk": 7}
{"article": "PMC4255369.txt", "subject": "Mis-disordered truncated tau", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Target vaccine development strategy", "chunk": 7}
{"article": "PMC4255369.txt", "subject": "HXPGGG", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment for AD", "chunk": 8}
{"article": "PMC4255369.txt", "subject": "HXPGGG", "relationship": "RELATED_TREATMENT", "object": "DC8E8 antibody therapy", "chunk": 8}
{"article": "PMC4255369.txt", "subject": "truncated tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "DC8E8 antibody treatment", "chunk": 8}
{"article": "PMC4255369.txt", "subject": "DC8E8", "relationship": "RESPONDED_TO", "object": "DC8E8 antibody treatment", "chunk": 8}
{"article": "PMC4255540.txt", "subject": "Mini-Mental Score Examination", "relationship": "RELATED_PROGNOSIS", "object": "defined by MMSE,  scores of 26 to 11/30 (mild to moderately severe stages of the disease)", "chunk": 2}
{"article": "PMC4283145.txt", "subject": "aerobic exercise", "relationship": "RELATED_TREATMENT", "object": "Treating cognitive impairment in Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4283145.txt", "subject": "aerobic exercise", "relationship": "RELATED_TREATMENT", "object": "Increasing gray-matter volumes in the hippocampus", "chunk": 1}
{"article": "PMC4283145.txt", "subject": "aerobic exercise", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "A potential treatment that may increase physical function and quality of life", "chunk": 1}
{"article": "PMC4283145.txt", "subject": "magnetic resonance imaging", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "An outcome measure in clinical trials", "chunk": 1}
{"article": "PMC4283145.txt", "subject": "hippocampal volume", "relationship": "RELATED_PROGNOSIS", "object": "Assess the effect of aerobic exercise on hippocampal volume over 12\u00a0months", "chunk": 1}
{"article": "PMC4283145.txt", "subject": "ADAS-Cog", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC4283145.txt", "subject": "ADAS-Cog", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive Decline", "chunk": 2}
{"article": "PMC4283145.txt", "subject": "hippocampal volume", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC4283145.txt", "subject": "hippocampal volume", "relationship": "RELATED_PROGNOSIS", "object": "Progression of Alzheimer's Disease", "chunk": 2}
{"article": "PMC4283145.txt", "subject": "CDR score", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild-to-moderate AD", "chunk": 3}
{"article": "PMC4283145.txt", "subject": "MMSE score", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild-to-moderate AD", "chunk": 3}
{"article": "PMC4283145.txt", "subject": "ADAS-Cog", "relationship": "RELATED_PROGNOSIS", "object": "Change from baseline after 6 months of intervention", "chunk": 3}
{"article": "PMC4283145.txt", "subject": "MMSE", "relationship": "USED_TO_DIAGNOSE", "object": "AD diagnosis", "chunk": 4}
{"article": "PMC4283145.txt", "subject": "CDR", "relationship": "USED_TO_DIAGNOSE", "object": "AD diagnosis", "chunk": 4}
{"article": "PMC4283145.txt", "subject": "CDR", "relationship": "RELATED_TO", "object": "MRI safety verification", "chunk": 4}
{"article": "PMC4283145.txt", "subject": "MMSE", "relationship": "RELATED_TO", "object": "MRI safety verification", "chunk": 4}
{"article": "PMC4283145.txt", "subject": "ADAS-Cog", "relationship": "RELATED_TREATMENT", "object": "Measures cognition", "chunk": 5}
{"article": "PMC4283145.txt", "subject": "ADAS-Cog", "relationship": "USED_TO_DIAGNOSE", "object": "Cognitive function in Alzheimer's Disease Drug RCTs", "chunk": 5}
{"article": "PMC4283145.txt", "subject": "ADAS-Cog", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive decline", "chunk": 5}
{"article": "PMC4283145.txt", "subject": "ADAS-Cog", "relationship": "PRIMARY_OUTCOME", "object": "Global Cognition", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "CDR", "relationship": "RELATED_TREATMENT", "object": "AD stage", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "MMSE", "relationship": "RELATED_TREATMENT", "object": "AD stage", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "CDR ", "relationship": "DIAGNOSTIC_OF", "object": "AD stage", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "MMSE", "relationship": "DIAGNOSTIC_OF", "object": "AD stage", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "Wechsler Digit Span", "relationship": "USED_TO_DIAGNOSE", "object": "Attention", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "Wechsler Digit Symbol", "relationship": "USED_TO_DIAGNOSE", "object": "Processing speed", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "TMT Part A", "relationship": "USED_TO_DIAGNOSE", "object": "Executive function", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "TMT Part B", "relationship": "USED_TO_DIAGNOSE", "object": "Executive function", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "EXIT-25", "relationship": "USED_TO_DIAGNOSE", "object": "Executive function", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "Behavioral Dyscontrol Scale (BDS)", "relationship": "USED_TO_DIAGNOSE", "object": "Executive function", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "Executive Clock Drawing Test (CLOX)", "relationship": "USED_TO_DIAGNOSE", "object": "Executive function", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "Wechsler Memory Scale-Revised Logical Memory Story A and B", "relationship": "USED_TO_DIAGNOSE", "object": "Memory", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "Animal and Vegetable Verbal Fluency", "relationship": "USED_TO_DIAGNOSE", "object": "Language", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "Boston Naming Test", "relationship": "USED_TO_DIAGNOSE", "object": "Language", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "Symptom-limited peak cycle-ergometer test, Shuttle-walk test", "relationship": "USED_TO_DIAGNOSE", "object": "Aerobic fitness", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "6-minute walk test", "relationship": "USED_TO_DIAGNOSE", "object": "Aerobic fitness", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "Short Physical Performance Battery (SPPB)", "relationship": "USED_TO_DIAGNOSE", "object": "Physical function", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "Disability in AD (DAD) scale", "relationship": "USED_TO_DIAGNOSE", "object": "Physical function", "chunk": 6}
{"article": "PMC4283145.txt", "subject": " Neuropsychiatric Inventory-Caregiver (NPI-Q)", "relationship": "INDICATES_PRESENCE_OF", "object": "BPSD", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "Alzheimer\u2019s Mood Scale (AMS)", "relationship": "INDICATES_PRESENCE_OF", "object": "BPSD", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "Cornell Scale for Depression in dementia (CSDD)", "relationship": "INDICATES_PRESENCE_OF", "object": "BPSD", "chunk": 6}
{"article": "PMC4283145.txt", "subject": "ADAS-Cog", "relationship": "INDICATES_PRESENCE_OF", "object": "Progression of Alzheimer's disease", "chunk": 7}
{"article": "PMC4283145.txt", "subject": "ADAS-Cog", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline in Alzheimer's disease", "chunk": 7}
{"article": "PMC4283145.txt", "subject": "Hippocampal volume", "relationship": "ASSOCIATED_WITH", "object": "Effects of aerobic exercise in AD", "chunk": 7}
{"article": "PMC4283145.txt", "subject": "ADAS-Cog", "relationship": "RELATED_PROGNOSIS", "object": "Change in ADAS-Cog scores from baseline to 6 months", "chunk": 8}
{"article": "PMC4283612.txt", "subject": "R-WAB", "relationship": "USED_TO_DIAGNOSE", "object": "Type and level of aphasia severity", "chunk": 4}
{"article": "PMC4283612.txt", "subject": "R-WAB", "relationship": "INDICATES_PRESENCE_OF", "object": "Cortical Quotient (CQ)", "chunk": 4}
{"article": "PMC4283612.txt", "subject": "CLQT", "relationship": "USED_TO_DIAGNOSE", "object": "Relate cognitive deficits to language dysfunction", "chunk": 4}
{"article": "PMC4283612.txt", "subject": "CLQT", "relationship": "USED_TO_DIAGNOSE", "object": "Rule out dementia", "chunk": 4}
{"article": "PMC4283612.txt", "subject": "Standard tests R-WAB", "relationship": "RELATED_PROGNOSIS", "object": "Language and cognitive profile ", "chunk": 5}
{"article": "PMC4294473.txt", "subject": "Tau protein", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Therapeutic strategies targeting Tau pathology", "chunk": 1}
{"article": "PMC4294473.txt", "subject": "Tau protein", "relationship": "RELATED_TREATMENT", "object": "development of treatments targeting Tau aggregation", "chunk": 1}
{"article": "PMC4294473.txt", "subject": "P301S Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Tau pathology; Neurodegenerative disorders", "chunk": 1}
{"article": "PMC4294473.txt", "subject": "Tau", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC4294473.txt", "subject": "Tau", "relationship": "RELATED_TREATMENT", "object": "Therapeutic avenues", "chunk": 2}
{"article": "PMC4294473.txt", "subject": "Aggregation-dependent manner", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment of Alzheimer's Disease", "chunk": 2}
{"article": "PMC4294473.txt", "subject": "Sarkosyl-insoluble Tau", "relationship": "RELATED_TREATMENT", "object": "Treatment of Alzheimer's Disease", "chunk": 2}
{"article": "PMC4294473.txt", "subject": "AT8", "relationship": "INDICATES_PRESENCE_OF", "object": "Phosphorylated Tau", "chunk": 3}
{"article": "PMC4294473.txt", "subject": "TAT8", "relationship": "RELATED_TO", "object": "Level of Tau phosphorylation", "chunk": 3}
{"article": "PMC4294473.txt", "subject": "TG5", "relationship": "INDICATES_PRESENCE_OF", "object": "Phosphorylated Tau", "chunk": 3}
{"article": "PMC4294473.txt", "subject": "MC1", "relationship": "INDICATES_PRESENCE_OF", "object": "Conformationally changed Tau", "chunk": 3}
{"article": "PMC4294473.txt", "subject": "DA9", "relationship": "USED_TO_DETECT", "object": "Tau protein levels", "chunk": 3}
{"article": "PMC4294473.txt", "subject": "AT8", "relationship": "DIAGNOSTIC_OF", "object": "Tau aggregation", "chunk": 4}
{"article": "PMC4294473.txt", "subject": "AT8", "relationship": "INDICATES_PRESENCE_OF", "object": "Phosphorylated Tau (Ser(P)202/Thr(P)205)", "chunk": 4}
{"article": "PMC4294473.txt", "subject": "Sarkosyl-insoluble Tau", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Analyzing Tau aggregation", "chunk": 4}
{"article": "PMC4294473.txt", "subject": "DA9", "relationship": "USED_TO_DIAGNOSE", "object": "Tau aggregation", "chunk": 4}
{"article": "PMC4294473.txt", "subject": "MC1 (conformationally changed Tau)", "relationship": "INDICATES_PRESENCE_OF", "object": "Seeding in HEK 293T cells transfected with human P301S 1N4R Tau", "chunk": 5}
{"article": "PMC4294473.txt", "subject": "AT8 (Ser(P)202/Thr(P)205)", "relationship": "INDICATES_PRESENCE_OF", "object": "Seeding in HEK 293T cells transfected with human P301S 1N4R Tau", "chunk": 5}
{"article": "PMC4294473.txt", "subject": "MC1 (conformationally changed)-positive Tau", "relationship": "RELATES_TO", "object": "Sarkosyl-insoluble fraction enriched for seed-competent Tau", "chunk": 5}
{"article": "PMC4294473.txt", "subject": "AT8 (Ser(P)202/Thr(P)205)-positive Tau", "relationship": "RELATES_TO", "object": "Sarkosyl-insoluble fraction enriched for seed-competent Tau", "chunk": 5}
{"article": "PMC4294473.txt", "subject": "TgP301S Tau aggregates", "relationship": "INDICATES_PRESENCE_OF", "object": "Sarkosyl-insoluble, hyperphosphorylated Tau", "chunk": 6}
{"article": "PMC4294473.txt", "subject": "TgP301S Tau aggregates", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment aiming to reduce phosphorylated Tau accumulation in Alzheimer's disease", "chunk": 6}
{"article": "PMC4294473.txt", "subject": "Recombinant P301S Tau aggregates", "relationship": "INDICATES_PRESENCE_OF", "object": "Sarkosyl-insoluble, hyperphosphorylated Tau", "chunk": 6}
{"article": "PMC4294473.txt", "subject": "Recombinant P301S Tau aggregates", "relationship": "RELATED_PROGNOSIS", "object": "Potency for seeding hyperphosphorylated Tau formation in cells expressing soluble P301S Tau", "chunk": 6}
{"article": "PMC4294473.txt", "subject": "HT7", "relationship": "GUIDE_TREATMENT_SELECTION", "object": "Selection of therapeutic strategies targeting hyperphosphorylated Tau in Alzheimer's disease", "chunk": 6}
{"article": "PMC4294473.txt", "subject": "AT100", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Selection of therapeutic strategies targeting hyperphosphorylated Tau in Alzheimer's disease", "chunk": 6}
{"article": "PMC4294473.txt", "subject": "Sarkosyl-insoluble Tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment strategies targeting Tau pathology in Alzheimer's disease", "chunk": 6}
{"article": "PMC4294473.txt", "subject": "TgP301S Tau aggregates", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "They were used in an assay to compare seeding activity", "chunk": 8}
{"article": "PMC4294473.txt", "subject": "TgP301S Tau aggregates", "relationship": "RELATED_PROGNOSIS", "object": "Seeding ability is likely related to spreading of disease.", "chunk": 8}
{"article": "PMC4294473.txt", "subject": "Sarkosyl-insoluble Tau", "relationship": "RELATED_PROGNOSIS", "object": "Seeding activity is likely related to spreading of disease.", "chunk": 8}
{"article": "PMC4294473.txt", "subject": "P301S Tau aggregates", "relationship": "INDICATES_PRESENCE_OF", "object": "Evidence of disease.", "chunk": 8}
{"article": "PMC4294473.txt", "subject": "levels of P301S Tau aggregates", "relationship": "MONITORED_DURING_TREATMENT", "object": "Analyzing changes helps understand treatment effect", "chunk": 8}
{"article": "PMC4294473.txt", "subject": "Hyperphosphorylated recombinant P301S Tau aggregates", "relationship": "RELATED_TREATMENT", "object": "Their formation and stability are studied in relation to treatment", "chunk": 8}
{"article": "PMC4294473.txt", "subject": "synthetic Tau aggregates", "relationship": "RELATED_TREATMENT", "object": "target for therapies like immunization, inhibition of fibril assembly, and enhanced cellular degradation", "chunk": 9}
{"article": "PMC4294473.txt", "subject": "conformation of aggregated Tau", "relationship": "RELATED_PROGNOSIS", "object": "may provide a molecular explanation for the tauopathies, which are defined by the presence of Tau inclusions in the brain but have distinct neuropathologies and rates of progression", "chunk": 9}
{"article": "PMC4294473.txt", "subject": "synthetic Tau aggregates", "relationship": "RELATED_TREATMENT", "object": "Target Therapies", "chunk": 9}
{"article": "PMC4294473.txt", "subject": "HT7 epitope", "relationship": "MONITORED_DURING_TREATMENT", "object": "exposure of the HT7 epitope was enhanced with low concentrations of guanidine hydrochloride", "chunk": 9}
{"article": "PMC4301197.txt", "subject": "Agitation", "relationship": "DIAGNOSITC_OF", "object": "A cognitive impairment or dementia syndrome", "chunk": 2}
{"article": "PMC4301197.txt", "subject": "Agitation", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Excess disability", "chunk": 2}
{"article": "PMC4301197.txt", "subject": "Agitation", "relationship": "INDICATES_PRESENCE_OF", "object": "rapid changes in mood, irritability, outbursts", "chunk": 2}
{"article": "PMC4301197.txt", "subject": "Agitation", "relationship": "INDICATES_PRESENCE_OF", "object": "Excessive motor activity", "chunk": 2}
{"article": "PMC4301197.txt", "subject": "Agitation", "relationship": "INDICATES_PRESENCE_OF", "object": "Verbal aggression (e.g. yelling, speaking in an excessively loud voice, using profanity, screaming, shouting)", "chunk": 2}
{"article": "PMC4301197.txt", "subject": "Agitation", "relationship": "INDICATES_PRESENCE_OF", "object": "Physical aggression (e.g. grabbing, shoving, pushing, resisting, hitting others, kicking objects or people, scratching, biting)", "chunk": 2}
{"article": "PMC4301197.txt", "subject": "Agitation", "relationship": "RELATED_TREATMENT", "object": "Anti-agitation agents", "chunk": 2}
{"article": "PMC4304279.txt", "subject": "\u03b2-amyloid (A\u03b2) peptide", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC4304279.txt", "subject": "\u03b2-amyloid (A\u03b2) peptide", "relationship": "RELATED_TO", "object": "etiology of Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4304279.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_PROGNOSIS", "object": "onset of dementia", "chunk": 1}
{"article": "PMC4304279.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT_ELIGIBILITY", "object": "effect of drugs targeting  \u03b2-secretase", "chunk": 1}
{"article": "PMC4304279.txt", "subject": "\u03b2-secretase inhibitors", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "intervention strategy for alzheimer's disease", "chunk": 1}
{"article": "PMC4304279.txt", "subject": "\u03b2-secretase", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "development of drugs to prevent or treat Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4304279.txt", "subject": "APP (amyloid precursor protein)", "relationship": "IS_TARGET_OF_TREATMENT", "object": "development of therapies aimed at reducing A\u03b2 production", "chunk": 1}
{"article": "PMC4304279.txt", "subject": "A\u03b2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Amyloid deposition and A\u03b2-associated memory impairments", "chunk": 2}
{"article": "PMC4304279.txt", "subject": "A\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "APP mutations likely have a reduction in A\u03b2 production of only ~20% yet they are still protected against AD", "chunk": 2}
{"article": "PMC4304279.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "AD and cognitive decline in the elderly", "chunk": 2}
{"article": "PMC4304279.txt", "subject": "A\u03b2", "relationship": "RELATED_TREATMENT", "object": "inhibition of \u03b2-secretase cleavage of APP should be beneficial for AD", "chunk": 2}
{"article": "PMC4304279.txt", "subject": "BACE", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "therapeutically target for the development of small molecule inhibitor drugs for the treatment of AD", "chunk": 2}
{"article": "PMC4304279.txt", "subject": "App", "relationship": "RELATED_TREATMENT", "object": "inhibition of \u03b2-secretase cleavage of APP should be beneficial for AD", "chunk": 2}
{"article": "PMC4304279.txt", "subject": "BACE", "relationship": "TARGET", "object": "inhibitor drugs", "chunk": 2}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene", "relationship": "MONITORED_DURING_TREATMENT", "object": "BACbche gene gene inhibitor drug development efforts", "chunk": 2}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Development of BACbche gene gene inhibitor drugs", "chunk": 3}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene", "relationship": "RELATED_TREATMENT", "object": "Therapeutic inhibition of BACbche gene gene", "chunk": 3}
{"article": "PMC4304279.txt", "subject": "NRG1 EGF domain", "relationship": "RELEASED_BY", "object": "BACbche gene gene cleavage", "chunk": 3}
{"article": "PMC4304279.txt", "subject": "CHL1", "relationship": "Cleavage by", "object": "BACbche gene gene", "chunk": 3}
{"article": "PMC4304279.txt", "subject": "Jagged 1 (Jag1)", "relationship": "Cleavage by", "object": "BACbche gene gene", "chunk": 3}
{"article": "PMC4304279.txt", "subject": "APP", "relationship": "Processed by", "object": "BACbche gene gene", "chunk": 3}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene substrates", "relationship": "Processed by", "object": "BACbche gene gene", "chunk": 3}
{"article": "PMC4304279.txt", "subject": "BACE2", "relationship": "RELATED_TREATMENT", "object": "Treatment of Type 2 diabetes", "chunk": 4}
{"article": "PMC4304279.txt", "subject": "BACE2", "relationship": "RELATED_TREATMENT", "object": "Inhibition of  BACE2", "chunk": 4}
{"article": "PMC4304279.txt", "subject": "LY2886721", "relationship": "RELATED_TREATMENT", "object": "Treatment A\u03b2 levels", "chunk": 4}
{"article": "PMC4304279.txt", "subject": "LY2886721", "relationship": "USED_TO_DIAGNOSE", "object": "Safety and tolerability, pharmacokinetics, and pharmacodynamics", "chunk": 4}
{"article": "PMC4304279.txt", "subject": "A\u03b240", "relationship": "RELATED_TREATMENT", "object": "Levels decreased in cerebral cerebral cerebral cerebral spinal fluid by LY2886721", "chunk": 5}
{"article": "PMC4304279.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "Levels reduced in cerebral cerebral cerebral cerebral spinal fluid by LY2886721", "chunk": 5}
{"article": "PMC4304279.txt", "subject": "sAPP\u03b2", "relationship": "RELATED_TREATMENT", "object": "Levels reduced in cerebral cerebral cerebral cerebral spinal fluid by LY2886721", "chunk": 5}
{"article": "PMC4304279.txt", "subject": "sAPP\u03b1", "relationship": "MONITORED_DURING_TREATMENT", "object": "Levels increased in cerebral cerebral cerebral cerebral spinal fluid by LY2886721", "chunk": 5}
{"article": "PMC4304279.txt", "subject": "A\u03b240", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Measuring reductions in cerebral cerebral cerebral cerebral spinal fluid to assess treatment efficacy", "chunk": 5}
{"article": "PMC4304279.txt", "subject": "A\u03b242", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Measuring reductions in cerebral cerebral cerebral cerebral spinal fluid to assess treatment efficacy", "chunk": 5}
{"article": "PMC4304279.txt", "subject": "sAPP\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Measuring reductions in cerebral cerebral cerebral cerebral spinal fluid to assess treatment efficacy", "chunk": 5}
{"article": "PMC4304279.txt", "subject": "A\u03b240", "relationship": "RELATED_TREATMENT", "object": "Decreased by MK-8931 in cerebral cerebral cerebral cerebral spinal fluid", "chunk": 5}
{"article": "PMC4304279.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "Decreased by MK-8931 in cerebral cerebral cerebral cerebral spinal fluid", "chunk": 5}
{"article": "PMC4304279.txt", "subject": "sAPP\u03b2", "relationship": "RELATED_TREATMENT", "object": "Decreased by MK-8931 in cerebral cerebral cerebral cerebral spinal fluid", "chunk": 5}
{"article": "PMC4304279.txt", "subject": "A\u03b240", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4304279.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4304279.txt", "subject": "sAPP\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4304279.txt", "subject": "sAPP\u03b1", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4304279.txt", "subject": "BACbche gene", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4304279.txt", "subject": "A\u03b2", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4304279.txt", "subject": "A\u03b2", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4304279.txt", "subject": "APP", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene", "relationship": "IS_TARGET_OF_TREATMENT", "object": "BACbche gene gene inhibitors", "chunk": 7}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene", "relationship": "RELATED_TREATMENT", "object": "disease-modifying therapies", "chunk": 7}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene", "relationship": "RELATED_TREATMENT", "object": "BACbche gene gene inhibitors", "chunk": 7}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene", "relationship": "INDICATES_PRESENCE_OF", "object": "cerebral A\u03b2 production", "chunk": 7}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Determination of BACbche gene gene inhibitor dose", "chunk": 7}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene", "relationship": "RELATED_PROGNOSIS", "object": "AD progression", "chunk": 7}
{"article": "PMC4304279.txt", "subject": "A\u03b2 levels", "relationship": "RELATED_PROGNOSIS", "object": "AD progression", "chunk": 7}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "increased peri-plaque A\u03b2 production", "chunk": 7}
{"article": "PMC4304279.txt", "subject": "A673T APP mutation", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "AD protection", "chunk": 7}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene inhibition", "relationship": "RELATED_PROGNOSIS", "object": "AD progression", "chunk": 7}
{"article": "PMC4304279.txt", "subject": "A\u03b2 accumulation", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathogenesis", "chunk": 7}
{"article": "PMC4304279.txt", "subject": "AB deposition", "relationship": "RELATED_PROGNOSIS", "object": "cognitive deficits", "chunk": 7}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "The therapy choice aims to inhibit its activity for AD", "chunk": 9}
{"article": "PMC4304279.txt", "subject": "BACbche gene gene", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Inhibition of activity is a therapeutic approach for AD", "chunk": 9}
{"article": "PMC4304279.txt", "subject": "A\u03b2", "relationship": "DIAGNOSITC_OF", "object": "Reduction of A\u03b2 in cerebral spinal fluid is a goal of treatment", "chunk": 9}
{"article": "PMC4304279.txt", "subject": "A\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "Reducing A\u03b2 levels is expected to improve AD prognosis", "chunk": 9}
{"article": "PMC4307639.txt", "subject": "Physical activity index", "relationship": "INDICATES_PRESENCE_OF", "object": "Interest in trial participation", "chunk": 3}
{"article": "PMC4307639.txt", "subject": "Personal computer usage", "relationship": "INDICATES_PRESENCE_OF", "object": "Interest in trial participation", "chunk": 3}
{"article": "PMC4307639.txt", "subject": "Age", "relationship": "RELATED_PROGNOSIS", "object": "Interest in trial participation (Younger participants were more likely to be interested)", "chunk": 3}
{"article": "PMC4307639.txt", "subject": "Loneliness scale", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Interest in trial participation (Higher scores were associated with higher interest)", "chunk": 3}
{"article": "PMC4307639.txt", "subject": "Self-rated health", "relationship": "RELATED_PROGNOSIS", "object": "Interest in trial participation", "chunk": 3}
{"article": "PMC4307639.txt", "subject": "internet access", "relationship": "RELATED_TO", "object": "elderly individuals' likelihood of participating in prevention studies", "chunk": 4}
{"article": "PMC4307639.txt", "subject": "current PC users", "relationship": "ASSOCIATED_WITH", "object": "greater interest in prevention studies using information communication technologies", "chunk": 4}
{"article": "PMC4307639.txt", "subject": "participants in PC-based conversational sessions", "relationship": "REQUIRED", "object": "no prior experience with PCs and internet", "chunk": 4}
{"article": "PMC4307822.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "functional impairment", "chunk": 1}
{"article": "PMC4307822.txt", "subject": "MMSE", "relationship": "RELATED_TO", "object": "VR-DOT functional index", "chunk": 4}
{"article": "PMC4307822.txt", "subject": "Bristol ADL scores", "relationship": "RELATED_TO", "object": "VR-DOT functional index", "chunk": 4}
{"article": "PMC4307822.txt", "subject": "upper extremity function psychomotor performance", "relationship": "PREDICTS_SURVIVAL", "object": "cognitive decline at year 3", "chunk": 4}
{"article": "PMC4307822.txt", "subject": "VR-DOT", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "functional independence", "chunk": 4}
{"article": "PMC4307822.txt", "subject": "MMSE", "relationship": "RELATED_TO", "object": "VR-DOT functional index", "chunk": 5}
{"article": "PMC4307822.txt", "subject": "MMSE", "relationship": "RELATED_TO", "object": "Bristol Activities of Daily Living (ADL)", "chunk": 5}
{"article": "PMC4307822.txt", "subject": "VR-DOT", "relationship": "PREDICTS_SURVIVAL", "object": "Conversion to AD", "chunk": 5}
{"article": "PMC4307822.txt", "subject": "VR-DOT REff", "relationship": "PREDICTS_SURVIVAL", "object": "Conversion to AD", "chunk": 5}
{"article": "PMC4307822.txt", "subject": "Bristol ADL", "relationship": "PREDICTS_SURVIVAL", "object": "Conversion to AD", "chunk": 5}
{"article": "PMC4307822.txt", "subject": "Blessed ADL", "relationship": "PREDICTS_SURVIVAL", "object": "Conversion to AD", "chunk": 5}
{"article": "PMC4307822.txt", "subject": "VR-DOT", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "PREDICTION for conversion to AD", "chunk": 6}
{"article": "PMC4307822.txt", "subject": "MMSE", "relationship": "DIAGNOSITC_OF", "object": "mild cognitive impairment  and AD", "chunk": 6}
{"article": "PMC4307822.txt", "subject": "Bristol scores ADL", "relationship": "DIAGNOSITC_OF", "object": "mild cognitive impairment  and AD", "chunk": 6}
{"article": "PMC4307822.txt", "subject": "Blessed score ADL", "relationship": "DIAGNOSITC_OF", "object": "mild cognitive impairment  and AD", "chunk": 6}
{"article": "PMC4307822.txt", "subject": "RAVLT delayed recall", "relationship": "DIAGNOSITC_OF", "object": "mild cognitive impairment  and AD", "chunk": 6}
{"article": "PMC4307822.txt", "subject": "DOT-VR", "relationship": "DIAGNOSITC_OF", "object": "mild cognitive impairment  and AD", "chunk": 6}
{"article": "PMC4307822.txt", "subject": "VR-DOT", "relationship": "RELATED_TO_PREDICTION", "object": "Functional Impairment", "chunk": 6}
{"article": "PMC4311425.txt", "subject": "APOE \u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased risk for Alzheimer's disease", "chunk": 1}
{"article": "PMC4311425.txt", "subject": "APOE \u03b54", "relationship": "RELATED_PROGNOSIS", "object": "Changes in putative AD-prevention behaviors", "chunk": 1}
{"article": "PMC4311425.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TREATMENT", "object": "Advance planning", "chunk": 1}
{"article": "PMC4311425.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TREATMENT", "object": "Lifestyle modifications", "chunk": 1}
{"article": "PMC4311425.txt", "subject": "APOE genotype", "relationship": "INDICATES_PRESENCE_OF", "object": "Risk of Alzheimer's Disease", "chunk": 2}
{"article": "PMC4311425.txt", "subject": "APOE genotype", "relationship": "RELATED_TREATMENT", "object": "Genetic risk assessment", "chunk": 2}
{"article": "PMC4311425.txt", "subject": "APOE4", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Lower  reassortment to mental activities and diet at 6 weeks", "chunk": 5}
{"article": "PMC4311425.txt", "subject": "APOE4", "relationship": "RELATED_PROGNOSIS", "object": "Changes to medications at 12 months", "chunk": 5}
{"article": "PMC4311425.txt", "subject": "APOE4", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased risk for AD", "chunk": 6}
{"article": "PMC4311425.txt", "subject": "APOE4", "relationship": "DIAGNOSITC_OF", "object": "Early-onset Alzheimer's Disease", "chunk": 6}
{"article": "PMC4324943.txt", "subject": "Physical function", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 1}
{"article": "PMC4324943.txt", "subject": "Cognitive function", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 1}
{"article": "PMC4324943.txt", "subject": "Quality of life", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 1}
{"article": "PMC4324943.txt", "subject": "Caregiver burden", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 1}
{"article": "PMC4324943.txt", "subject": "implicit memory", "relationship": "PROVIDES_BASIS_FOR_THERAPY_CHOICE", "object": "Develop a exercise program for dementia patients", "chunk": 2}
{"article": "PMC4324943.txt", "subject": "ADAS-cog", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment", "chunk": 5}
{"article": "PMC4324943.txt", "subject": "ADAS-cog", "relationship": "RELATED_TREATMENT", "object": "Dementia drug treatment trials", "chunk": 5}
{"article": "PMC4324943.txt", "subject": "NPI", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia-related behaviors", "chunk": 5}
{"article": "PMC4324943.txt", "subject": "3MS", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Cognitive function assessment", "chunk": 5}
{"article": "PMC4324943.txt", "subject": "ADCS-ADL", "relationship": "RELATED_PROGNOSIS", "object": "Functional status in dementia", "chunk": 5}
{"article": "PMC4324943.txt", "subject": "QOL-AD", "relationship": "RELATED_TREATMENT", "object": "Quality of life assessment in Alzheimer's disease", "chunk": 5}
{"article": "PMC4324943.txt", "subject": "ADAS-cog", "relationship": "RELATED_PROGNOSIS", "object": "Positive change in score suggests better cognitive function", "chunk": 7}
{"article": "PMC4324943.txt", "subject": "QOL-AD", "relationship": "RELATED_PROGNOSIS", "object": "Higher scores indicate better quality of life", "chunk": 7}
{"article": "PMC4324943.txt", "subject": "SPPB", "relationship": "RELATED_PROGNOSIS", "object": "Higher scores indicate better physical performance", "chunk": 7}
{"article": "PMC4324943.txt", "subject": "NPI-FS", "relationship": "INDICATES_PRESENCE_OF", "object": "Frequency and severity of dementia-related behaviors", "chunk": 7}
{"article": "PMC4324943.txt", "subject": "NPI-CD", "relationship": "INDICATES_PRESENCE_OF", "object": "Caregiver distress related to dementia behaviors", "chunk": 7}
{"article": "PMC4324943.txt", "subject": "CBI", "relationship": "INDICATES_PRESENCE_OF", "object": "Caregiver burden", "chunk": 7}
{"article": "PMC4324943.txt", "subject": "ADAS-cog", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive function", "chunk": 8}
{"article": "PMC4324943.txt", "subject": "ADAS-cog", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 8}
{"article": "PMC4324943.txt", "subject": "Physical performance (SPPB)", "relationship": "RELATED_TREATMENT", "object": "PLI\u00c9 program", "chunk": 8}
{"article": "PMC4324943.txt", "subject": "Quality of Life in Alzheimer\u2019s Disease scale (QOL-AD)", "relationship": "RELATED_TREATMENT", "object": "PLI\u00c9 program", "chunk": 8}
{"article": "PMC4324943.txt", "subject": "Caregiver Burden Inventory (CBI)", "relationship": "RELATED_TREATMENT", "object": "PLI\u00c9 program", "chunk": 8}
{"article": "PMC4333880.txt", "subject": "Apolipoprotein apoe4", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4333880.txt", "subject": "APOE4", "relationship": "RELATED_TO_PREDICTOR_VARIABLE", "object": "risk of Alzheimer's disease", "chunk": 2}
{"article": "PMC4333880.txt", "subject": "brain-derived neurotrophic factor (BDNF)", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "neuroprotection", "chunk": 3}
{"article": "PMC4333880.txt", "subject": "insulin-like growth factor (IGF-1)", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "neuroprotection", "chunk": 3}
{"article": "PMC4335024.txt", "subject": "Alzheimer's Disease", "relationship": "RELATED_PROGNOSIS", "object": "This is because two thirds of dementia patients in Sweden are estimated to have Alzheimer's disease.", "chunk": 1}
{"article": "PMC4335024.txt", "subject": "Alzheimer's Disease", "relationship": "DIAGNOSITC_OF", "object": "SveDem was initiated to achieve dementia care of similar and high quality for the whole country.", "chunk": 1}
{"article": "PMC4335024.txt", "subject": "Alzheimer's Disease", "relationship": "INDICATES_PRESENCE_OF", "object": "In Sweden, it is estimated that 150,000 individuals suffer from dementia and two thirds of them have Alzheimer's disease.", "chunk": 1}
{"article": "PMC4335024.txt", "subject": "BMI", "relationship": "RELATED_PROGNOSIS", "object": "BMI provides information about the patient's weight and health status, which can be related to the prognosis.", "chunk": 2}
{"article": "PMC4335024.txt", "subject": "MMSE Score", "relationship": "INDICATES_PRESENCE_OF", "object": "A low MMSE score indicates the presence of cognitive impairment.", "chunk": 2}
{"article": "PMC4335024.txt", "subject": "MMSE Score", "relationship": "RELATED_TREATMENT", "object": "MMSE score can help guide treatment decisions for dementia patients.", "chunk": 2}
{"article": "PMC4335024.txt", "subject": "MMSE score", "relationship": "USED_TO_DIAGNOSE", "object": "diagnose dementia", "chunk": 3}
{"article": "PMC4335024.txt", "subject": "MMSE score", "relationship": "RELATED_PROGNOSIS", "object": "cognitive impairment", "chunk": 3}
{"article": "PMC4335024.txt", "subject": "MMSE score", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive impairment is mild (20\u201330 points) or moderate (10 to <20 points)", "chunk": 3}
{"article": "PMC4335024.txt", "subject": "calcium", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "basic dementia work-up", "chunk": 3}
{"article": "PMC4335024.txt", "subject": "homocysteine", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "basic dementia work-up", "chunk": 3}
{"article": "PMC4335024.txt", "subject": "thyroid function", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "basic dementia work-up", "chunk": 3}
{"article": "PMC4346122.txt", "subject": "Pittsburgh compound B", "relationship": "RELATED_TO_TREATMENT", "object": "Amyloid PET scan", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "Amyloid (Pittsburgh compound B; PIB)", "relationship": "RELATED_TO_TREATMENT", "object": "Surrogate of Alzheimer\u2019s disease neuropathology", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "PIB+", "relationship": "INDICATES_PRESENCE_OF", "object": "Underlying Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "Alzheimer\u2019s disease pathology", "relationship": "ASSOCIATED_WITH_GREATER_EPISODIC_MEMORY_LOSS", "object": "CBS-AD patients", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "Alzheimer\u2019s disease pathology", "relationship": "ASSOCIATED_WITH_GREATER_VISUOSPATIAL_DEFICITS", "object": "CBS-AD patients", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "Alzheimer\u2019s disease pathology", "relationship": "PREDICTED_BY", "object": "Temporoparietal-predominant neuroimaging patterns", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "Alzheimer\u2019s disease pathology", "relationship": "ASSOCIATED_WITH_GREATER_TEMPOROPARIETAL_INVOLVEMENT", "object": "neuroimaging", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "Amyloid deposition", "relationship": "SURROGATE_FOR", "object": "Alzheimer\u2019s disease neuropathology", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "PIB positivity", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease pathology", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "amyloid deposition", "relationship": "SURROGATE_OF", "object": "Alzheimer\u2019s disease neuropathology", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "temporoparietal-predominant neuroimaging patterns", "relationship": "RELATED_WITH_BETTER_OUTCOME", "object": "sensitivity for AD", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "Pittsburgh compound B; PIB", "relationship": "RELATED_TO", "object": "PET scans showing amyloid deposition", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "frontal variant CBS (fvCBS)", "relationship": "RELATED_TO", "object": "patients with lower likelihood of underlying AD", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "temporoparietal variant CBS (tpvCBS)", "relationship": "RELATED_TO", "object": "patients with higher likelihood of underlying AD", "chunk": 1}
{"article": "PMC4346122.txt", "subject": "PIB-PET", "relationship": "SURROGATE_MARKER_OF", "object": "AD pathology", "chunk": 2}
{"article": "PMC4346122.txt", "subject": "amyloid PET scans", "relationship": "MAY_PREDICT", "object": "AD pathology in CBS patients", "chunk": 2}
{"article": "PMC4346122.txt", "subject": "APOE4", "relationship": "RELATED_PROGNOSIS", "object": "Neither 'CBS-PIB+' nor 'CBS-PIB-' patients showed significant differences in age at...", "chunk": 2}
{"article": "PMC4346122.txt", "subject": "Apolipoprotein E \u03b54 allele", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid burden (CBS-PIB+)", "chunk": 3}
{"article": "PMC4346122.txt", "subject": "PIB", "relationship": "INDICATES_PRESENCE_OF", "object": "Cotictobasal syndrome (CBS)", "chunk": 4}
{"article": "PMC4346122.txt", "subject": "apoe4 allele", "relationship": "RELATED_TREATMENT", "object": "100% of patients", "chunk": 4}
{"article": "PMC4346122.txt", "subject": "PIB-PET", "relationship": "USED_TO_DIAGNOSE", "object": "Determine CBS-PIB status", "chunk": 5}
{"article": "PMC4346122.txt", "subject": "FDG-PET", "relationship": "RELATED_PROGNOSIS", "object": "Predicting PIB-PET findings", "chunk": 5}
{"article": "PMC4346122.txt", "subject": "FDG-PET", "relationship": "RELATED_PROGNOSIS", "object": "Predicting PIB status", "chunk": 5}
{"article": "PMC4346122.txt", "subject": "CBS-PIB+", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Showed greater lateralization of FDG uptake", "chunk": 5}
{"article": "PMC4346122.txt", "subject": "CBS-PIB-", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Showed greater lateralization of FDG uptake", "chunk": 5}
{"article": "PMC4346122.txt", "subject": "CBS-PIB+", "relationship": "INDICATES_PRESENCE_OF", "object": "High probability AD and CBD", "chunk": 5}
{"article": "PMC4346122.txt", "subject": "CBS-PIB+", "relationship": "INDICATES_PRESENCE_OF", "object": "Frequent neocortical neuritic plaques (CERAD score)", "chunk": 5}
{"article": "PMC4346122.txt", "subject": "CBS-PIB+", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurofibrillary tangles (Braak Stage VI)", "chunk": 5}
{"article": "PMC4346122.txt", "subject": "CBS-PIB+", "relationship": "INDICATES_PRESENCE_OF", "object": "Tau-positive glial cytoplasmic inclusions (astrocytes and oligodendroglia)", "chunk": 5}
{"article": "PMC4346122.txt", "subject": "CBS-PIB-", "relationship": "INDICATES_PRESENCE_OF", "object": "Negative PIB-PET scans", "chunk": 5}
{"article": "PMC4346122.txt", "subject": "PIB+ status", "relationship": "PREDICTS", "object": "visuospatial and episodic memory loss", "chunk": 6}
{"article": "PMC4346122.txt", "subject": "PIB+ status", "relationship": "PREDICTS", "object": "worse performance on the Benson figure copy", "chunk": 6}
{"article": "PMC4346122.txt", "subject": "FDG-PET", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "differentiating AD from FTLD", "chunk": 6}
{"article": "PMC4346122.txt", "subject": "temporal-parietal overlap (tpv)-predominant clinical criteria", "relationship": "RELATED_WITH", "object": "FDG-PET", "chunk": 6}
{"article": "PMC4346122.txt", "subject": "ftd", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "greater temporoparietal hypometabolism", "chunk": 6}
{"article": "PMC4346122.txt", "subject": "CBS-PIB-", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "FDG-PET scan", "chunk": 6}
{"article": "PMC4346122.txt", "subject": "frontal-predominant hypometabolism", "relationship": "USED_TO_DIAGNOSE", "object": " CBS", "chunk": 6}
{"article": "PMC4346122.txt", "subject": "amyloid beta peptides peptides (A\u03b2)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "future diagnostic algorithm", "chunk": 7}
{"article": "PMC4346122.txt", "subject": "Tau", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "future diagnostic algorithm", "chunk": 7}
{"article": "PMC4346122.txt", "subject": "A\u03b2", "relationship": "RELATED_TREATMENT", "object": "predict pathology for the individual patient", "chunk": 7}
{"article": "PMC4346122.txt", "subject": "Tau", "relationship": "RELATED_TREATMENT", "object": "predict pathology for the individual patient", "chunk": 7}
{"article": "PMC4346122.txt", "subject": "amyloid PET", "relationship": "RELATED_TREATMENT", "object": "predict pathology for the individual patient", "chunk": 7}
{"article": "PMC4346122.txt", "subject": "tau PET", "relationship": "RELATED_TREATMENT", "object": "predict pathology for the individual patient", "chunk": 7}
{"article": "PMC4353453.txt", "subject": "ADAS-cog score", "relationship": "USED_TO_DIAGNOSE", "object": "Determine  improvement or lack of decline in patients with Alzheimer's Disease", "chunk": 2}
{"article": "PMC4353453.txt", "subject": "ADAS-cog score", "relationship": "RELATED_PROGNOSIS", "object": "Significant improvement on ADAS-cog score is associated with better clinical outcomes in patients with Alzheimer's Disease", "chunk": 2}
{"article": "PMC4353453.txt", "subject": "ADCS-IADL score", "relationship": "RELATED_PROGNOSIS", "object": "No decline on ADCS-IADL score is associated with better functional outcomes in patients with Alzheimer's Disease", "chunk": 2}
{"article": "PMC4353453.txt", "subject": "MMSE score", "relationship": "INDICATES_PRESENCE_OF", "object": "MMSE score of 10 to 24 is a diagnostic criterion for mild-to-moderate Alzheimer's Disease", "chunk": 2}
{"article": "PMC4353453.txt", "subject": "Mini-Mental State Examination (MMSE) score", "relationship": "RELATED_PROGNOSIS", "object": "A lower MMSE score is associated with a greater decline in cognitive function in patients with Alzheimer's Disease", "chunk": 2}
{"article": "PMC4353453.txt", "subject": "ADAS-cog", "relationship": "RELATED_PROGNOSIS", "object": "Probability of improvement", "chunk": 3}
{"article": "PMC4353453.txt", "subject": "ADAS-cog", "relationship": "INDICATES_PRESENCE_OF", "object": "More severe cognitive impairment", "chunk": 3}
{"article": "PMC4353453.txt", "subject": "ADCS-IADL", "relationship": "RELATED_PROGNOSIS", "object": "Probability of improvement", "chunk": 3}
{"article": "PMC4353453.txt", "subject": "ADCS-IADL", "relationship": "INDICATES_PRESENCE_OF", "object": "More severe functional impairment", "chunk": 3}
{"article": "PMC4353453.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "More severe cognitive impairment", "chunk": 3}
{"article": "PMC4353453.txt", "subject": "13.3\u00a0mg/24\u00a0h rivastigmine patch", "relationship": "RELATED_TREATMENT", "object": "Increased probability of improvement", "chunk": 3}
{"article": "PMC4353453.txt", "subject": "9.5\u00a0mg/24\u00a0h rivastigmine patch", "relationship": "RELATED_TREATMENT", "object": "Decreased probability of improvement", "chunk": 3}
{"article": "PMC4353453.txt", "subject": "ADAS-cog", "relationship": "USED_TO_DIAGNOSE", "object": "Deterioration from DB-BL to Week 48", "chunk": 4}
{"article": "PMC4353453.txt", "subject": "ADCS-IADL", "relationship": "USED_TO_DIAGNOSE", "object": "Deterioration from DB-BL to Week 48", "chunk": 4}
{"article": "PMC4353453.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Moderate stage of AD", "chunk": 4}
{"article": "PMC4353453.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Reduced chance of improvement after 24 weeks", "chunk": 4}
{"article": "PMC4353453.txt", "subject": "ADAS-cog", "relationship": "RELATED_PROGNOSIS", "object": "Significantly greater chance of improvement with rivastigmine after 24 weeks", "chunk": 4}
{"article": "PMC4353453.txt", "subject": "ADCS-IADL", "relationship": "RELATED_PROGNOSIS", "object": "Significantly greater chance of improvement with rivastigmine after 24 weeks", "chunk": 4}
{"article": "PMC4362220.txt", "subject": "Antidepressant medication", "relationship": "RELATED_TREATMENT", "object": "Treatment resistant depression", "chunk": 6}
{"article": "PMC4362220.txt", "subject": "tDCS", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment for depression", "chunk": 6}
{"article": "PMC4362220.txt", "subject": "tDCS", "relationship": "RELATED_TREATMENT", "object": "Non pharmacotherapy resistant depression", "chunk": 6}
{"article": "PMC4362220.txt", "subject": "tDCS", "relationship": "INDICATES_PRESENCE_OF", "object": "Antidepressant effects", "chunk": 6}
{"article": "PMC4362220.txt", "subject": "Expanded Disability Status Scale (EDSS) score", "relationship": "USED_TO_DIAGNOSE", "object": "exlcude those with scores of 6.5 or greater from a remotely-supervised tDCS protocol", "chunk": 7}
{"article": "PMC4362220.txt", "subject": "Brief International Cognitive Assessment in MS (BICAMS)", "relationship": "USED_TO_DIAGNOSE", "object": "exclude those with severe cognitive deficits from a remotely-supervised tDCS protocol", "chunk": 7}
{"article": "PMC4366075.txt", "subject": "A\u03b2 (amyloid beta)", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Investigational anti-A\u03b2 treatments", "chunk": 1}
{"article": "PMC4366075.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Senile plaques, a hallmark of Alzheimer\u2019s disease brain pathology", "chunk": 1}
{"article": "PMC4366075.txt", "subject": "A\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "Unwanted effects such as vasogenic cerebral edema (ARIA-E)", "chunk": 1}
{"article": "PMC4366075.txt", "subject": "A\u03b2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Amyloid-related imaging abnormalities-edema (ARIA-E)", "chunk": 1}
{"article": "PMC4366075.txt", "subject": "bapineuzumab and gantenerumab", "relationship": "INDICATES_PRESENCE_OF", "object": "Anti-A\u03b2 monoclonal antibodies targeting the N-terminus of A\u03b2", "chunk": 1}
{"article": "PMC4366075.txt", "subject": "bapineuzumab", "relationship": "RELATED_TREATMENT", "object": "Clinical trials associated with unwanted effects like ARIA-E", "chunk": 1}
{"article": "PMC4366075.txt", "subject": "gantenerumab", "relationship": "RELATED_TREATMENT", "object": "Clinical trials associated with unwanted effects like ARIA-E", "chunk": 1}
{"article": "PMC4366075.txt", "subject": "GSK933776", "relationship": "RELATED_TREATMENT", "object": "Treatment for mild AD", "chunk": 2}
{"article": "PMC4366075.txt", "subject": "GSK933776", "relationship": "RELATED_TREATMENT", "object": "Treatment for mild cognitive impairment", "chunk": 2}
{"article": "PMC4366075.txt", "subject": "A\u03b2 N-terminus (aa1\u20135)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Passive immunization strategy targeting A\u03b2", "chunk": 2}
{"article": "PMC4366075.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild AD", "chunk": 2}
{"article": "PMC4366075.txt", "subject": "total A\u03b242", "relationship": "RELATED_TREATMENT", "object": "Cerebral spinal fluid biomarker for prodromal or mild AD", "chunk": 2}
{"article": "PMC4366075.txt", "subject": "phosphorylated tau", "relationship": "RELATED_TREATMENT", "object": "Cerebral spinal fluid biomarker for prodromal or mild AD", "chunk": 2}
{"article": "PMC4366075.txt", "subject": "total tau", "relationship": "RELATED_TREATMENT", "object": "Cerebral spinal fluid biomarker for prodromal or mild AD", "chunk": 2}
{"article": "PMC4366075.txt", "subject": "A\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Measurement in plasma and cerebrospinal fluid", "chunk": 3}
{"article": "PMC4366075.txt", "subject": "A\u03b2X\u201338", "relationship": "RELATED_TREATMENT", "object": " Measured using a commercially available assay", "chunk": 3}
{"article": "PMC4366075.txt", "subject": "A\u03b2X\u201340", "relationship": "RELATED_TREATMENT", "object": " Measured using a commercially available assay", "chunk": 3}
{"article": "PMC4366075.txt", "subject": "A\u03b2X\u201342", "relationship": "RELATED_TREATMENT", "object": " Measured using a commercially available assay", "chunk": 3}
{"article": "PMC4366075.txt", "subject": "A\u03b21\u201342", "relationship": "RELATED_TREATMENT", "object": "Measured using a commercially available assay", "chunk": 3}
{"article": "PMC4366075.txt", "subject": "ApoE", "relationship": "RELATED_TREATMENT", "object": " Measured using a commercially available assay", "chunk": 3}
{"article": "PMC4366075.txt", "subject": "total tau", "relationship": "RELATED_TREATMENT", "object": " Measured using a commercially available assay", "chunk": 3}
{"article": "PMC4366075.txt", "subject": "phosphorylated tau", "relationship": "RELATED_TREATMENT", "object": " Measured using a commercially available assay", "chunk": 3}
{"article": "PMC4366075.txt", "subject": "GSK933776", "relationship": "INDIATES_PRESENCE_OF", "object": "Antibodies", "chunk": 3}
{"article": "PMC4366075.txt", "subject": "GSK933776", "relationship": "RELATED_PROGNOSIS", "object": "Incidence of ARIA-E (amyloid-related imaging abnormalities-edema)", "chunk": 3}
{"article": "PMC4366075.txt", "subject": "APOE \u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "Early Alzheimer's Disease", "chunk": 4}
{"article": "PMC4366075.txt", "subject": "A\u03b21\u201342", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Solanezumab-triggered changes in patients", "chunk": 6}
{"article": "PMC4366075.txt", "subject": "A\u03b21\u201340", "relationship": "RELATED_TO_A_DISEASE", "object": "Cerebrospinal fluid levels are decreased", "chunk": 6}
{"article": "PMC4366075.txt", "subject": "A\u03b2 X\u201338", "relationship": "IS_TARGET_OF_TREATMENT", "object": "GSK933776, a monoclonal antibody", "chunk": 6}
{"article": "PMC4366075.txt", "subject": "A\u03b2 X\u201342", "relationship": "IS_TARGET_OF_TREATMENT", "object": "GSK933776, a monoclonal antibody", "chunk": 6}
{"article": "PMC4366075.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TREATMENT", "object": "GSK933776 may need adjustments in dosage regimen depending on APOE genotype", "chunk": 6}
{"article": "PMC4366075.txt", "subject": "total A\u03b2", "relationship": "RISKS_ASSOCIATED_WITH_TREATMENT", "object": "GSK933776 may increase risk of ARIA-E in higher doses if Fc activity is high", "chunk": 6}
{"article": "PMC4366075.txt", "subject": "ARIA-E", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Selection of anti-A\u03b2 antibodies (such as GSK933776) with an inactivated Fc region", "chunk": 6}
{"article": "PMC4366075.txt", "subject": "A\u03b2X\u201342", "relationship": "CAPTURED_USING", "object": "MSD Capture (aa37\u201342)", "chunk": 7}
{"article": "PMC4366075.txt", "subject": "A\u03b2X\u201342", "relationship": "DETECTED_USING", "object": "4G8 (aa18\u201322; Covance)", "chunk": 7}
{"article": "PMC4366075.txt", "subject": "fragments", "relationship": "CAPTURED_USING", "object": "Meso Scale Discovery (MSD) 21F12 clone (aa37\u201342)", "chunk": 7}
{"article": "PMC4366075.txt", "subject": "fragments", "relationship": "DETECTED_USING", "object": "3D6 clone (aa1\u20136)", "chunk": 7}
{"article": "PMC4366075.txt", "subject": "A\u03b2", "relationship": "DETERMINED_IN_CSF", "object": "cerebral spinal fluid", "chunk": 7}
{"article": "PMC4366075.txt", "subject": "Total A\u03b242 [aa28\u201342]", "relationship": "COMPARED_BETWEEN_DOSES", "object": "GSK933776", "chunk": 7}
{"article": "PMC4366075.txt", "subject": "total A\u03b2 [aa18\u201335]", "relationship": "COMPARED_BETWEEN_DOSES", "object": "GSK933776", "chunk": 7}
{"article": "PMC4366075.txt", "subject": "A\u03b2X\u201340", "relationship": "DETERMINED_IN_CSF", "object": "cerebral spinal fluid", "chunk": 7}
{"article": "PMC4366075.txt", "subject": "pan-APOE", "relationship": "DETERMINED_IN_CSF", "object": "cerebral spinal fluid", "chunk": 7}
{"article": "PMC4366075.txt", "subject": "total tau", "relationship": "DETERMINED_IN_CSF", "object": "cerebral spinal fluid", "chunk": 7}
{"article": "PMC4366075.txt", "subject": "phosphorylated-tau", "relationship": "DETERMINED_IN_CSF", "object": "cerebral spinal fluid", "chunk": 7}
{"article": "PMC4374455.txt", "subject": "SRT latencies", "relationship": "RELATED_PROGNOSIS", "object": "SRT latencies  failed to correlate with age", "chunk": 5}
{"article": "PMC4374455.txt", "subject": "SRT latencies", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "SRT latencies were prolonged at the shortest SOA", "chunk": 5}
{"article": "PMC4374455.txt", "subject": "SRT latencies", "relationship": "RELATED_PROGNOSIS", "object": "SRT latencies increased at the shortest SOA", "chunk": 5}
{"article": "PMC4374455.txt", "subject": "SRT latencies", "relationship": "RELATED_TREATMENT", "object": "Comparing SRT latencies measured in the current experiment and MIT, the time needed to depress the response button", "chunk": 5}
{"article": "PMC4374455.txt", "subject": "SDT latencies", "relationship": "PREDICTED_SURVIVAL", "object": "SDT latencies did not increase with age", "chunk": 5}
{"article": "PMC4374455.txt", "subject": "MIT latencies", "relationship": "RELATED_PROGNOSIS", "object": "Comparisons of the correlations of age with MIT latency and age with SRT latency showed significantly larger correlations of age with MIT latency", "chunk": 5}
{"article": "PMC4380493.txt", "subject": "CDR-SOB", "relationship": "INDICATES_PRESENCE_OF", "object": "More severe cognitive impairment", "chunk": 3}
{"article": "PMC4380493.txt", "subject": "ADAS-Cog", "relationship": "INDICATES_PRESENCE_OF", "object": "Early Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4380493.txt", "subject": "CMMSE", "relationship": "RELATED_PROGNOSIS", "object": "Better cognitive function", "chunk": 3}
{"article": "PMC4380493.txt", "subject": "CSDD", "relationship": "INDICATES_PRESENCE_OF", "object": "Severity of depression in older adults with cognitive impairment", "chunk": 3}
{"article": "PMC4380493.txt", "subject": "MIC", "relationship": "RELATED_PROGNOSIS", "object": "More cognitive complaints", "chunk": 3}
{"article": "PMC4380493.txt", "subject": "CDAD", "relationship": "RELATED_TREATMENT", "object": "Assessment for older adults with different degree of cognitive abilities", "chunk": 3}
{"article": "PMC4380493.txt", "subject": "CDR-SOB", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 4}
{"article": "PMC4380493.txt", "subject": "CMMSE", "relationship": "RELATED_TO", "object": "Cognitive Performance", "chunk": 4}
{"article": "PMC4380493.txt", "subject": "ADAS-Cog", "relationship": "RELATED_TO", "object": "Cognitive Performance", "chunk": 4}
{"article": "PMC4380493.txt", "subject": "Delayed Recall", "relationship": "RELATED_TO", "object": "Cognitive Performance", "chunk": 4}
{"article": "PMC4380493.txt", "subject": "CVFT", "relationship": "RELATED_TO", "object": "Cognitive Performance", "chunk": 4}
{"article": "PMC4380493.txt", "subject": "Digit Span (Forward)", "relationship": "RELATED_TO", "object": "Cognitive Performance", "chunk": 4}
{"article": "PMC4380493.txt", "subject": "Digit Span (Backward)", "relationship": "RELATED_TO", "object": "Cognitive Performance", "chunk": 4}
{"article": "PMC4380493.txt", "subject": "Trail A (in Seconds)", "relationship": "RELATED_TO", "object": "Cognitive Performance", "chunk": 4}
{"article": "PMC4380493.txt", "subject": "Trail B (in Seconds)", "relationship": "RELATED_TO", "object": "Cognitive Performance", "chunk": 4}
{"article": "PMC4380493.txt", "subject": "CSDD", "relationship": "RELATED_TO", "object": "Mood, Depression", "chunk": 4}
{"article": "PMC4380493.txt", "subject": "CDR-SOB", "relationship": "RELATED_TO_TREATMENT_EFFECT", "object": "Improvements in ADAS-Cog, delayed recall, subjective cognitive complaints (MIC) and CVFT were found with time", "chunk": 5}
{"article": "PMC4380493.txt", "subject": "CMMSE", "relationship": "RELATED_TO_TREATMENT_EFFECT", "object": "For the sdmild cognitive impairment  group, a time trend for lower CMMSE scores was observed (p = 0.04).", "chunk": 5}
{"article": "PMC4380493.txt", "subject": "ADAS-Cog", "relationship": "RELATED_TO_TREATMENT_EFFECT", "object": "For the sdmild cognitive impairment group, integrated CP intervention were associated with better performance in ADAS-Cog (time \u00d7 group effects, \u03c72 = 10.25, p = 0.02)", "chunk": 5}
{"article": "PMC4380493.txt", "subject": "Delayed Recall", "relationship": "RELATED_TO_TREATMENT_EFFECT", "object": "For the sdmild cognitive impairment group, integrated CP intervention were associated with better performance in delayed recall (time \u00d7 group effects, \u03c72 = 9.45, p = 0.02)", "chunk": 5}
{"article": "PMC4380493.txt", "subject": "CVFT", "relationship": "RELATED_TO_TREATMENT_EFFECT", "object": "For the sdmild cognitive impairment group, integrated CP intervention were associated with better performance in CVFT (time \u00d7 group effects, \u03c72 = 12.41, p = 0.006). For the mdmild cognitive impairment participants, the CP group was associated with greater improvement in CVFT (time \u00d7 group effects, \u03c72 = 11.64, p = 0.009)", "chunk": 5}
{"article": "PMC4380493.txt", "subject": "CDAD-IADL", "relationship": "RELATED_TO_TREATMENT_EFFECT", "object": "No change in CDAD-IADL", "chunk": 5}
{"article": "PMC4380493.txt", "subject": "CSDD (total)", "relationship": "RELATED_TO_TREATMENT_EFFECT", "object": "For the sdmild cognitive impairment group, integrated CP intervention were associated with better performance in ADAS-Cog (time \u00d7 group effects, \u03c72 = 10.25, p = 0.02)", "chunk": 5}
{"article": "PMC4380493.txt", "subject": "Subjective cognitive complaints (SCC)", "relationship": "RELATED_TO_TREATMENT_EFFECT", "object": "Improvements in subjective cognitive complaints (MIC)", "chunk": 5}
{"article": "PMC4380493.txt", "subject": "ADAS-Cog", "relationship": "RELATED_TO_TREATMENT", "object": "showed significant improvements", "chunk": 6}
{"article": "PMC4380493.txt", "subject": "ADAS-Cog", "relationship": "RELATED_TO_TREATMENT", "object": "improvements in cognitive scores", "chunk": 6}
{"article": "PMC4380493.txt", "subject": "Delayed Recall", "relationship": "RELATED_TO_TREATMENT", "object": "showed significant improvements", "chunk": 6}
{"article": "PMC4380493.txt", "subject": "CVFT", "relationship": "RELATED_TO_TREATMENT", "object": "showed significant improvements", "chunk": 6}
{"article": "PMC4380493.txt", "subject": "CMMSE", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "may be affected by ceiling effects, so subtle changes may not be detected", "chunk": 6}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "INDICATES_PRESENCE_OF", "object": "Molecular changes in response to Yogic breathing", "chunk": 1}
{"article": "PMC4383272.txt", "subject": "IGLC2", "relationship": "INDICATES_PRESENCE_OF", "object": "Molecular changes in response to Yogic breathing", "chunk": 1}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "The authors chose it based on its abundance in saliva, spectral counts and level of statistical significance in MS data, and the roles of these proteins in immune regulation, epithelial differentiation, tumor suppression, and stress response", "chunk": 2}
{"article": "PMC4383272.txt", "subject": "IGLC2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "The authors chose it based on its abundance in saliva, spectral counts and level of statistical significance in MS data, and the roles of these proteins in immune regulation, epithelial differentiation, tumor suppression, and stress response", "chunk": 2}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "INDICATES_PRESENCE_OF", "object": "Elevated expression in 7 out of 10 subjects from the YB group and none in the AC group", "chunk": 3}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Yogic Breathing exercises", "chunk": 3}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "RELATED_TREATMENT", "object": "Yogic Breathing exercises", "chunk": 3}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "INDICATES_PRESENCE_OF", "object": "Elevated levels in YB group compared to AC group after 10 and 15 minutes", "chunk": 4}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "RELATED_TO", "object": "Innate immune response", "chunk": 4}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "IS_TARGET_OF_TREATMENT", "object": "reduction of infectivity of HIV1 and influenza A viruses", "chunk": 4}
{"article": "PMC4383272.txt", "subject": "IGLC2", "relationship": "INDICATES_PRESENCE_OF", "object": "Marked increase in YB group after 5 minutes", "chunk": 4}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "RELATED_TO", "object": "Epithelial cell differentiation", "chunk": 4}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "RELATED_TO", "object": "Angiogenesis at the vascular extracellular matrix", "chunk": 4}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "RELATED_TO", "object": "Binding to galectin-3", "chunk": 4}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "RELATED_PROGNOSIS", "object": "Tumor suppressor gene", "chunk": 4}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased level in saliva following Yogic Breathing", "chunk": 5}
{"article": "PMC4383272.txt", "subject": "IGLC2", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased level in saliva following Yogic Breathing", "chunk": 5}
{"article": "PMC4383272.txt", "subject": "DMBT1", "relationship": "RESPONSED_TO", "object": "Yogic Breathing", "chunk": 5}
{"article": "PMC4383272.txt", "subject": "IGLC2", "relationship": "RESPONSED_TO", "object": "Yogic Breathing", "chunk": 5}
{"article": "PMC4396171.txt", "subject": "A\u03b240", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment with AZD0530", "chunk": 3}
{"article": "PMC4396171.txt", "subject": "A\u03b242", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment with AZD0530", "chunk": 3}
{"article": "PMC4396171.txt", "subject": "Tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment with AZD0530", "chunk": 3}
{"article": "PMC4396171.txt", "subject": "P231-Tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment with AZD0530", "chunk": 3}
{"article": "PMC4396171.txt", "subject": "sCTX", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment with AZD0530", "chunk": 3}
{"article": "PMC4396171.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "provides an assessment of cognitive function and is used to monitor disease progression in Alzheimer's disease", "chunk": 4}
{"article": "PMC4396171.txt", "subject": "AZD0530", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of Alzheimer's disease  ", "chunk": 5}
{"article": "PMC4396171.txt", "subject": "A\u03b240", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4396171.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4396171.txt", "subject": "Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4396171.txt", "subject": "p-Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4396171.txt", "subject": "18F-FDG PET imaging", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment of Alzheimer's disease", "chunk": 6}
{"article": "PMC4396171.txt", "subject": "sCTX", "relationship": "RELATED_PROGNOSIS", "object": "Treatment Effect on Alzheimer's disease", "chunk": 6}
{"article": "PMC4396171.txt", "subject": "AZD0530", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4396171.txt", "subject": "AZD0530", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC4396171.txt", "subject": "AZD0530", "relationship": "PREDICTS_SURVIVAL", "object": "Patients with Alzheimer's Disease", "chunk": 6}
{"article": "PMC4396171.txt", "subject": "AB amyloid-beta", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Developing NgR- and PrP-based therapeutics", "chunk": 7}
{"article": "PMC4396171.txt", "subject": "A\u03b2 oligomeric amyloid-beta", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Developing NgR- and PrP-based therapeutics", "chunk": 7}
{"article": "PMC4396171.txt", "subject": "cellular prion protein", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Developing NgR- and PrP-based therapeutics", "chunk": 7}
{"article": "PMC4397698.txt", "subject": "Aluminum concentration", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Aluminum chloride (AlCl3) administration resulted in a significant increase in the aluminum concentration", "chunk": 1}
{"article": "PMC4397698.txt", "subject": "Acetylcholinesterase activity", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "AlCl3 administration resulted in a significant increase in the acetylcholinesterase activity", "chunk": 1}
{"article": "PMC4397698.txt", "subject": "Amyloid beta peptides peptides peptidesss (A\u03b2) deposition", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "AlCl3 administration resulted in a significant increase in the amyloid beta peptides peptides peptidesss (A\u03b2) deposition", "chunk": 1}
{"article": "PMC4397698.txt", "subject": "BDNF", "relationship": "RELATED_TREATMENT", "object": "Increased levels of BDNF has great potential for the treatment of AD", "chunk": 1}
{"article": "PMC4397698.txt", "subject": "GDNF", "relationship": "RELATED_TREATMENT", "object": "Increased levels of GDNF has great potential for the treatment of AD", "chunk": 1}
{"article": "PMC4397698.txt", "subject": "VEGF", "relationship": "RELATED_TREATMENT", "object": "Emerging treatment strategies focus on reducing A\u03b2 plaques from the brain of AD patients", "chunk": 1}
{"article": "PMC4397698.txt", "subject": "LIPUS", "relationship": "RELATED_TREATMENT", "object": "This study was designed to investigate the neuroprotective effect of LIPUS against AlCl3-induced cognitive dysfunction and associated cerebral damage in rats.", "chunk": 1}
{"article": "PMC4397698.txt", "subject": "Brain-derived neurotrophic factor (BDNF)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "The results suggested the enhancement of endogenous neurotrophic factors via LIPUS could be a novel treatment strategy for brain disorder.", "chunk": 1}
{"article": "PMC4397698.txt", "subject": "LIDPUS", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Recently, one study demonstrated that FUS enhanced delivery of anti-A\u03b2 antibodies rapidly reduces plaque in a model of AD with aggressive A\u03b2 pathology", "chunk": 1}
{"article": "PMC4397698.txt", "subject": "AChE activity", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease risk", "chunk": 2}
{"article": "PMC4397698.txt", "subject": "A\u03b21-42 expression", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Brain damage", "chunk": 2}
{"article": "PMC4397698.txt", "subject": "A\u03b21-42 content", "relationship": "RELATED_PROGNOSIS", "object": "Brain damage", "chunk": 2}
{"article": "PMC4397698.txt", "subject": "Aluminum concentration", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease risk", "chunk": 2}
{"article": "PMC4397698.txt", "subject": "Karyopyknosis", "relationship": "RELATED_PROGNOSIS", "object": "Brain damage", "chunk": 2}
{"article": "PMC4397698.txt", "subject": "A\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "Significantly improved memory retention and attenuated AChE activity levels, and A\u03b2 deposition produced by LIPUS lend support to our hypothesis that transcranial LIPUS has a neuroprotective effect against Al-induced cerebral damage", "chunk": 3}
{"article": "PMC4397698.txt", "subject": "AChE", "relationship": "RELATED_PROGNOSIS", "object": "Significantly improved memory retention and attenuated AChE activity levels, and A\u03b2 deposition produced by LIPUS lend support to our hypothesis that transcranial LIPUS has a neuroprotective effect against Al-induced cerebral damage", "chunk": 3}
{"article": "PMC4397698.txt", "subject": "VEGF", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "This might explain why the A\u03b2 content significantly decreased in AlCl3-treated rats after chronic LIPUS application", "chunk": 3}
{"article": "PMC4397698.txt", "subject": "A\u03b2", "relationship": "RELATED_TREATMENT", "object": "The use of LIPUS could potentially increase neurotrophic factors and perhaps aid with controlling or reversing related brain disorders such as AD", "chunk": 3}
{"article": "PMC4397698.txt", "subject": "A\u03b2 protein", "relationship": "RELATED_PROGNOSIS", "object": "accumulation of A\u03b2 in cortex and hippocampus of brain", "chunk": 4}
{"article": "PMC4397698.txt", "subject": "Acetylcholinesterase activity", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "  AchE is a marker of extensive loss of cholinergic neurons in the forebrain", "chunk": 4}
{"article": "PMC4397698.txt", "subject": "BDNF", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurotrophic factor expression in the rat brain", "chunk": 5}
{"article": "PMC4397698.txt", "subject": "GDNF", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurotrophic factor expression in the rat brain", "chunk": 5}
{"article": "PMC4397698.txt", "subject": "VEGF", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurotrophic factor expression in the rat brain", "chunk": 5}
{"article": "PMC4397698.txt", "subject": "Aluminum (Al)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Aluminum levels in the brain", "chunk": 5}
{"article": "PMC4397698.txt", "subject": "Acetylcholinesterase activity", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Ammonium chloride induced neurodegeneration", "chunk": 5}
{"article": "PMC4397698.txt", "subject": "A\u03b2 content", "relationship": "associated_with_poor_outcome", "object": "Alzheimer's disease related cognitive decline", "chunk": 5}
{"article": "PMC4397698.txt", "subject": "Cognitive impairment", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid beta excess", "chunk": 5}
{"article": "PMC4401690.txt", "subject": "Alzheimer\u2019s dementia", "relationship": "INDICATES_PRESENCE_OF", "object": "MMSE: 20.6\u00b16.5 points", "chunk": 1}
{"article": "PMC4401690.txt", "subject": "Alzheimer\u2019s dementia", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "home-based PA program performed on a movement trainer", "chunk": 1}
{"article": "PMC4401690.txt", "subject": "Alzheimer\u2019s dementia", "relationship": "RELATED_TO", "object": "ADL performance", "chunk": 1}
{"article": "PMC4401690.txt", "subject": "Alzheimer\u2019s dementia", "relationship": "RELATED_TO", "object": "executive function & language ability", "chunk": 1}
{"article": "PMC4401690.txt", "subject": "Alzheimer\u2019s dementia", "relationship": "RELATED_TO", "object": "physical skill", "chunk": 1}
{"article": "PMC4401690.txt", "subject": "Alzheimer\u2019s dementia", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "cognitive decline", "chunk": 1}
{"article": "PMC4401690.txt", "subject": "Alzheimer\u2019s dementia", "relationship": "RELATED_TREATMENT", "object": "physical activity training ", "chunk": 1}
{"article": "PMC4401690.txt", "subject": "acetylcholinesterase inhibitor", "relationship": "RELATED_TREATMENT", "object": "stable treatment for AD ", "chunk": 3}
{"article": "PMC4401690.txt", "subject": "memantin", "relationship": "RELATED_TREATMENT", "object": "stable treatment for AD ", "chunk": 3}
{"article": "PMC4401690.txt", "subject": "MMSE (total score)", "relationship": "RELATED_PROGNOSIS", "object": "The study demonstrates long-term effects three months after completion of the intervention on ADL and behavioural symptoms.", "chunk": 4}
{"article": "PMC4401690.txt", "subject": "brain-derived neurotrophic factor", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Potential to improve brain functionality", "chunk": 5}
{"article": "PMC4406069.txt", "subject": "Apolipoprotein-E \u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "Risk factor for Alzheimer's disease", "chunk": 1}
{"article": "PMC4406069.txt", "subject": "Apolipoprotein-E \u03b54 allele", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased risk of Alzheimer's disease", "chunk": 1}
{"article": "PMC4406069.txt", "subject": "Hippocampal atrophy", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurodegenerative changes characteristic of Alzheimer's disease", "chunk": 1}
{"article": "PMC4406069.txt", "subject": "Amyloid plaques", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC4406069.txt", "subject": "Neurofibrillary tangles", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC4406069.txt", "subject": "abnormal Abeta42 or tau protein concentrations", "relationship": "INDICATES_PRESENCE_OF", "object": "Diagnosis: AD", "chunk": 3}
{"article": "PMC4406069.txt", "subject": "APOE \u03b54 allele", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnose: Alzheimer's Disease", "chunk": 6}
{"article": "PMC4406069.txt", "subject": "APOE \u03b54", "relationship": "RELATED_PROGNOSIS", "object": "Increased within-domain IIV in HCS and amild cognitive impairment groups", "chunk": 7}
{"article": "PMC4406069.txt", "subject": "APOE4", "relationship": "RELATED_PROGNOSIS", "object": "Population status", "chunk": 8}
{"article": "PMC4406069.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TREATMENT", "object": "the frontal lobe is believed to be the basis of IIV (MacDonald et al., 2009), our findings add evidence to recent studies (K\u00e4lin et al., 2014) and further support the relationship between within-domain IIV and APOE status.", "chunk": 9}
{"article": "PMC4406069.txt", "subject": "APOE \u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "increased IIV in HCS \u03b54 carriers vs. non-carriers", "chunk": 9}
{"article": "PMC4406069.txt", "subject": "APOE \u03b54", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "the frontal lobe constitutes a brain region that manifests \u03b54-effects very early in the disease (Filbey et al., 2010)", "chunk": 9}
{"article": "PMC4406069.txt", "subject": "MRI", "relationship": "DIAGNOSTIC_OF", "object": "Early stage of the disease", "chunk": 10}
{"article": "PMC4410460.txt", "subject": "amyloid-\u03b2 (A\u03b2) peptide", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC4410460.txt", "subject": "amyloid-\u03b2 (A\u03b2) peptide", "relationship": "IS_TARGET_OF_TREATMENT", "object": "disease-modifying immunotherapies", "chunk": 1}
{"article": "PMC4410460.txt", "subject": "A\u03b21\u20136", "relationship": "IS_TARGET_OF_TREATMENT", "object": "CAD106", "chunk": 1}
{"article": "PMC4410460.txt", "subject": "A\u03b21\u20136", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "CAD106", "chunk": 1}
{"article": "PMC4410460.txt", "subject": "A\u03b2-specific antibodies", "relationship": "RELATED_PROGNOSIS", "object": "reduced amyloid accumulation in the brain", "chunk": 1}
{"article": "PMC4410460.txt", "subject": "A\u03b2-specific antibodies", "relationship": "RELATED_PROGNOSIS", "object": "increasing with additional injections", "chunk": 1}
{"article": "PMC4410460.txt", "subject": "A\u03b21\u201340", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment choice measured using total plasma A\u03b21\u201340 (free and bound) levels", "chunk": 3}
{"article": "PMC4410460.txt", "subject": "A\u03b21\u201342", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Measurement of A\u03b21-42 concentration", "chunk": 3}
{"article": "PMC4410460.txt", "subject": "total tau", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Measurement of total tau concentration", "chunk": 3}
{"article": "PMC4410460.txt", "subject": "phospho-tau181", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Measurement of phospho-tau181 concentration", "chunk": 3}
{"article": "PMC4410460.txt", "subject": "apoe4", "relationship": "DIAGNOSTIC_OF", "object": "Early-onset Alzheimer's Disease", "chunk": 5}
{"article": "PMC4410460.txt", "subject": "A\u03b2-IgG titers", "relationship": "INDICATES_PRESENCE_OF", "object": "Antibody response to CAD106", "chunk": 6}
{"article": "PMC4410460.txt", "subject": "A\u03b2-IgG titers", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment with CAD106", "chunk": 6}
{"article": "PMC4410460.txt", "subject": "A\u03b2-IgG titers", "relationship": "RELATED_PROGNOSIS", "object": "Progression of disease", "chunk": 6}
{"article": "PMC4410460.txt", "subject": "A\u03b21-40 levels", "relationship": "RELATED_TO_TREATMENT", "object": "CAD106 administration", "chunk": 6}
{"article": "PMC4410460.txt", "subject": "phospho-tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "CAD106 treatment", "chunk": 7}
{"article": "PMC4410460.txt", "subject": "phospho-tau", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "CAD106 treatment response", "chunk": 7}
{"article": "PMC4410460.txt", "subject": "apoe4", "relationship": "RELATED_TREATMENT", "object": "CAD106 treatment", "chunk": 7}
{"article": "PMC4410460.txt", "subject": "A\u03b2-specific IgGs", "relationship": "MONITORED_DURING_TREATMENT", "object": "CAD106 treatment", "chunk": 7}
{"article": "PMC4410460.txt", "subject": "A\u03b2-specific IgGs", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "CAD106 treatment", "chunk": 7}
{"article": "PMC4410460.txt", "subject": "A\u03b2-specific antibodies", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Choice of CAD106 dosing regimen", "chunk": 7}
{"article": "PMC4410460.txt", "subject": "A\u03b21\u201340", "relationship": "ASSOCIATED_WITH_TREATMENT", "object": "Long-term CAD106 treatment", "chunk": 7}
{"article": "PMC4410460.txt", "subject": "CAD106", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of Alzheimer's Disease", "chunk": 7}
{"article": "PMC4410460.txt", "subject": "A\u03b21\u20136", "relationship": "IS_TARGET_OF_TREATMENT", "object": "CAD106 antibodies", "chunk": 7}
{"article": "PMC4410460.txt", "subject": "A\u03b2 accumulation", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 8}
{"article": "PMC4410460.txt", "subject": "phospho-tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment with CAD106", "chunk": 8}
{"article": "PMC4410460.txt", "subject": "phospho-tau", "relationship": "RELATED_PROGNOSIS", "object": "later stages of AD", "chunk": 8}
{"article": "PMC4410460.txt", "subject": "A\u03b21\u201340", "relationship": "RELATED_TREATMENT", "object": "long-term treatment with CAD106 ", "chunk": 8}
{"article": "PMC4431827.txt", "subject": "falls", "relationship": "INDICATES_PRESENCE_OF", "object": "reduced balance", "chunk": 1}
{"article": "PMC4431827.txt", "subject": "Falls and fractures", "relationship": "ASSOCIATED_WITH", "object": "dementia residents", "chunk": 1}
{"article": "PMC4431827.txt", "subject": "dementia", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "muscle strength training", "chunk": 1}
{"article": "PMC4431827.txt", "subject": "knee extension muscle strength", "relationship": "THRESHOLD_LEVELS_PREDICT", "object": "lower extremity dysfunction", "chunk": 1}
{"article": "PMC4431827.txt", "subject": "Neuropsychiatric symptoms (NPS)", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 2}
{"article": "PMC4431827.txt", "subject": "Agitation", "relationship": "RELATED_PROGNOSIS", "object": "Predictor of fall for nursing home patients, causing considerable morbidity and mortality", "chunk": 2}
{"article": "PMC4431827.txt", "subject": "Apathy", "relationship": "RELATED_PROGNOSIS", "object": "Predictor of fall for nursing home patients, causing considerable morbidity and mortality", "chunk": 2}
{"article": "PMC4431827.txt", "subject": "Agitation", "relationship": "RELATED_PROGNOSIS", "object": "Can be reduced by exercise", "chunk": 2}
{"article": "PMC4431827.txt", "subject": "Exercise", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Improved physical function and mental health in dementia patients", "chunk": 2}
{"article": "PMC4431827.txt", "subject": "Exercise", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Selection of physical functional exercise program for dementia patients", "chunk": 2}
{"article": "PMC4431827.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4431827.txt", "subject": "CDR", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 3}
{"article": "PMC4431827.txt", "subject": "CDR", "relationship": "DIAGNOSITC_OF", "object": "Dementia", "chunk": 3}
{"article": "PMC4431827.txt", "subject": "Cornell Scale for Depression in dementia", "relationship": "DIAGNOSITC_OF", "object": "Depression", "chunk": 3}
{"article": "PMC4431827.txt", "subject": "Cornell Scale for Depression in Dementia", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Lower score on Cornell Scale for Depression in Dementia at baseline was associated with poorer BI score (p<0.01).", "chunk": 5}
{"article": "PMC4431827.txt", "subject": "Berg Balance Scale", "relationship": "RELATED_PROGNOSIS", "object": "Higher score on Berg Balance Scale at baseline", "chunk": 5}
{"article": "PMC4431827.txt", "subject": "Berg Balance Scale", "relationship": "USED_TO_DIAGNOSE", "object": "Lower score on BBS at baseline was associated with poorer BI score (p<0.01).", "chunk": 5}
{"article": "PMC4431827.txt", "subject": "Barthel Index", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Lower score on BBS at baseline increased to be associated with poorer BI score (p<0.01).", "chunk": 5}
{"article": "PMC4431827.txt", "subject": "Walking speed", "relationship": "RELATED_PROGNOSIS", "object": "Walking speed is given in meters/ second; all other variables are given in points.", "chunk": 5}
{"article": "PMC4431827.txt", "subject": "Neurological Disease", "relationship": "RELATED_PROGNOSIS", "object": "The participants with neurological disease scored significantly poorer on BBS at baseline (p<0.01) than those with no neurological disease.", "chunk": 5}
{"article": "PMC4431827.txt", "subject": "BBS", "relationship": "RELATED_PROGNOSIS", "object": "Balance, which was the predetermined primary outcome", "chunk": 6}
{"article": "PMC4431827.txt", "subject": "BBS", "relationship": "PREDICTED_SURVIVAL", "object": "Higher scores on sit to stand test after intervention", "chunk": 6}
{"article": "PMC4431827.txt", "subject": "BI score", "relationship": "RELATED_TREATMENT", "object": "correlated with the baseline score of BBS", "chunk": 6}
{"article": "PMC4431827.txt", "subject": "BI score", "relationship": "RELATED_TREATMENT", "object": "correlations between the scores on the BI and the CST at baseline", "chunk": 6}
{"article": "PMC4436517.txt", "subject": "H2DCF-DA", "relationship": "USED_TO_DIAGNOSE", "object": "intracellular ROS level", "chunk": 2}
{"article": "PMC4436517.txt", "subject": "H2DCF-DA", "relationship": "MONITORED_DURING_TREATMENT", "object": "thermal stress", "chunk": 2}
{"article": "PMC4436517.txt", "subject": "SYTOX Green Nucleic Acid Stain", "relationship": "MONITORED_DURING_TREATMENT", "object": "Thermal stress to determine cellular damage and viability of nematodes", "chunk": 3}
{"article": "PMC4436517.txt", "subject": "SYTOX Green Nucleic Acid Stain", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Cellular damage caused by thermal stress", "chunk": 3}
{"article": "PMC4436517.txt", "subject": "quercetin", "relationship": "INDICATES_PRESENCE_OF", "object": "Antioxidative effects", "chunk": 4}
{"article": "PMC4436517.txt", "subject": "quercetin", "relationship": "RELATED_TO", "object": "superior antioxidative capacity", "chunk": 4}
{"article": "PMC4436517.txt", "subject": "quercetin", "relationship": "ASSOCIATED_WITH", "object": " reduction of DCF fluorescence", "chunk": 4}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Reduced induction of SOD-3 expression", "chunk": 4}
{"article": "PMC4436517.txt", "subject": "resveratrol", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Reduced induction of SOD-3 expression", "chunk": 4}
{"article": "PMC4436517.txt", "subject": "quercetin", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Significantly diminished the induction of GST-4", "chunk": 4}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "to understand its potential to protect against stress conditions", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "resveratrol", "relationship": "RELATED_TREATMENT", "object": "has been reported to be beneficial in cases of ageing-related cardiovascular and neurodegenerative disorders", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "resveratrol", "relationship": "RELATED_TREATMENT", "object": "was reported to be beneficial in cases of ageing-related cardiovascular and neurodegenerative disorders", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "resveratrol", "relationship": "RELATED_TREATMENT", "object": "reported an increase of life span after treatment with resveratrol (100\u2009\u03bcM).  ", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "resveratrol", "relationship": "RELATED_TREATMENT", "object": "reported that resveratrol significantly extends C. elegans life span already at a concentration of 5\u2009\u03bcM by 3.6% (mean life span) and 3.4% (maximum life span).", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Resveratrol showed a slightly weaker decrease in lipofuscin fluorescence (846.8\u2009rfu), while quercetin again showed the strongest reduction in this parameter. ", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "MONITORED_DURING_TREATMENT", "object": "since it is known that a reduction of lipofuscin mostly correlates with an increase in life span of C. elegans,  ", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "to verify the antioxidative effects of the compounds in the nematode and (ii) to estimate effects of these compounds on the ageing process in C. elegans.", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "RESPONDED_TO", "object": "TSG strongly increases the resistance against thermal stress: 50\u2009\u03bcM TSG induces a 22% increase in the mean survival time.", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "INDICATES_PRESENCE_OF", "object": "It is known that a reduction of lipofuscin mostly correlates with an increase in life span of C. elegans", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "quercetin", "relationship": "RESPONDED_TO", "object": "Incubation with 100\u2009\u03bcM quercetin reduces the lipofuscin fluorescence by 27.85% (686.9 \u00b1 14\u2009rfu). ", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "quercetin", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Incubation with 100\u2009\u03bcM quercetin reduces the lipofuscin fluorescence by 27.85% (686.9 \u00b1 14\u2009rfu). These results show that TSG is capable of decreasing lipofuscin accumulation in C. elegans ", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "resveratrol", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": " reported that resveratrol significantly extends C. elegans life span already at a concentration of 5\u2009\u03bcM by 3.6% (mean life span) and 3.4% (maximum life span).", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "resveratrol", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "reported an increase of life span after treatment with resveratrol (100\u2009\u03bcM).", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "resveratrol", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "The mean life span of DMSO-treated nematodes was 17.4 \u00b1 0.56 days; in case of TSG, resveratrol, and quercetin, the mean life span was 21.1 \u00b1 0.58\u2009d, 20.7 \u00b1 0.67\u2009d, and 21.3 \u00b1 0.5\u2009d, respectively.", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "resveratrol", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "The median life span of DMSO-treated nematodes was 18.0 \u00b1 0.61 days; in case of TSG, resveratrol, and quercetin, the median life span was 22.0 \u00b1 0.81\u2009d, 22.0 \u00b1 0.71\u2009d, and 23.0 \u00b1 1.01\u2009d, respectively.", "chunk": 5}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treat as anti-ageing drug", "chunk": 6}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "RELATED_TREATMENT", "object": "Alleviates lipofuscin accumulation", "chunk": 6}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "RELATED_TREATMENT", "object": "Prolongevity effect during adult life", "chunk": 6}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "RELATED_TREATMENT", "object": "Increased resistance against heat stress", "chunk": 6}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Acts as an active component in Polygonum multiflorum extract for anti-ageing", "chunk": 6}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Modulation of SOD-3 and GST-4", "chunk": 6}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Modulation of ROS accumulation", "chunk": 6}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Increased lifespans in C. elegans", "chunk": 6}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "RESPONDED_TO", "object": "Increased stress resistance", "chunk": 6}
{"article": "PMC4436517.txt", "subject": "TSG", "relationship": "MONITORED_DURING_TREATMENT", "object": "Antioxidative effects in C. elegans", "chunk": 6}
{"article": "PMC4461930.txt", "subject": "amyloid-\u03b2 peptide 42 (A\u03b242)", "relationship": "RELATED_TREATMENT", "object": "Semagacestat", "chunk": 1}
{"article": "PMC4461930.txt", "subject": "A\u03b242", "relationship": "IN_TREATMENT_WITH", "object": "Semagacestat alters levels", "chunk": 1}
{"article": "PMC4461930.txt", "subject": "phosphorylated tau (p-tau)", "relationship": "RELATED_TREATMENT", "object": "Semagacestat", "chunk": 1}
{"article": "PMC4461930.txt", "subject": "amino-\u03b2 peptide 42 (A\u03b242)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "cognitive and other adverse effects", "chunk": 1}
{"article": "PMC4461930.txt", "subject": "ventricular volume", "relationship": "RELATED_TREATMENT", "object": "Semagacestat", "chunk": 1}
{"article": "PMC4461930.txt", "subject": "\u03b3-secretase", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "inhibition", "chunk": 1}
{"article": "PMC4461930.txt", "subject": "amyloid precursor protein (APP)", "relationship": "IS_TARGET_OF_TREATMENT", "object": "\u03b3-secretase inhibitors", "chunk": 1}
{"article": "PMC4461930.txt", "subject": "Apolipoprotein E polymorphisms", "relationship": "RELATED_TREATMENT", "object": "Genotyped at baseline and end point of the trial.", "chunk": 2}
{"article": "PMC4461930.txt", "subject": " plasma A\u03b2 peptides", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease (dose-related reduction through treatment)", "chunk": 2}
{"article": "PMC4461930.txt", "subject": "plasma A\u03b2 peptides", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma A\u03b2 was assessed at baseline and weeks 6, 12 and 52 or early termination.", "chunk": 2}
{"article": "PMC4461930.txt", "subject": "A\u03b2 peptides", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Optional cerebral cerebral cerebral cerebral spinal fluid analysis for A\u03b2 peptides and tau and phosphorylated tau (p-tau) proteins was conducted in willing subjects.", "chunk": 2}
{"article": "PMC4461930.txt", "subject": "tau", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Optional cerebral cerebral cerebral cerebral spinal fluid analysis for A\u03b2 peptides and tau and phosphorylated tau (p-tau) proteins was conducted in willing subjects.", "chunk": 2}
{"article": "PMC4461930.txt", "subject": "phosphorylated tau (p-tau)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Optional cerebral cerebral cerebral cerebral spinal fluid analysis for A\u03b2 peptides and tau and phosphorylated tau (p-tau) proteins was conducted in willing subjects.", "chunk": 2}
{"article": "PMC4461930.txt", "subject": "p-tau", "relationship": "RELATED_PROGNOSIS", "object": "cognitive decline", "chunk": 3}
{"article": "PMC4461930.txt", "subject": "A\u03b240", "relationship": "RELATED_TREATMENT", "object": "Correlational analyses suggested that gastrointestinal symptoms, rash and skin cancer may be related to each other, while uric acid reduction, albumin reduction and infection formed a cluster", "chunk": 3}
{"article": "PMC4461930.txt", "subject": "amloid-\u03b2 peptide 40", "relationship": "RELATED_TREATMENT", "object": "Correlational analyses suggested that gastrointestinal symptoms, rash and skin cancer may be related to each other, while uric acid reduction, albumin reduction and infection formed a cluster", "chunk": 3}
{"article": "PMC4461930.txt", "subject": "A\u03b242", "relationship": "RELATED_TREATMENT", "object": "Correlational analyses suggested that gastrointestinal symptoms, rash and skin cancer may be related to each other, while uric acid reduction, albumin reduction and infection formed a cluster", "chunk": 3}
{"article": "PMC4461930.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid A\u03b242", "relationship": "RELATED_TREATMENT", "object": "Correlational analyses suggested that gastrointestinal symptoms, rash and skin cancer may be related to each other, while uric acid reduction, albumin reduction and infection formed a cluster", "chunk": 3}
{"article": "PMC4461930.txt", "subject": "ADAScog11", "relationship": "RELATED_TREATMENT", "object": "Correlational analyses suggested that gastrointestinal symptoms, rash and skin cancer may be related to each other, while uric acid reduction, albumin reduction and infection formed a cluster", "chunk": 3}
{"article": "PMC4461930.txt", "subject": "MMSE", "relationship": "RELATED_TREATMENT", "object": "Correlational analyses suggested that gastrointestinal symptoms, rash and skin cancer may be related to each other, while uric acid reduction, albumin reduction and infection formed a cluster", "chunk": 3}
{"article": "PMC4461930.txt", "subject": "Ventricular volume", "relationship": "RELATED_TREATMENT", "object": "Correlational analyses suggested that gastrointestinal symptoms, rash and skin cancer may be related to each other, while uric acid reduction, albumin reduction and infection formed a cluster", "chunk": 3}
{"article": "PMC4461930.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid A\u03b242", "relationship": "RELATED_TREATMENT", "object": "Correlational analyses suggested that gastrointestinal symptoms, rash and skin cancer may be related to each other, while uric acid reduction, albumin reduction and infection formed a cluster", "chunk": 3}
{"article": "PMC4461930.txt", "subject": "A\u03b240", "relationship": "RELATED_TREATMENT", "object": "Reduced plasma levels of A\u03b2 peptides", "chunk": 4}
{"article": "PMC4461930.txt", "subject": "A\u03b240", "relationship": "RELATED_TREATMENT", "object": "Consistent with \u03b3-secretase inhibition in the periphery", "chunk": 4}
{"article": "PMC4461930.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Reduction in cerebral cerebral cerebral cerebral spinal fluid A\u03b2 peptide levels", "chunk": 4}
{"article": "PMC4461930.txt", "subject": "A\u03b242", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Stable isotope labeling kinetic technique", "chunk": 4}
{"article": "PMC4461930.txt", "subject": "p-tau", "relationship": "PREDICTOR_OF", "object": "Early termination of the trial", "chunk": 4}
{"article": "PMC4461930.txt", "subject": "p-tau", "relationship": "RELATED_PROGNOSIS", "object": "A possible beneficial effect on disease pathology", "chunk": 4}
{"article": "PMC4461930.txt", "subject": "p-tau", "relationship": "RELATED_PROGNOSIS", "object": "An increase in neurodegeneration due to accelerated disease", "chunk": 4}
{"article": "PMC4461930.txt", "subject": "ventricular volume", "relationship": "INDICATES_PRESENCE_OF", "object": "Brain atrophy", "chunk": 4}
{"article": "PMC4461930.txt", "subject": "A\u03b240", "relationship": "RELATED_TO", "object": "Gastrointestinal symptoms", "chunk": 4}
{"article": "PMC4461930.txt", "subject": "A\u03b240", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Pharmacological effect on the disease process", "chunk": 4}
{"article": "PMC4461930.txt", "subject": "p-tau", "relationship": "RELATED_PROGNOSIS", "object": "worsening cognition", "chunk": 5}
{"article": "PMC4461930.txt", "subject": "clearance of amyloid beta", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "design of studies targeting secretases", "chunk": 5}
{"article": "PMC4461930.txt", "subject": "A\u03b2 peptides", "relationship": "MONITORED_DURING_TREATMENT", "object": "exposure to drug", "chunk": 5}
{"article": "PMC4461930.txt", "subject": "clearance of APP ", "relationship": "ASSOSIATED_WITH_POOR_OUTCOME", "object": " gastrointestinal symptoms", "chunk": 5}
{"article": "PMC4465490.txt", "subject": "C-TMT completion times", "relationship": "INDICATES_PRESENCE_OF", "object": "Malingering", "chunk": 10}
{"article": "PMC4465490.txt", "subject": "C-TMT-A completion times", "relationship": "RELATED_TO", "object": "Detection of malingering", "chunk": 10}
{"article": "PMC4465490.txt", "subject": "C-TMT-B completion times", "relationship": "RELATED_TO", "object": "Detection of malingering", "chunk": 10}
{"article": "PMC4465490.txt", "subject": "Velocity", "relationship": "RELATED_TO", "object": "Detection of malingering", "chunk": 10}
{"article": "PMC4465490.txt", "subject": "dwell-time/total-time ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "Malingering", "chunk": 10}
{"article": "PMC4465490.txt", "subject": "Differences in z-scores on the C-TMT-B and C-TMT-A", "relationship": "INDICATES_PRESENCE_OF", "object": "Malingering", "chunk": 10}
{"article": "PMC4465490.txt", "subject": "C-TMT-B completion times", "relationship": "INDICATES_PRESENCE_OF", "object": "TBI", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT-B completion times", "relationship": "RELATED_PROGNOSIS", "object": "functional outcome", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT-B completion times", "relationship": "PREDICTS_SURVIVAL", "object": "Eventual functional outcome", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT-A  completion times", "relationship": "RELATED_PROGNOSIS", "object": "functional outcome", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT-B/C-TMT-A ratios", "relationship": "RELATED_PROGNOSIS", "object": "Functional outcome", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "movement velocities", "relationship": "RELATED_PROGNOSIS", "object": "Functional outcome", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT completion times", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Mild TBI", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "Movement velocities", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Mild TBI", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT-A abnormalities", "relationship": "associated with", "object": "sTBI", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT-B abnormalities", "relationship": "associated with", "object": "sTBI", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT-A completion times", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "TBI patients", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT-B completion times", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "TBI patients", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT-B completion times", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "TBI patients", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT-A completion times", "relationship": "MONITORED_DURING_TREATMENT", "object": "TBI patients", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT-B completion times", "relationship": "MONITORED_DURING_TREATMENT", "object": "TBI patients", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "dwell-time/total-time ratios", "relationship": "MONITORED_DURING_TREATMENT", "object": "TBI patients", "chunk": 11}
{"article": "PMC4465490.txt", "subject": "C-TMT-B completion times", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "TBI treatment", "chunk": 11}
{"article": "PMC4468784.txt", "subject": "PSS-14", "relationship": "PREDICT_SURVIVAL", "object": "Predict caregivers' stress levels at 3 months", "chunk": 2}
{"article": "PMC4468784.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "USED_TO_DIAGNOSE", "object": "Baseline Alzheimer's disease", "chunk": 3}
{"article": "PMC4468784.txt", "subject": "Instrumental Activities of Daily Living (IADL)", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's disease progression", "chunk": 3}
{"article": "PMC4468784.txt", "subject": "BDI-II", "relationship": "RELATED_TO", "object": "Beck Depression Inventory-second version", "chunk": 7}
{"article": "PMC4468784.txt", "subject": "BPSD", "relationship": "RELATED_TO", "object": "behavioral and psychological symptoms of dementia", "chunk": 7}
{"article": "PMC4468784.txt", "subject": "IADL", "relationship": "RELATED_TO", "object": "Instrumental Activities of Daily Living", "chunk": 7}
{"article": "PMC4468784.txt", "subject": "MMS", "relationship": "RELATED_TO", "object": "Mini-Mental State Examination", "chunk": 7}
{"article": "PMC4468784.txt", "subject": "NHP", "relationship": "RELATED_TO", "object": "Nottingham Health Profile", "chunk": 7}
{"article": "PMC4468784.txt", "subject": "PSS-14", "relationship": "RELATED_TO", "object": "Perceived Stress Scale", "chunk": 7}
{"article": "PMC4468784.txt", "subject": "PWAD", "relationship": "RELATED_TO", "object": "Persons with Alzheimer\u2019s disease", "chunk": 7}
{"article": "PMC4468784.txt", "subject": "RCT", "relationship": "RELATED_TO", "object": "Randomized controlled trial", "chunk": 7}
{"article": "PMC4468784.txt", "subject": "RMBP", "relationship": "RELATED_TO", "object": "Revised Memory and Behavior Problems Checklist", "chunk": 7}
{"article": "PMC4468784.txt", "subject": "RSCS", "relationship": "RELATED_TO", "object": "Revised Scale for Caregiving Self-Efficacy", "chunk": 7}
{"article": "PMC4468784.txt", "subject": "VAS", "relationship": "RELATED_TO", "object": "Visual analog scales", "chunk": 7}
{"article": "PMC4468784.txt", "subject": "ZBIZ", "relationship": "RELATED_TO", "object": "Zarit Burden Interview", "chunk": 7}
{"article": "PMC4481070.txt", "subject": "APOE \u03b54 allele", "relationship": "RELATED_RISK_FACTOR", "object": "Alzheimer's Disease", "chunk": 1}
{"article": "PMC4481070.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "INDICATES_PRESENCE_OF", "object": "AD dementia", "chunk": 2}
{"article": "PMC4481070.txt", "subject": "Clinical dementia Rating scored by the sum of boxes method (CDR-SB)", "relationship": "RELATED_PROGNOSIS", "object": "Disease progression", "chunk": 2}
{"article": "PMC4481070.txt", "subject": "Alzheimer\u2019s Disease Assessment Scale \u2013 cognitive subscale (ADAS-cog11)", "relationship": "USED_TO_DIAGNOSE", "object": "Disease progression", "chunk": 2}
{"article": "PMC4481070.txt", "subject": "Alzheimer\u2019s Disease Cooperative Study \u2013 Activities of Daily Living Scale (ADCS-ADL)", "relationship": "USED_TO_DIAGNOSE", "object": "Disease progression", "chunk": 2}
{"article": "PMC4481070.txt", "subject": "Neuropsychiatric Inventory (NPI)", "relationship": "RELATED_PROGNOSIS", "object": "Disease progression", "chunk": 2}
{"article": "PMC4481070.txt", "subject": "APOE \u03b54", "relationship": "RELATED_PROGNOSIS", "object": "Most common in Western Europe/Israel and North America and least common in Asia", "chunk": 3}
{"article": "PMC4481070.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TREATMENT", "object": "more rapid clinical disease progression", "chunk": 5}
{"article": "PMC4481070.txt", "subject": "ADAS-cog11", "relationship": "INDICATES_PRESENCE_OF", "object": "AD progression", "chunk": 6}
{"article": "PMC4481070.txt", "subject": "ADAS-cog11", "relationship": "RELATED_PROGNOSIS", "object": "Response to treatment", "chunk": 6}
{"article": "PMC4481070.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "AD progression", "chunk": 6}
{"article": "PMC4481070.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Response to treatment", "chunk": 6}
{"article": "PMC4481070.txt", "subject": "ADCS-ADL", "relationship": "RELATED_PROGNOSIS", "object": "Response to treatment", "chunk": 6}
{"article": "PMC4481070.txt", "subject": "CDR-SB", "relationship": "RELATED_PROGNOSIS", "object": "Response to treatment", "chunk": 6}
{"article": "PMC4481906.txt", "subject": "activities of daily living (ADL)", "relationship": "RELATED_PROGNOSIS", "object": "quality of life", "chunk": 1}
{"article": "PMC4481906.txt", "subject": "activities of daily living (ADL)", "relationship": "RELATED_TREATMENT", "object": "medicinal product-related improvements in everyday function", "chunk": 1}
{"article": "PMC4481906.txt", "subject": "ADL", "relationship": "PREDICTOR", "object": "quality of life", "chunk": 1}
{"article": "PMC4481906.txt", "subject": "ECG", "relationship": "USED_TO_DIAGNOSE", "object": "ADL events", "chunk": 2}
{"article": "PMC4481906.txt", "subject": "Wearable devices", "relationship": "RELATED_TREATMENT", "object": "assess older peoples\u2019 motor function performance", "chunk": 2}
{"article": "PMC4481906.txt", "subject": "Wearable devices", "relationship": "RELATED_TREATMENT", "object": "to identify disturbances in gait patterns that could be associated with disease progression", "chunk": 2}
{"article": "PMC4481906.txt", "subject": "Wearable devices", "relationship": "RELATED_TREATMENT", "object": "to personalize patient care", "chunk": 2}
{"article": "PMC4481906.txt", "subject": "Wearable devices", "relationship": "RELATED_TREATMENT", "object": "to assess the independent living associated risks", "chunk": 2}
{"article": "PMC4481906.txt", "subject": "Wearable devices", "relationship": "RELATED_TREATMENT", "object": "to decide on institutionalization", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Oxidative stress and mitochondrial dysfunction", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "A\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "Accelerated oxidative stress and mitochondrial dysfunction", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "Oxidative stress", "relationship": "RELATED_PROGNOSIS", "object": "Considered as a primary factor of Neurofibrillary tangles formation in AD", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "Mitochondrial SOD2 deficiency", "relationship": "RELATED_PROGNOSIS", "object": "Increases the levels of Ser396 phosphorylated tau in the Tg2576 mouse model of AD", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "tau protein", "relationship": "RELATED_PROGNOSIS", "object": "Outgrowth of neuronal processes and the development of neuronal polarity", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "tau protein", "relationship": "RELATED_PROGNOSIS", "object": "Promote microtubule assembly, stabilize microtubules, affect the dynamics of microtubules in neurons", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "tau protein", "relationship": "RELATED_PROGNOSIS", "object": "Inhibit apoptosis, particularly in axons", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "hyperphosphorylated tau", "relationship": "RELATED_PROGNOSIS", "object": "Destabilizes microtubules by decreasing the binding affinity of tau, affecting its axonal transport and resulting in its aggregation in Neurofibrillary tangless", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "hyperphosphorylated tau", "relationship": "RELATED_PROGNOSIS", "object": "Proposed as the likely pathological processes that induce the loss of function or gain of tau toxicity, which caused neurodegeneration", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "GSK3\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "Plays a key role in the pathogenesis of AD, contributing to A\u03b2 production and A\u03b2-mediated neuronal death by phosphorylating tau in most serine and threonine residues and inducing hyperphosphorylation in Neurofibrillary tangles", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "CDK5", "relationship": "RELATED_PROGNOSIS", "object": "May be a key candidate target for therapeutic gene silencing", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "p38 MAPK", "relationship": "RELATED_PROGNOSIS", "object": "Likely to play a role in the hyperphosphorylation of tau under pathological conditions", "chunk": 2}
{"article": "PMC4485995.txt", "subject": "PP2A", "relationship": "IS_RELATED_TO", "object": "Abnormally hyperphosphorylated tau protein and is the most efficient phosphatase", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "PP2A", "relationship": "REDUCED_ACTIVTY_IN", "object": "AD brain", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "PP2A", "relationship": "INHIBITED_BY", "object": "I2PP2A", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "I2PP2A", "relationship": "PHYSICAL_INTERACTION_WITH", "object": "PP2A", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "I2PP2A", "relationship": "ACTIVATED_BY", "object": "Oxidative stress", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "GSK-3\u03b2", "relationship": "INCREASED_ACTIVITY_IN", "object": "Oxidative stress", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "GSK-3\u03b2", "relationship": "INHIBITS", "object": "PP2A", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "Oxidative stress", "relationship": "CONTRIBUTES_TO", "object": "Tau phosphorylation", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "Okadaic acid", "relationship": "INHIBITS", "object": "PP2A", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "HSP70", "relationship": "UPREGULATED_BY", "object": "Antioxidants", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "Melatonin", "relationship": "REDUCES", "object": "GSK-3\u03b2 activity", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "Melatonin", "relationship": "BLOCKS", "object": "Tau hyperphosphorylation", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "Vitamins E and C", "relationship": "HAS_A_PROTECTIVE_EFFECT", "object": "Against neurotoxicity", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "Gossypin", "relationship": "HAS_A_PROTECTIVE_EFFECT", "object": "Against neurotoxicity", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "Curcumin", "relationship": "HAS_A_PROTECTIVE_EFFECT", "object": "Against neurotoxicity", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "Beta-carotene", "relationship": "HAS_A_PROTECTIVE_EFFECT", "object": "Against neurotoxicity", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "Ginkgo biloba", "relationship": "HAS_A_PROTECTIVE_EFFECT", "object": "Against neurotoxicity", "chunk": 3}
{"article": "PMC4485995.txt", "subject": "tau hyperphosphorylation", "relationship": "RELATED_TO", "object": "autophagic dysfunction", "chunk": 5}
{"article": "PMC4485995.txt", "subject": "tau hyperphosphorylation", "relationship": "ASSOCIATED_WITH", "object": "destabilization of neuronal microtubules", "chunk": 5}
{"article": "PMC4485995.txt", "subject": "tau hyperphosphorylation", "relationship": "ASSOCIATED_WITH", "object": "Neurofibrillary tangles formation", "chunk": 5}
{"article": "PMC4485995.txt", "subject": "tau hyperphosphorylation", "relationship": "INDICATES_PRESENCE_OF", "object": "neuronal dysfunction and death", "chunk": 5}
{"article": "PMC4485995.txt", "subject": "PP2A downregulation", "relationship": "ASSOCIATED_WITH", "object": "autophagy disruption", "chunk": 5}
{"article": "PMC4485995.txt", "subject": "Atg7 conditional knockout", "relationship": "RELATED_TO", "object": "accumulation of phosphorylated tau and GSK3\u03b2", "chunk": 5}
{"article": "PMC4485995.txt", "subject": "genetic reduction of mammalian target of rapamycin", "relationship": "RELATED_TO", "object": "increase in autophagy induction and amelioration of Alzheimer's disease-like cognitive and pathological deficits", "chunk": 5}
{"article": "PMC4485995.txt", "subject": "Induction autophagy adaptor protein NDP52", "relationship": "RELATED_TO", "object": "reduction of tau protein phosphorylation in neurons", "chunk": 5}
{"article": "PMC4487699.txt", "subject": "N-methyl-D-aspartate (NMDA) receptor activity", "relationship": "INDICATES_PRESENCE_OF", "object": "HF rTMS", "chunk": 2}
{"article": "PMC4487699.txt", "subject": "gamma-aminobutyric acid (GABA) mediated inhibition", "relationship": "INDICATES_PRESENCE_OF", "object": "HF rTMS", "chunk": 2}
{"article": "PMC4487699.txt", "subject": "Brain derived neurotrophic factor (BDNF)", "relationship": "RELATED_TREATMENT", "object": "synaptic plasticity", "chunk": 2}
{"article": "PMC4487699.txt", "subject": "total tau (t-Tau)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "stronger inhibition of MEPs, suggesting that also t-Tau modulates excitatory activity and may alter mechanisms of cortical plasticity", "chunk": 5}
{"article": "PMC4487699.txt", "subject": "total tau (t-Tau)", "relationship": "INDICATES_PRESENCE_OF", "object": "higher cerebral spinal fluid t-Tau levels", "chunk": 5}
{"article": "PMC4487699.txt", "subject": "MoCA Test", "relationship": "USED_TO_DIAGNOSE", "object": "Screening for mild cognitive impairment", "chunk": 6}
{"article": "PMC4487699.txt", "subject": "CDR", "relationship": "USED_TO_DIAGNOSE", "object": "Screening for mild cognitive impairment", "chunk": 6}
{"article": "PMC4487699.txt", "subject": "GDS-15", "relationship": "USED_TO_DIAGNOSE", "object": "Screening for depression", "chunk": 6}
{"article": "PMC4487699.txt", "subject": "HAMD-17", "relationship": "USED_TO_DIAGNOSE", "object": "Screening for depression", "chunk": 6}
{"article": "PMC4487699.txt", "subject": "HAMA-14", "relationship": "USED_TO_DIAGNOSE", "object": "Screening for anxiety", "chunk": 6}
{"article": "PMC4487699.txt", "subject": "IQCODE", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Decline in the Elderly", "chunk": 6}
{"article": "PMC4487699.txt", "subject": "B-ADL", "relationship": "INDICATES_PRESENCE_OF", "object": "Functional Impairment", "chunk": 6}
{"article": "PMC4487699.txt", "subject": "RBMT", "relationship": "EVALUATES", "object": "Behavioral Memory", "chunk": 6}
{"article": "PMC4487699.txt", "subject": "WMS", "relationship": "EVALUATES", "object": "Memory Function", "chunk": 6}
{"article": "PMC4487699.txt", "subject": "WAIS", "relationship": "EVALUATES", "object": "Cognitive Abilities", "chunk": 6}
{"article": "PMC4487699.txt", "subject": "RAVLT", "relationship": "EVALUATES", "object": "Auditory Verbal Learning and Memory", "chunk": 6}
{"article": "PMC4487699.txt", "subject": "Stroop", "relationship": "EVALUATES", "object": "Executive Function", "chunk": 6}
{"article": "PMC4487699.txt", "subject": "Trail Making Test", "relationship": "EVALUATES", "object": "Executive Function and Visuomotor Skills", "chunk": 6}
{"article": "PMC4489713.txt", "subject": "TDP-43", "relationship": "RELATED_TO", "object": "Ubiquitinated inclusion bodies", "chunk": 1}
{"article": "PMC4489713.txt", "subject": "LC3-I/II", "relationship": "RELATED_TO_DISEASE", "object": "VCPR155H/+ disease pathology", "chunk": 2}
{"article": "PMC4489713.txt", "subject": "p62/SQSTM1", "relationship": "RELATED_TO_DISEASE", "object": "VCPR155H/+ disease pathology", "chunk": 2}
{"article": "PMC4489713.txt", "subject": "TDP-43", "relationship": "RELATED_TO_DISEASE", "object": "VCPR155H/+ disease pathology", "chunk": 2}
{"article": "PMC4489713.txt", "subject": "Ubiquitin", "relationship": "RELATED_TO_DISEASE", "object": "VCPR155H/+ disease pathology", "chunk": 2}
{"article": "PMC4489713.txt", "subject": "Optineurin", "relationship": "RELATED_TO_DISEASE", "object": "VCPR155H/+ disease pathology", "chunk": 2}
{"article": "PMC4489713.txt", "subject": "LC3-I/II", "relationship": "RELATED_TREATMENT", "object": "Increased LED levels display comparable levels of ubiquitin, however, decreased levels of LC3-I and LC3-II protein expressions", "chunk": 3}
{"article": "PMC4489713.txt", "subject": "p62/SQSTM1", "relationship": "RELATED_TREATMENT", "object": "Increased LED levels display comparable levels of ubiquitin, however, decreased levels of LC3-I and LC3-II protein expressions, as well as reduced levels in p62/SQSTM1 protein", "chunk": 3}
{"article": "PMC4489713.txt", "subject": "p62/SQSTM1", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "increased levels in mice fed LED", "chunk": 4}
{"article": "PMC4489713.txt", "subject": "TDP-43", "relationship": "RELATED_PROGNOSIS", "object": "nuclear TDP-43 expression suggests reduced pathological phenotype", "chunk": 4}
{"article": "PMC4489713.txt", "subject": "acid phosphatase", "relationship": "RELATED_TREATMENT", "object": "decreased levels potentially associated with VCP disease", "chunk": 4}
{"article": "PMC4489713.txt", "subject": "lysosomal acid lipase (LAL)", "relationship": "RELATED_TREATMENT", "object": "unchanged expression levels in response to LEDs", "chunk": 4}
{"article": "PMC4489713.txt", "subject": "lipid-enriched diets (LED)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "different percentages investigated for effects on VCP pathology", "chunk": 4}
{"article": "PMC4489713.txt", "subject": "TRPML1", "relationship": "RELATED_TREATMENT", "object": "TRPML1 upregulation potentially for membrane repair in skeletal muscle to prevent muscle dystrophy", "chunk": 5}
{"article": "PMC4489713.txt", "subject": "TRPML1", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Decreased expression associated with lipid accumulation leading to a block in lysosomal trafficking", "chunk": 5}
{"article": "PMC4489713.txt", "subject": "p62/SQSTM1", "relationship": "MONITORED_DURING_TREATMENT", "object": "Decreased expression levels observed in VCPR155H/+ animals on increasing LED in comparison to those on a normal diet", "chunk": 5}
{"article": "PMC4489713.txt", "subject": "LC3", "relationship": "MONITORED_DURING_TREATMENT", "object": "Decreased expression levels of LC3 autophagy intermediates observed in VCPR155H/+ animals on increasing LED compared to those on a normal diet", "chunk": 5}
{"article": "PMC4489713.txt", "subject": "acid phosphatase", "relationship": "MONITORED_DURING_TREATMENT", "object": "Increased levels observed, suggesting the functionality of the autophagy-lysosomal cascade in VCP disease", "chunk": 5}
{"article": "PMC4489713.txt", "subject": "LAL", "relationship": "MONITORED_DURING_TREATMENT", "object": "Increased levels observed, suggesting the functionality of the autophagy-lysosomal cascade in VCP disease", "chunk": 5}
{"article": "PMC4497726.txt", "subject": "cardiorespiratory fitness", "relationship": "RELATED_PROGNOSIS", "object": "slower longitundinal cognitive decline", "chunk": 1}
{"article": "PMC4497726.txt", "subject": "cardiorespiratory fitness", "relationship": "PREDICT_SURVIVAL", "object": "increased cognitive gains", "chunk": 1}
{"article": "PMC4497726.txt", "subject": "VO2 peak", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Measuring cardiorespiratory fitness to personalize exercise prescriptions", "chunk": 2}
{"article": "PMC4497726.txt", "subject": "CDR", "relationship": "USED_TO_DIAGNOSE", "object": "Presence of dementia", "chunk": 2}
{"article": "PMC4497726.txt", "subject": "VO2 peak", "relationship": "RELATED_PROGNOSIS", "object": "VO2 peak was greater in higher dose exercise groups", "chunk": 3}
{"article": "PMC4497726.txt", "subject": "VO2 peak", "relationship": "RELATED_PROGNOSIS", "object": "improved VO2 peak associated with gains in Visuospatial Processing", "chunk": 4}
{"article": "PMC4497726.txt", "subject": "VO2 peak", "relationship": "RELATED_TREATMENT", "object": "Improved VO2 peak mediated the exercise duration effect on improvements in Visuospatial Processing", "chunk": 4}
{"article": "PMC4497726.txt", "subject": "Visuospatial Processing", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Visuospatial Processing improved with 6-months of any exercise", "chunk": 4}
{"article": "PMC4497726.txt", "subject": "Visuospatial Processing", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "improved Visuospatial Processing associated with gains in VO2 peak", "chunk": 4}
{"article": "PMC4497726.txt", "subject": "Simple Attention", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "improved Simple Attention in all exercise groups equivalently indicating an intervention effect", "chunk": 4}
{"article": "PMC4497726.txt", "subject": "cardiorespiratory fitness", "relationship": "INDICATES_PRESENCE_OF", "object": "mortality", "chunk": 5}
{"article": "PMC4497726.txt", "subject": "cardiorespiratory fitness", "relationship": "RELATED_PROGNOSIS", "object": "cognitive decline", "chunk": 5}
{"article": "PMC4497726.txt", "subject": "cardiorespiratory fitness", "relationship": "RELATED_PROGNOSIS", "object": "cardiovascular disease risk", "chunk": 5}
{"article": "PMC4497726.txt", "subject": "cardiorespiratory fitness", "relationship": "RELATED_PROGNOSIS", "object": "functional health", "chunk": 5}
{"article": "PMC4497726.txt", "subject": "cardiorespiratory fitness", "relationship": "IS_TARGET_OF_TREATMENT", "object": "achieving cognitive benefits", "chunk": 5}
{"article": "PMC4497726.txt", "subject": "cardiorespiratory fitness", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "exercise prescription", "chunk": 5}
{"article": "PMC4497726.txt", "subject": "cardiorespiratory fitness", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "individualized exercise", "chunk": 5}
{"article": "PMC4503593.txt", "subject": "APOE \u03b54", "relationship": "RELATED_PROGNOSIS", "object": "Risk for Alzheimer's Disease", "chunk": 1}
{"article": "PMC4503593.txt", "subject": "APOE \u03b54 carriers", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "understanding the development of AD", "chunk": 1}
{"article": "PMC4503593.txt", "subject": "APOE \u03b54 carriers", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "for better understanding the development of AD", "chunk": 1}
{"article": "PMC4503593.txt", "subject": "APOE \u03b54 carriers", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "good candidates for learning the development of AD", "chunk": 1}
{"article": "PMC4503593.txt", "subject": "APOE \u03b54", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive performance", "chunk": 2}
{"article": "PMC4503593.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TREATMENT", "object": "functional changes between cerebellar tonsils and retrosplenial", "chunk": 3}
{"article": "PMC4503593.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TREATMENT", "object": "increased functional connectivity between left parahippocampal gyrus and right superior frontal cortex", "chunk": 3}
{"article": "PMC4503593.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TREATMENT", "object": "increased  functional connectivity between left parahippocampal gyrus and medial prefrontal cortex (ventral)", "chunk": 3}
{"article": "PMC4503593.txt", "subject": "APOE \u03b54", "relationship": "DIAGNOSTIC_OF", "object": "Risk for Alzheimer's Disease", "chunk": 4}
{"article": "PMC4503593.txt", "subject": "APOE \u03b54", "relationship": "RELATED_TREATMENT", "object": "Understanding genetic influence on  DMN and cognitive performance in clinical practice", "chunk": 4}
{"article": "PMC4503593.txt", "subject": "APOE \u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased amyloid-\u03b2 deposition", "chunk": 4}
{"article": "PMC4503593.txt", "subject": "APOE \u03b53\u03b54 allele", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Myelin breakdown and disrupted functional connectivity", "chunk": 4}
{"article": "PMC4511231.txt", "subject": "genetic testing", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "clinical trials for ADAD", "chunk": 1}
{"article": "PMC4511231.txt", "subject": "mutation status", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "participation in clinical trials", "chunk": 1}
{"article": "PMC4511231.txt", "subject": "genetic status", "relationship": "RELATED_PROGNOSIS", "object": "future dementia", "chunk": 1}
{"article": "PMC4511231.txt", "subject": "mutation carriers", "relationship": "RELATED_TREATMENT", "object": "experimental preventative therapies for AD", "chunk": 1}
{"article": "PMC4511231.txt", "subject": "PSEN1", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosis: Familial Alzheimer's disease", "chunk": 2}
{"article": "PMC4511231.txt", "subject": "PSEN2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosis: Familial Alzheimer's disease", "chunk": 2}
{"article": "PMC4511231.txt", "subject": "APP", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosis: Familial Alzheimer's disease", "chunk": 2}
{"article": "PMC4511231.txt", "subject": "APP", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "treatment for Alzheimer\u2019s disease", "chunk": 6}
{"article": "PMC4511231.txt", "subject": "amyloid precursor protein", "relationship": "IS_TARGET_OF_TREATMENT", "object": "drugs to treat Alzheimer\u2019s disease", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "amyloid-\u03b2 (A\u03b2)", "relationship": "INDICATES_PRESENCE_OF", "object": "Abnormal brain amyloid-\u03b2 level", "chunk": 1}
{"article": "PMC4519341.txt", "subject": "apical brain amyloid deposition", "relationship": "ASSOCIATED_WITH", "object": "Faster decline in executive/speed cognitive function", "chunk": 1}
{"article": "PMC4519341.txt", "subject": "apical brain amyloid deposition", "relationship": "ASSOCIATED_WITH", "object": "Faster decline in mean cognition", "chunk": 1}
{"article": "PMC4519341.txt", "subject": "apical brain amyloid deposition", "relationship": "ASSOCIATED_WITH", "object": "Faster decline in language cognitive function", "chunk": 1}
{"article": "PMC4519341.txt", "subject": "apical brain amyloid deposition", "relationship": "ASSOCIATED_WITH", "object": "Faster decline in executive/speed cognitive function in African-Americans", "chunk": 1}
{"article": "PMC4519341.txt", "subject": "apical brain amyloid deposition", "relationship": "ASSOCIATED_WITH", "object": "Faster memory decline in APOE \u03b54 carriers", "chunk": 1}
{"article": "PMC4519341.txt", "subject": "amyloid-\u03b2 (A\u03b2)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "PET imaging is used to detect A\u03b2 plaques in the brain", "chunk": 2}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 2}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_PROGNOSIS", "object": "Faster cognitive decline in later years", "chunk": 2}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_PROGNOSIS", "object": "Underlying subtle cognitive deficit", "chunk": 2}
{"article": "PMC4519341.txt", "subject": "apoE4 (APOE)", "relationship": "USED_TO_DIAGNOSE", "object": "Early-onset Alzheimer's Disease", "chunk": 2}
{"article": "PMC4519341.txt", "subject": "18F-Florbetaben", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Visual rating of brain A\u03b2 deposition", "chunk": 3}
{"article": "PMC4519341.txt", "subject": "APOE \u03b54 allele", "relationship": "RELATED_PROGNOSIS", "object": "Participants with one or two APOE \u03b54 alleles had significantly higher SUVR than those without \u03b54 allele globally and in each region", "chunk": 4}
{"article": "PMC4519341.txt", "subject": "APOE \u03b54 allele", "relationship": "DIAGNOSTIC_OF", "object": "Diagnose: Prospective", "chunk": 4}
{"article": "PMC4519341.txt", "subject": "vA\u03b2 positive", "relationship": "INDICATES_PRESENCE_OF", "object": "higher global SUVR values, higher A\u03b2 SUVR values in each of the ROIs", "chunk": 4}
{"article": "PMC4519341.txt", "subject": "AGE", "relationship": "INDICATES_PRESENCE_OF", "object": "Trending to increase  A\u03b2 SUVR, although not significantly", "chunk": 4}
{"article": "PMC4519341.txt", "subject": "vA\u03b2 positive", "relationship": "RELATED_TREATMENT", "object": "Participants with positive vA\u03b2 declined in executive/speed at a rate that was 0.034 points/year greater than that of subjects with negative vA\u03b2", "chunk": 4}
{"article": "PMC4519341.txt", "subject": "higher A\u03b2 burden in the temporal region", "relationship": "RELATED_TREATMENT", "object": "associated with faster decline in speed (one unit increase in SUVR values was associated with 0.080 points/year faster decline)", "chunk": 4}
{"article": "PMC4519341.txt", "subject": "PET A\u03b2", "relationship": "RELATED_TREATMENT", "object": "associated with a larger amount of annual decline on mean cognition, language, and executive/speed scores in African-Americans but not in Whites", "chunk": 5}
{"article": "PMC4519341.txt", "subject": "PET A\u03b2", "relationship": "RELATED_TREATMENT", "object": "associated with a faster decline in memory in APOE \u03b54 carriers, but not in APOE \u03b54 negative subjects", "chunk": 5}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_TO_PROGNOSIS", "object": "faster decline in executive/speed", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_TO_PROGNOSIS", "object": "faster decline in language, speed, and mean cognitive scores", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_TO_PROGNOSIS", "object": "faster decline in verbal memory", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_TO_PROGNOSIS", "object": "faster decline in visual memory", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_TO_PROGNOSIS", "object": "steeper trajectories of semantic fluency", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_TO_PROGNOSIS", "object": "steeper trajectories of working memory", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_TO_PROGNOSIS", "object": "steeper trajectories of visuospatial ability", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "faster decline in executive/speed", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "faster decline in language, speed, and mean cognitive scores", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "faster decline in verbal memory", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "faster decline in visual memory", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "steeper trajectories of semantic fluency", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "steeper trajectories of working memory", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 deposition", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "steeper trajectories of visuospatial ability", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 SUVR", "relationship": "RELATED_TO_PROGNOSIS", "object": "faster decline in executive/speed scores", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2 SUVR", "relationship": "RELATED_TO_PROGNOSIS", "object": "faster decline in mean cognition", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "APOE \u03b54 allele", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Genetic risk factor for Alzheimer's Disease", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "APOE \u03b54 allele", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Risk factor for Alzheimer's Disease", "chunk": 6}
{"article": "PMC4519341.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive decline", "chunk": 7}
{"article": "PMC4519341.txt", "subject": "A\u03b2", "relationship": "ASSOCIATED_WITH", "object": "Accelerated decline in executive/speed function", "chunk": 7}
{"article": "PMC4519341.txt", "subject": "APOE genotype", "relationship": "RELATED_TO", "object": "Cognitive decline", "chunk": 7}
{"article": "PMC4526582.txt", "subject": "[18F]flutemetamol", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Treatment with flutemetamol (18F) injection", "chunk": 3}
{"article": "PMC4526582.txt", "subject": "[18F]flutemetamol", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC4526582.txt", "subject": "[18F]flutemetamol", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "INDICATES_PRESENCE_OF", "object": "mild cognitive impairment", "chunk": 1}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "RELATED_PROGNOSIS", "object": "progression of AD", "chunk": 1}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "assessing the effectiveness of purported AD treatments", "chunk": 1}
{"article": "PMC4529274.txt", "subject": "retinal thickness", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 2}
{"article": "PMC4529274.txt", "subject": "reduced retinal thickness", "relationship": "RELATED_PROGNOSIS", "object": "age-related processes, such as for instance supranuclear cataract and opacities of ocular lens", "chunk": 2}
{"article": "PMC4529274.txt", "subject": "reduced retinal thickness", "relationship": "RELATED_PROGNOSIS", "object": "pathological neural degeneration undoubtedly associated with mild cognitive impairment  and AD", "chunk": 2}
{"article": "PMC4529274.txt", "subject": "retinal thickness", "relationship": "MONITORED_DURING_TREATMENT", "object": "Progression from normal and abnormal age-related processes", "chunk": 2}
{"article": "PMC4529274.txt", "subject": "RNFL (retinal nerve fiber layer)", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "RELATED_PROGNOSIS", "object": "AD diagnosis", "chunk": 3}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "RELATED_PROGNOSIS", "object": "MMSE score", "chunk": 3}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Reduced RNFL in AD patients", "chunk": 3}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Significant association between RNFL thickness in superior and nasal quadrants, and MMSE score", "chunk": 3}
{"article": "PMC4529274.txt", "subject": "Retinal involvement", "relationship": "INDICATES_PRESENCE_OF", "object": "Early event in the course of Alzheimer's disease", "chunk": 3}
{"article": "PMC4529274.txt", "subject": "Enlarged optic cup to disc ratio", "relationship": "RELATED_TO", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC4529274.txt", "subject": "PERG (pattern electroretinography)", "relationship": "RELATED_TO", "object": "NFL overall values", "chunk": 3}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "RELATED_TO", "object": "Severity of AD", "chunk": 4}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "DIAGNOSTIC_OF", "object": "Differentiating AD from normal ageing", "chunk": 5}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "INDICATES_PRESENCE_OF", "object": "Degeneration of retinal ganglion cells", "chunk": 5}
{"article": "PMC4529274.txt", "subject": "RNFL thickness", "relationship": "RELATED_PROGNOSIS", "object": "Annual incidence of conversion to AD", "chunk": 5}
{"article": "PMC4529274.txt", "subject": "MRI measurements of the brain", "relationship": "RELATED_TO", "object": "Potential correlation", "chunk": 5}
{"article": "PMC4545875.txt", "subject": "Mini Mental State Examination (MMSE)", "relationship": "RELATED_PROGNOSIS", "object": "Disease Severity Classification (Mild, Moderate, Severe)", "chunk": 1}
{"article": "PMC4545875.txt", "subject": "PLI", "relationship": "RELATED_PROGNOSIS", "object": "decrease in functional connectivity is associated with increasing disease severity", "chunk": 3}
{"article": "PMC4545875.txt", "subject": "BC", "relationship": "RELATED_PROGNOSIS", "object": " increasing BC values in the global and anterior regions in the lower alpha band, in the global, anterior, and central regions in the upper alpha band, and in the anterior region in the beta band", "chunk": 3}
{"article": "PMC4545875.txt", "subject": "BC", "relationship": "RELATED_PROGNOSIS", "object": "decreasing BC values in the beta band in the posterior region", "chunk": 3}
{"article": "PMC4545875.txt", "subject": "center of mass of the BC values", "relationship": "RELATED_PROGNOSIS", "object": " back-to-front shifting of the center of mass from the posterior to the central regions, as indicated by the y-values, increased with increasing disease severity", "chunk": 3}
{"article": "PMC4545875.txt", "subject": "center of mass of the BC values", "relationship": "RELATED_PROGNOSIS", "object": "left-to-right shifting of the center of mass was significant only in the beta band indicating a shift to the right side of the brain in the most severely affected AD patients", "chunk": 3}
{"article": "PMC4562190.txt", "subject": "MMSE", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnose: Early cognitive impairment (includes mild cognitive impairment and Alzheimer's disease)", "chunk": 1}
{"article": "PMC4562190.txt", "subject": "MMSE", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Staging of Alzheimer's disease", "chunk": 1}
{"article": "PMC4562190.txt", "subject": "MoCA", "relationship": "RELATED_PROGNOSIS", "object": "Provides better sensitivity for detecting mild cognitive impairment and Alzheimer's disease compared to MMSE", "chunk": 1}
{"article": "PMC4562190.txt", "subject": "MoCA", "relationship": "RELATED_PROGNOSIS", "object": "Captures wide range of mild cognitive impairment cases with less ceiling effect compared to MMSE", "chunk": 1}
{"article": "PMC4562190.txt", "subject": "MoCA", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Can aid in the earlier diagnosis and management of Alzheimer's disease", "chunk": 1}
{"article": "PMC4562190.txt", "subject": "MoCA \u226517", "relationship": "DIAGNOSITC_OF", "object": "Mild cognitive impairment cases", "chunk": 1}
{"article": "PMC4562190.txt", "subject": "MoCA", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild Cognitive Impairment", "chunk": 2}
{"article": "PMC4562190.txt", "subject": "MMSE", "relationship": "DIAGNOSTIC_OF", "object": "AD dementia", "chunk": 2}
{"article": "PMC4562190.txt", "subject": "MMSE", "relationship": "DIAGNOSTIC_OF", "object": "Mild Cognitive Impairment", "chunk": 2}
{"article": "PMC4562190.txt", "subject": "MoCA", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Distinguishing Mild Cognitive Impairment cases from HC and AD Dementia", "chunk": 2}
{"article": "PMC4562190.txt", "subject": "MoCA", "relationship": "RELATED_TREATMENT", "object": "Functional scale evaluation", "chunk": 2}
{"article": "PMC4562190.txt", "subject": "MMSE", "relationship": "RELATED_TREATMENT", "object": "Functional scale evaluation", "chunk": 2}
{"article": "PMC4562190.txt", "subject": "MoCA domain subscores", "relationship": "RELATED_TREATMENT", "object": "Functional scale evaluation", "chunk": 2}
{"article": "PMC4562190.txt", "subject": "MMSE", "relationship": "DIAGNOSITC_OF", "object": "Dementia", "chunk": 3}
{"article": "PMC4562190.txt", "subject": "MoCA", "relationship": "DIAGNOSITC_OF", "object": "Dementia", "chunk": 3}
{"article": "PMC4562190.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Impairment level", "chunk": 3}
{"article": "PMC4562190.txt", "subject": "MoCA", "relationship": "RELATED_PROGNOSIS", "object": "Impairment level", "chunk": 3}
{"article": "PMC4562190.txt", "subject": "FAQ", "relationship": "INDICATES_PRESENCE_OF", "object": "Impaired function consistent with dementia", "chunk": 3}
{"article": "PMC4562190.txt", "subject": "MoCA", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment", "chunk": 4}
{"article": "PMC4562190.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment", "chunk": 4}
{"article": "PMC4562190.txt", "subject": "MoCA", "relationship": "DIAGNOSITC_OF", "object": "Mild cognitive impairment", "chunk": 4}
{"article": "PMC4562190.txt", "subject": "MoCA", "relationship": "RELATED_PROGNOSIS", "object": "Earlier detection of mild cognitive impairment", "chunk": 4}
{"article": "PMC4562190.txt", "subject": "MoCA", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Helps clinicians select appropriate treatment options", "chunk": 4}
{"article": "PMC4562190.txt", "subject": "MoCA score (\u226430)", "relationship": "INDICATES_PRESENCE_OF", "object": "Range of severity of mild cognitive impairment   patients", "chunk": 5}
{"article": "PMC4562190.txt", "subject": "MoCA cutoff value (\u226517 to 19)", "relationship": "INDICATES_PRESENCE_OF", "object": "mild cognitive impairment   cases", "chunk": 5}
{"article": "PMC4562190.txt", "subject": "MoCA score (<24)", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia cases", "chunk": 5}
{"article": "PMC4562190.txt", "subject": "MoCA score (\u226517)", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia cases", "chunk": 5}
